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Many developmental genes are located in gene-poor genomic regions and are 
activated by long-range enhancers located up to 1Mb away. Modification and 
reorganisation of chromatin structure is pivotal to such long-range gene regulation. A 
prerequisite for enhancer activity is the binding of transcription factors and co-factors 
with the interplay between activating and repressive factors determining tissue, 
spatial and temporal specificity. 
Spatiotemporal control of sonic hedgehog (Shh) and the 5′ Hoxd genes 
(especially Hoxd13) is crucial for vertebrate limb anterior-posterior (A-P) axis and 
autopod patterning. Shh tissue specificity is controlled by multiple enhancers 
throughout an adjacent gene desert. The ~0.8Mb-distant limb enhancer (ZRS) 
bypasses nearby genes to activate only Shh. In contrast, limb-specific HoxD 
expression is regulated by multiple enhancers, with the ~200kb-distant global control 
region (GCR) regulatory element the most characterised. In this thesis I investigated 
the mechanisms of ZRS and GCR regulation of Shh and Hoxd13 respectively. The 
model system used was immortalised cell lines derived from the anterior and 
posterior distal forelimb buds of E10.5 and E11.5 mouse embryos. Cell line data 
were confirmed in dissected limb tissue. 
Increased expression of the 5′ Hoxd genes, particularly Hoxd13, correlated 
with the loss of the repressive, polycomb catalysed, histone modification H3K27me3 
and decompaction of chromatin structure over the HoxD locus at the distal posterior 
forelimb bud at stage E10.5. Moreover, I show that the GCR spatially co-localises 
with the 5′ HoxD locus at the distal posterior region of E10.5-11 embryos. These 
data are consistent with the formation of a chromatin loop between Hoxd13 and the 
GCR at the time and place of distal limb bud development when the GCR is required 
to initiate 5′ Hoxd gene expression. This is the first example of A-P differences in 
chromatin compaction and local folding in the limb. 
Point mutations within the ZRS cause ectopic (anterior) Shh expression, 
which results in preaxial polydactyly (PPD). The ZRS contains multiple canonical 
ETS transcription factor binding motifs, and point mutations in two families with 
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PPD results in the formation of additional ETS binding sites. The point mutations 
cause the loss or reduction of ETV4/5 transcription factor binding at a non-canonical 
ETS binding site and enable additional binding instead of ETS1. I show that ETV4/5, 
ETS1 and another ETS protein GABP all bind to the ZRS. This work has revealed 
the differential effect on Shh expression of two groups of ETS factors mediated 
through the ZRS. The binding of ETS1/ GABP determines the posterior Shh 
expression domain while ETV4/5 restricts anterior Shh expression. Two point 
mutations alter the ETS-binding profile, creating an additional ETS1/ GABP site 
that is sufficient to drive ectopic Shh expression.  
DNA FISH on E11.5 forelimb and floorplate tissue sections revealed that the 
Shh-ZRS genomic locus is in a compact chromatin conformation in both Shh-
expressing and non-expressing cells. However, I show that the ZRS co-localises with 
Shh to a significantly greater extent in the distal posterior limb bud and the floorplate 
compared with cells where Shh is not expressed. 
This thesis presents novel research into long-range gene regulation during limb 
development, elucidating the role of chromatin re-organisation and how spatial-
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From the characterisation of the operon in E. coli (Jacob and Monod, 1961) through 
Drosophila and then mouse genetics – in tandem with human Mendelian disease 
genetics – the crucial role of non-coding cis-regulatory regions in directing gene 
expression has become apparent. Over the last decade, due to the rapidly increasing 
capabilities of genomic research, the identification of potential cis-regulatory regions 
has escalated; however, many of these proposed regulatory regions await functional 
characterisation. Multi-species conservation of not only coding, but also non-coding, 
genomic regions has overturned the view of the latter as being largely composed of 
just non-functional DNA sequences accumulated over evolutionary time. And as 
advances in the genomics field gather pace, in harness with biochemical and 
molecular biology techniques that enable more extensive (genome-wide) and in-
depth (high resolution) analysis, it is becoming increasingly clear that a substantial 
proportion of the non-coding genome is required to control gene activity. 
As well as reviewing the literature on cis regulation in general, and enhancers 
in particular, this introduction will also cover the two main themes of my project. (1) 
the role of chromatin in regulating gene activity; and (2) how enhancers are regulated 
– that is, how trans factors that bind to regulatory sequences form functional 
nucleoprotein complexes. My project focuses on long-range gene regulation in the 
mouse; almost exclusively on limb bud development and two regulatory regions 
spanning up to a megabase (Mb) in size that contain multiple cis-regulatory 
sequences controlling the key developmental genes Sonic hedgehog (Shh) and the 
HoxD cluster. Therefore, I will discuss the gene networks involved in the growth and 
patterning of the vertebrate limb, emphasising the importance of maintaining tight 







1.1 Chromatin structure and nuclear organisation: how modification 
and conformation impinge upon transcription 
The mammalian genome is over three billion DNA base pairs in size (about two 
metres in length) and is contained within a nucleus about six micrometres (m) in 
diameter. In all eukaryotes DNA is intricately bound up with an extensive suite of 
chromatin proteins with a wide range of functions. The assembly of long DNA 
chains into chromatin serves not only for compaction but also to protect the DNA 
from physical and chemical damage and as a platform for DNA metabolism; 
including transcription. Here, I concentrate on aspects of chromatin composition and 
organisation that influence gene activity; first, how manipulation of chromatin 
structure determines whether specific genomic regions have an active or repressed 
configuration as it pertains to transcription; second, the three dimensional 
architecture of chromatin within the nucleus, and how reorganisation of higher-order 
structure enables activation or repression of transcription within localised regions or 
over long distances.    
 
1.1.1 Transcriptional status of genomic loci determined by nucleosome 
dynamics, chromatin modification, and bound protein factors and co-factors 
1.1.1.1 Nucleosome dynamics 
The basic unit of chromatin is the nucleosome, composed of ~147 base pairs (bp) of 
DNA wrapped around an octamer of histone proteins and results in the ‘beads-on-a-
string’ 10 nm chromatin fibre (20-50bp of linker DNA joins each nucleosome). Four 
histone proteins, H2A, H2B, H3 and H4 comprise the core histone octamer: a H3:H4 
tetramer and two H2A:H2B dimers. N terminal “tails” of core histones project out 
from the nucleosome and are susceptible to post-translational modification. The 
nucleosome creates a physical barrier that the factors involved in transcription, 
replication and DNA repair have to overcome. Incorporation of histone variants (e.g. 
H2A.Z and H3.3) generally result in more labile nucleosomes and frequently occur at 
regulatory sites, such as promoters and enhancers, thereby easing their removal to 
facilitate transcription factor/ co-factor binding (Jin et al., 2009).  
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A study that mapped potential enhancer locations in the human genome 
(binding of androgen receptor to predominantly distal regulatory sites induced by 
treatment of cancer cells with androgen) identified nucleosome removal at androgen 
receptor and FOXA1 binding sites while the neighbouring nucleosomes were marked 
by mono- and dimethylation of the H3 tail at lysine four (H3K4me1/2) (He et al., 
2010). This histone mark is characteristic of enhancers (see below). The evicted 
central nucleosome was more likely to contain the H2A.Z variant and the underlying 
genomic sequence was more highly conserved than the sequences of the flanking 
nucleosomes and was A/T and AA/TT/TA/AT dinucleotide rich. Previous work had 
observed that whereas nucleosome-enriched genomic regions contain high levels of 
C/G and GC dinucleotides, the opposite is true for nucleosome-depleted regions, 
which are AT-rich (Peckham et al., 2007; Yuan & Liu, 2008). Therefore, a 
combination of transcription factor binding, core histone composition and DNA 
sequence can determine nucleosome stability; with regulatory elements 
characteristically nucleosome-depleted, H2A.Z-enriched, and marked by histone 
modifications associated with an active chromatin state. 
1.1.1.2 Histone modification marks associated with active, repressed and 
silent loci 
Histones are subject to an extensive suite of post-translational modifications at 
various amino acid residues within the globular core but particularly throughout their 
N and C terminal “tails” (Fig. 1.1). Residues can be acetylated (lysine, K), 
methylated (K and arginine, R) phosphorylated (serine, S, and threonine, T), 
ubiquitylated (K), sumoylated (K), deiminated (R), or undergo isomerization 
(proline, P-cis > P-trans) (Bannister & Kouzarides 2011). Whereas acetylation of H3 
and H4 residues is exclusively associated with more open, decondensed chromatin, 
modifications such as methylation and ubiquitination are present in both active and 
repressed genomic regions, depending on the residue modified and/or, in the case of 
methylation, the number of covalently bound groups at a specific residue. Before 
describing in more depth the active and repressive marks (and the enzymes 
responsible) found at promoters and enhancers, I will briefly discuss the concepts of 




Figure 1.1. Modifications to residues on histone tails. Locations within the histone “tails” 
of residues that undergo post-translational modification are identified. Amino acid residues: 
K, lysine; R, arginine; S, serine; T, threonine. Histone modifications: me, methylation; ph, 













Heterochromatin can describe either permanently compacted pericentric and 
telomeric chromosome regions (constitutive), or densely compacted chromatin at 
genomic regions in certain tissues or at varying stages in differentiation and 
development (facultative). In the mouse, constitutive heterochromatin is associated 
with repetitive DNA such as tandem satellite repeats and has characteristic histone 
modifications such as tri-methylation of lysines 9 and 20 of H3 (H3K9me3, 
H4K20me3) (Martens et al. 2005). Interspersed repeats and transposons (LINEs, 
SINEs) have more variable associations with different degrees of H3K9, H3K20 and 
H3K27 methylation dependent on the cell differentiation state. A classic example of 
facultative heterochromatin is the inactive X chromosome (XCI) in which the long 
non-coding RNA (lncRNA) Xist recruits the polycomb complex PRC2 (I discuss 
polycomb more extensively in sections 1.1.1.4-1.1.1.7), resulting in the silenced X 
chromosome being covered by the PRC2-catalysed H3K27me3 (Mak et al., 2004; 
Okamoto et al., 2004). 
Euchromatic domains are generally described as “open” and are often more 
gene-rich, compared to consitutive heterochromatin. Multiple acetylation of lysine 
residues of H3 and H4 is a feature of chromatin structure over transcriptionally active 
genes and regulatory elements (Kuo et al. 1998), and the recruitment of histone 
acetyl transferases (HATs) by transcription factors bound to promoters and 
enhancers is well established (Bannister & Kouzarides, 1996; Mizzen et al., 1996; 
Ogryzko et al., 1996; Chen et al., 1997; Kouzarides, 2007).  However, histone 
deacetylases (HDACs) – enzymes frequently identified at facultative 
heterochromatin – have been found on active genes (Wang et al. 2009).  
Methylation of K4 on H3 is associated with active or poised regulatory 
elements (Zhou et al. 2010).  H3K4me2/3 are found at active gene promoters with 
generally lower more widespread levels of the mono-methyl mark, and in addition 
H3K4me3 is also found at the promoters of bivalently marked genes (section 
1.1.1.6). Mono- and di-methylation of H3K4 mark distal regulatory elements, 
although the tri-methyl modification has been identified at enhancers also (section 
1.1.1.3). The histone methyltransferase (HMTase) responsible for most H3K4me3 is 
Set1 of the COMPASS (COMplex Proteins ASsociated with Set1) complex 
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(Ardehali et al. 2011) though the MLL family of HMTases also bring about 
H3K4me3 at specific target genes, with MLL1/2 responsible for modifying Hox 
promoters (Milne et al., 2002; Ernst et al., 2004; Wang et al., 2009). Drosophila 
studies suggest that the continuous presence of H3K4 methylases at gene promoters 
is required to maintain expression, and that the H3K4me3 mark is either not 
maintained following their removal or is insufficient on its own to maintain 
transcription (Ingham, 1985; Klymenko & Mullert, 2004). The role of the 
modification itself is likely to be as a marker recognised by chromatin modifying 
enzymes and other factors required to facilitate RNA polymerase II (RNAPII) 
binding to the DNA (Eissenberg & Shilatifard, 2010). 
1.1.1.3 Histone modifications associated with enhancers 
Histone modification patterns at enhancers are highly cell type-specific (Heintzman 
et al., 2009). Analysis of 30Mb of the human genome (selected by the ENCODE 
project), in immortalised human HeLa cells, by chromatin immunoprecipitation 
(ChIP) on arrays (ChIP-chip) identified H3K4me1 but not H4K3me3 as being 
associated with putative enhancer sites (Heintzman et al., 2007); that is, the mono-
methylated mark was present at the same distal loci as the transcriptional activator 
and acetyltransferase p300 (Eckner et al., 1994; Merika et al., 1998; Maston et al., 
2006). These results agreed with the initial ENCODE study based on multiple human 
cell lines (Birney et al., 2007); however, ChIP-seq analysis on human T-cells 
suggested that both H3K4me1 and H3K4me3 are enriched at putative enhancers 
(Barski et al., 2007; Wang et al., 2008). To resolve this discrepancy and establish if 
these histone modifications can distinguish enhancers from active promoters, 
Robertson et al. (2008) identified DNA-binding sites for two transcription factors 
that bind predominantly at distal regulatory elements: STAT1 in unstimulated and 
IFNstimulated HeLa cells, and Foxa2 in mouse adult liver. H3K4me1 was the 
dominant modification at distal regulatory elements, but a sizeable proportion of 
these distal sites had both H3K4 methylation marks. The authors suggest that this 
discrepancy may either be due to different modifications associating with 
functionally different transcription factors at distal elements or that the variation 
stems from different tissues or cellular states. In human T cell differentiation 
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H3K4me1 was shown to be associated with enhancers whether active or not, while 
increased H3K4me3 correlated with RNAPII occupancy of enhancers and greater 
regulatory activity (Pekowska et al., 2011).  
Whereas the methylases responsible for H3K4me3 are well defined 
(Eissenberg & Shilatifard, 2010), HMTases that specifically catalyse H3K4me1 are 
not known; although COMPASS is capable of mono- di- and tri-methylation of 
H3K4 in yeast (Wood et al., 2007). In contrast, demethylation of H3K4me1 and 
H3K4me3 is catalysed by different demethylases. The JARID1 family have been 
identified as specific demethylases of H3K4me2/3, and the JARID1 RBP2 enzyme is 
associated with repressed Hox genes in undifferentiated ES cells (Christensen et al., 
2007; Iwase et al., 2007; Lee et al., 2007). The lysine-specific LSD1 was the first 
demethylase to be characterised (Shi & Whetstine, 2007). LSD1 demethylates H3K4 
and K9 mono- or di-methyl marks but is unable to remove the tri-methyl 
modification. A recent study implicates LSD1 in silencing enhancers of genes that 
maintain mouse ES cell pluripotency during differentiation and following the loss of 
Pou5f1 binding. LSD1 is not essential for maintaining ES cells in an undifferentiated 
state (Whyte et al., 2012).  
Acetylation of H3K27 (H3K27ac) – a mark that can be deposited by the p300 
and CBP acetyltransferases (Tie et al., 2009) – is prevalent at the transcription start 
sites (TSS) of active genes in mammalian cells (Wang et al., 2008), but can also 
identify active enhancers (Rada-Iglesias et al., 2010; Creyghton et al., 2010). 
Whereas enhancers active in human embryonic stem cells (hESCs) are marked not 
only by H3K4me1 but also H3K27ac, enhancers that activate genes involved in early 
embryogenesis – “poised enhancers” – are distinguished by a lack of H3K27ac and 
enrichment of the repressive H3K27me3 mark (Rada-Iglesias et al., 2010). A subset 
of poised enhancers acquires H3K27ac during neuronal differentiation. This also 
suggests a role for H3K27me3 in regulating enhancer activity, at least in ES cells.     
1.1.1.4 The polycomb repressive complexes  
H3K27me3 correlates with gene repression in development and is mediated by the 
polycomb repressive complex 2 (PRC2) (Fig. 1.2). Originally identified in 
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Drosophila, the PRC2 complex co-operates with the PRC1 (Fig. 1.2) complex to 
maintain gene-silencing. PRC2 tri-methylates H3K27 (Cao et al., 2002) through the 
Ezh methyltransferase component of the complex, a function conserved from 
mammals (Ezh2 and Ezh1 (Shen et al., 2008)) to flies (in Drosophila the homologue 
is E(Z) (Czermin et al., 2002)). Ezh2-catalysed H3K27me3 can be bound by the 
second polycomb complex, PRC1, through the chromodomain of the polycomb 
protein homologues (Cbxs in mammals) that specifically recognise H3K27me3 (Cao 
et al., 2002). The functions and target specificity of the different Cbx paralogues is 
not fully understood, but Cbx7 seems to be the main polycomb homologue important 
in pluripotent ES cells (Morey et al., 2012). Moreover, PRC1, in a complex with 
RYBP, can bind to target sites, albeit at generally low levels, in PRC2-deficient 
mouse ES cells, therefore revealing a H3K27me3-independent PRC1 recruitment 
pathway (Tavares et al., 2012). PRC1 can also be recruited to the inactive X in the 
absence of PRC2 (Schoeftner et al., 2006).  
PRC1 can ubiquitinate H2A at lysine 119 (uH2A) through the E3 ligase 
activity of Ring1A/1B (de Napoles et al. 2004) (Wang et al. 2004) (Buchwald et al. 
2006). Ring1B is the predominant ubiquitin E3 ligase during differentiation and early 
development;  loss of the Ring1B results in an extensive depletion of uH2A whereas 
the loss of uH2A is minimal in the absence of the Ring1A (de Napoles et al., 2004). 
The relative importance of the two mammalian Ring proteins in early development 
was demonstrated by Ring1A knockout mice being viable with only minor skeletal 
defects, while loss of Ring1B results in embryonic lethality (Lorente et al., 2000; 
Voncken et al., 2003). 
1.1.1.5 Targets and targeting of polycomb 
Mouse embryos lacking Eed, Ezh2 or Suz12 either fail to develop following 
implantation or complete gastrulation (Faust et al., 1995; O’Carroll et al., 2001; 
Pasini et al., 2004). Extensive H3K27me3 profiles have been determined for both 
human and mouse ES cells (Mikkelsen et al., 2007; Pan et al., 2007; Ku et al., 2008). 
Several studies into the role of polycomb in mammalian development have 
established the involvement of both PRC2 and PRC1 in maintaining ES cell 





Figure 1.2. Components of the mammalian polycomb response complexes. PRC2 
complexes contain four core elements: the catalytic subunit EZH2, Su(z)12, EED and 
nucleosome remodelling factor RbAp46/48. In PRC1 complexes the core components are: 















genes (Azuara et al., 2006; Boyer et al., 2006; Lee et al., Jorgensen et al., 2006; 
Stock et al., 2007; Endoh et al., 2008) and also during the terminal differentiation of 
multipotent cells in embryogenesis (Caretti et al., 2004). PRC2 occupies large 
repressed domains containing genes encoding developmental regulators in human ES 
cells (Lee et al., 2006). In murine ES cells, removal of the PRC2 component Eed 
results in the loss of PRC1, and H3K27me3 and derepression of polycomb-target 
genes (Boyer et al., 2006).  
Unlike in flies, where polycomb response elements (PREs) have been widely 
characterised (Ringrose & Paro, 2007), specific mammalian PRE complexes – with a 
couple of exceptions (Sing et al., 2009; Woo et al., 2010) – have yet to be identified. 
However, several studies noted that polycomb targets tended to correlate with the 
presence of CpG islands (Ku et al., 2008; Mohn et al., 2008). Moreover, using 
murine ES cells engineered to contain modified bacterial artificial chromosomes and 
novel CpG island–like sequences, free of active motifs, inactive GC-rich genomic 
sequences were shown to be sufficient to recruit PRC2 (Mendenhall et al., 2010). 
Taking this analysis further, a recent study showed that bivalent chromatin regions in 
ES cells (containing both H3K27me3 and H3K4me3) result from the competition 
between polycomb recruitment and transcriptional activation at non-methylated CpG 
islands (Lynch et al., 2011). Using a humanised mouse model, the authors show that 
the extensive recruitment of polycomb complexes and chromatin bivalency at the 
human CpG island-containing -globin locus  is due to cis-acting sequences, as a 
4kb region of the human locus can establish a novel bivalent domain when inserted 
into the mouse locus - which lacks CpG islands.  
Further means of recruiting PRC2 invoke the activity of lncRNAs – both in 
cis (Xist in X chromosome inactivation (Zhao et al., 2008)) and in trans (HOTAIR in 
repression of HOXD (Rinn et al., 2007)).  Moreover, many small RNAs have been 
co-purified with PRC2 (Kanhere et al., 2010; Zhao et al., 2010; Kotake et al., 2011). 
1.1.1.6 Bivalent chromatin domains  
In ES cells polycomb-marked (H3K27me3) domains are pervasively marked with 
both H3K4me3 and H3K27me3 – not only in and around promoter regions but 
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throughout the genomic regions in which they are situated. Initially characterised at 
highly conserved noncoding elements (HCNEs) predominantly associated with genes 
active in development in mouse ES cells (Bernstein et al., 2006; Azuara et al., 2006), 
these “bivalent” modifications were subsequently identified genome-wide at 
developmental genes in both mouse (Mikkelsen et al., 2007) and humans ES cells 
(Pan et al., 2007). Many of the bivalent genes identified in the latter study are 
upregulated early on in differentiation and are therefore described as being in a 
“poised” state. Further genome-wide analysis in human T-cells demonstrated that 
this bivalency is not unique to ES cells (Roh et al., 2006). Loss of H3K4me3, 
through mutation of the DPY-30 component of COMPASS, does not affect 
undifferentiated ES cell renewal but is detrimental to differentiation – suggesting that 
H3K4me3 at bivalent genes is required for their upregulation during early 
development (Jiang et al., 2011).  
1.1.1.7 Polycomb and mechanisms of transcriptional repression  
The mechanisms by which polycomb-repressive complexes repress their target genes 
has still to be fully elucidated, but it appears to be at a step downstream of 
transcription initiation. The C-terminal domain (CTD) of the largest RNAPII subunit, 
RPB1, contains multiples of the same heptapeptide consensus sequence with three 
serine residues (Ser) phosphorylated at various stages of the RNAPII cycle. RNAPII 
is recruited to TSSs in a hypophosphorylated form and its release from the gene 
promoter is dependent upon phosphorylation of Ser 5 (S5p) by TFIIH. 
Phosphorylation of S5 correlates with transcription initiation, capping of the 5′ end of 
the nascent RNA and histone methyl transferase (HMT) recruitment. If not aborted, 
RNAPII-S5p reaches an intrinsic pausing site and requires phosphorylation of Ser 2 
(S2p) by the P-TEFb kinase for productive elongation. Phosphorylation of Ser 7 
(S7p) is present at the promoter and exons of active genes and is associated with both 
S5p and S2p (Brookes & Pombo, 2009). ChIP has revealed that RNAPII is present at 
the ‘silent’ polycomb targets in ES cells, but that this polymerase is in an unusual 
form (Stock et al. 2007). The presence of S5p, and absence of S2p, suggests that the 
polymerase is in a form that can initiate transcription, but that cannot elongate. Co-
occupation of RNAPII-S5p, in this poised configuration, and PRC1 at bivalent genes 
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in murine ES cells has been elucidated (Stock et al., 2007).  The poised configuration 
is unusual in that although S2p is absent, RNAPII cannot be detected by the 8WG16 
antibody that specifically recognizes non-phosphorylated S2 residues, indicating that 
the residues are inaccessible due to another CTD modification or conformational 
change (Brookes & Pombo, 2009). Loss of PRC1 and H2Aub1 releases this poised 
RNAPII to allow expression of the target genes. Genome-wide, PRC and RNAPII-
S5p simultaneously co-occupy both promoters and coding regions of silenced 
developmental genes in murine ES cells, which results in transcripts that fail to 
mature into mRNA (Brookes et al., 2012).  
 
1.1.2 Higher-order chromatin structure and the regulation of transcription 
Chromatin is composed of DNA and proteins in an approximately 1:2 ratio by mass 
(Lee & Young, 2000). At the gross nuclear level of interphase cells there are two 
types of chromatin packaging: tightly wound condensed heterochromatin and the 
relatively open structure of euchromatin. Chromatin organisation above the 10 nm 
fibre level is not well defined. Evidence for a 30 nm fibre largely comes from in vitro 
assays on pure polynucleosomes (Fussner et al., 2011).  In vivo, the linker histone 
H1 has been implicated in the formation of 30 nm fibres (Allan et al., 1981; Bates et 
al., 1981) and is particularly prevalent in heterochromatin and depleted in ES cells 
(Fan et al., 2003; Fan et al. 2005). Indeed, downregulation of H1 in Drosophila 
causes heterochromatin dispersal (Lu et al., 2009), and observation by electron 
microscopy (e.m.) of polynucleosomes (20-40) from wild type and H1 knockout 
mouse ES cells indicated that reduced H1:nucleosome  stoichiometry results in 
chromatin decondensation in mammals (Fan et al., 2005). Although in vivo 
observation by e.m. of structured 30 nm fibres has been rare (Fussner et al. 2011), 
regions of densely compacted chromatin can be detected by cytological analysis; and 
have been confirmed by biophysical fractionation of chromatin (Gilbert et al., 2004; 
Ghirlando & Felsenfeld, 2008). Analysis of the fractionated chromatin suggests that 
heterochromatin structure is heterogenous and that compact chromatin fibres are also 
located in euchromatin. Moreover, although open chromatin fibres are prevalent in 
gene-rich regions, there is no correlation of open chromatin structure and gene 
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expression. Rather, an open chromatin configuration implies a sub-nuclear 
environment conducive to gene transcription dependent upon the presence of the 
correct activating factors. 
FISH was used to confirm the biophysical data in Gilbert et al. (2004). 
Squared interprobe distances (d
2
) between two FISH probes have a linear 
relationship to the genomic distance that separates them (van den Engh et al., 1992) 
and can be used to compare chromatin compaction between different regions in the 
same cell type (Yokota et al., 1997), at the same locus between cells at different 
stages of differentiation (Chambeyron & Bickmore, 2004), or at the same locus in 
different tissues during embryogenesis (Morey et al., 2007). Structural properties of 
interphase chromosomes over intermediate (> 0.1-< 1.5 Mbp) and large (2-200 Mbp) 
scales can be ascertained by calculating statistical ratios of standard deviation/mean 
and median/mean from interprobe distance data sets. Ratios approximate to ~0.52 - 
~0.94 describe a random walk path – in other words chromatin structure at the region 
being measured is flexible and in a random configuration (Sachs et al., 1995).   
1.1.2.1 Nuclear location and re-location from chromosome territories 
correlates with expression state of some genes 
Various applications of FISH, to locate whole chromosomes or specific loci within 
the interphase nucleus, have been employed to characterise nuclear organisation and 
higher-order chromatin structure. Interphase chromosomes inhabit discrete 
chromosome territories (CTs), with relatively gene-rich chromosomes generally 
located near the centre of the nucleus while more gene-poor chromosomes locate 
towards the periphery (Boyle et al., 2001). When inactive, the -globin locus is 
associated with centromeric heterochromatin at the nuclear periphery. During 
successive stages of erythroid differentiation there is progressive re-location of the 
locus to the nuclear centre with a corresponding upregulation of gene transcription 
(Ragoczy et al., 2006). Activation of -globin occurs upon movement away from the 
heterochromatic region but still within the nuclear periphery, albeit at levels 
relatively lower than subsequent expression upon re-location to the centre. 
Furthermore, upregulation was shown to involve association of the -globin genes 
with RNAP II foci that is dependent on a group of distal regulatory elements known 
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as the locus control region (LCR).  Artificial tethering of genes to nuclear membrane 
structures can reduce the transcriptional efficiency of some but not all, confirming 
that the nuclear periphery is not incompatible with gene expression (Finlan et al., 
2008; Kumaran & Spector, 2008; Reddy et al., 2008).  
Relocation of chromatin fibres associated with co-ordinately expressed gene 
clusters to the periphery or even the outside of visible CTs often correlates with their 
activation, (Volpi et al., 2000; Mahy et al., 2002b). The murine and human -globin 
loci loop out of their CTs in proerythroblast cells prior to their activation (Ragoczy et 
al., 2003), providing evidence that looping out from the CT can reflect poised and 
even repressed states as well as active states. This re-localisation depends on the 
LCR. However, a contradictory study reported that in mouse spleen cells and human 
erythroblasts the -globin locus mostly remained within the CT at various stages of 
differentiation, including the stages of maximum expression and those immediately 
preceding (poised state) (Brown et al., 2006).  In an elegant experiment to determine 
the relative importance of LCR activity and its correlation with chromatin 
decondensation, spread of histone modification marks,  locus repositioning away 
from the CT, association with RNAPII foci and gene activation by long-range 
regulation through chromatin loops, the human -globin LCR was inserted into a 
gene-rich region of the mouse genome (Noordermeer et al., 2008). The human LCR 
strongly increased the frequency of this locus being re-located outside its CT, 
however, upregulation of gene transcription was more dependent on orientation of 
the LCR and its ability to interact with specific genes – i.e. through enhancer activity 
from long-range chromatin loops (discussed further in Section 1.2.4). And the re-
location of the Hoxb cluster outside of its chromosome territory during ES cell 
differentiation has no effect on the expression levels of neighbouring genes (Morey 
et al., 2009). An oligonucleotide pool generated to recognise the complete exome of 
murine chromosome 2 (MMU2) by FISH revealed that the coding sequences are 
contained within decondensed chromatin regions away from the periphery-located 
CT core and towards the nuclear interior in ES cells (Boyle et al., 2011). Localised 
chromatin conformation, then, is more crucial in creating the conditions required for 
transcription to occur than nuclear position or re-location from CTs, as gene 
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expression also occurs within the territories (Mahy et al., 2002a) – which shows that 
the transcriptional machinery can access internal genes. 
1.1.2.2 Long-range chromatin interactions demarcate chromosome sub-
compartments  
Chromatin loops, distinct from the mechanism by which chromatin fibres project out 
of the CT, are structures that result from long-range interactions in cis. Interactions 
within chromosomes from tens of kilobases to over megabase scales have been 
detected using techniques such as chromatin conformation capture (3C) and its 
derivatives, and FISH. The Hi-C adaptation couples the capture of sheared 
biotinylated 3C products by streptavidin beads with massively parallel sequencing to 
allow genome-wide probing of three-dimensional architecture. Long-range cis 
interactions across human p and q chromosome arms can be detected by Hi-C, 
whereas contacts across the centromere are limited (Lieberman-Aiden et al., 2009). 
This data corresponds with FISH analysis that shows p and q arms occupying mostly 
distinct, non-overlapping territories (Dostie & Bickmore, 2012). Hi-C contact maps 
of human and Drosophila chromosomes reveal that active and inactive domains 
generally segregate. Inactive domains tend to remain within CTs whereas active 
domains are less compact, locate to CT peripheries, and are more likely to form 
interchromosomal contacts with other active regions (Lieberman-Aiden et al., 2009; 
Yaffe & Tanay, 2011; Sexton et al., 2012). Hi-C allows the spatial organisation of 
entire genomes to be probed; however, DNA sequencing cost and depth limits the 
resolution scale to about 1 Mb (Dostie & Bickmore, 2012). Domains with a high 
gene density and an open chromatin configuration or high levels of transcription can 
also be detected together by 4C (Simonis et al., 2006), which has also been used to 
reveal specific enhancer-promoter interactions (Montavon et al., 2011). 
In Drosophila, 4C and FISH assays demonstrated that polycomb-bound chromatin 
domains within the same chromosome arm co-localise in nuclear space, therefore 
implicating polycomb proteins as facilitators of long-range interactions (of polycomb 
targets) in cis (Bantignies et al., 2011). Restriction of contacts between polycomb-
bound domains to discrete chromosome arms are imposed by the centromere; a 
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percentric inversion enabled contacts to be made between polycomb targets normally 
located on separate arms (Tolhuis et al., 2011).      
1.1.3 Chromatin modification and higher-order reorganisation are involved in 
regulation of the Hox clusters  
There are four mammalian Hox clusters which encode homeobox transcription 
factors with crucial roles in anterior-posterior (A-P) patterning of the main 
embryonic body axis (Fig.1.3). They show the property of colinearity: their 
activation occurs in a tight spatial and temporal manner from the 3′ to 5′ ends of the 
clusters corresponding to anterior to progressively more posterior expression 
domains across the main body axis (Kmita & Duboule, 2003). Two of the 
mammalian Hox clusters – A and D – are also involved in limb and genital 
development (Deschamps, 2007). 
 Hox are classic polycomb targets – from flies to mammals – coated by 
H3K27me3 in ES cells and upregulated in polycomb mutants (Azuara et al. 2006; 
Boyer et al. 2006; Jørgensen et al. 2006; Lee et al. 2006; Endoh et al. 2008).  Upon 
differentiation of murine ES cells H3K27me3 is progressively lost from the HoxB 
and HoxD clusters from the 3′ to the 5′ direction in each loci – i.e. from the earliest 
activated genes to the progressively later activated genes (Eskeland et al., 2010) (Fig. 
1.4A). A similar polar loss of H3K27me3 is seen during embryogenesis (Soshnikova 
& Duboule 2009). As the progressively more 5′ Hoxd genes are being expressed in 
the developing tail bud region of stages E8.5 to E9.5 embryos, H3K27me3 is lost as 
the genes become highly marked with H3K4me3. Furthermore, the 3′ genes become 
enriched for H3K27me3 as they are being switched off. Both these studies highlight 
the crucial role played by the modifying complexes – polycomb for H3K27me3 and 
Set1/MLL for H3K4me3 – that lay down these histone marks in Hox regulation. 
1.1.3.1 Polycomb complexes determine Hox chromatin conformation and 
consequent gene repression  
Several studies also implicate polycomb in the regulation of higher-order chromatin 
compaction in Drosophila (Marchetti, 2003; Francis et al., 2004). In ES cells the 
silent Hox clusters are maintained in a compact chromatin state (Chambeyron & 
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Bickmore, 2004), that then unfolds upon the activation of Hox clusters – upon ES 
cell differentiation (Chambeyron & Bickmore, 2004; Morey et al., 2007) (Fig. 1.4B). 
There is also a looping out from the CT as the genes become expressed. These levels 
of chromatin and nuclear organisation are recapitulated during embryogenesis 
(Chambeyron & Bickmore, 2004; Morey et al., 2007). However, by looking at 
chromatin compaction and CT organisation simultaneously using 4 colour FISH, 
Morey et al. (2007) also detected decompaction at HoxD loci still located within in 
their CTs during ES cell differentiation. These results show that although nuclear 
reorganisation and chromatin decompaction are conserved mechanisms involved in 
Hox activation, they are not one and the same process; and provide further evidence 
for decondensation rather than looping out of CTs as being more indicative of an 
active chromatin state.  
The compact chromatin conformation at Hox loci in ES cells is mediated by 
the polycomb complexes (Eskeland et al., 2010). In Ring1B
-/-
 ES cells both the HoxB 
and HoxD loci decompact and there is an upregulation of gene expression, whereas 
in Ring1B
+/-
 ES cells both clusters are in a more decompact state but gene expression 
is not significantly increased (Eskeland et al., 2010). Chromatin unfolding, then, is a 
direct result of a reduction in Ring1B levels and is not a consequence of gene 
transcription. The addition of full length wild type (WT) Ring1B or a catalytically 
inactive version into Ring1B
-/-
 ES cells specifically rescued chromatin compaction at 
the Hox loci (Eskeland et al., 2010). This paper has unravelled the key functional 
role of polycomb in Hox gene regulation and demonstrated causation between 
polycomb-binding, chromatin conformation and gene repression, and has shown that 
Ring1B can repress gene expression through chromatin compaction independent of 





       
Figure 1.3. Hox expresssion domains and genomic organisation. Top left panel 
indicates the expression domains of Hox genes across the anterior-posterior (A-P) axis 
(anterior to the left) of Drosophila melanogaster embryos and top right panel indicates the 
domains across the mouse embryo. Below is a schematic representing the 3′ to 5′ sequence 
of Hox genes in flies and mammals, which have four clusters (A, B, C and D) with 
overlapping  expression domains across the A-P axis. Colour coding across the embryos 
correspond to the different groups of genes, 3′ genes expressed in anterior regions and 5′ 
progressively more posterior. (Md, mandibular; Mx, maxillary; Lb, labial; T1–T3, thoracic 
segments; A1–A9, abdominal segments; R1, R4, R7, hindbrain rhombomeres.) (Adapted 









Figure 1.4. Loss of the polycomb-catalysed modification H3K27me3 and chromatin 
decompaction upon differentiation at the HoxB locus in ES cells. A, In pluripotent ES 
cells the Hoxb genes are silent and the cluster in covered with the repressive chromatin 
mark H3K27me3, as shown on these UCSC browser tracks from ChIP-chip data. 
Differentiation down the neuronal pathway results in the progressive 3′ to 5′ loss of the 
polycomb-catalysed modification, correlating with the order of Hoxb expression. B, 2D FISH 
analysis of the HoxB locus reveals a decompaction of chromatin structure over the locus 
corresponding to the loss of H3K27me3 upon differentiation of ES cells. There was no 
change in compaction at a control region on the same chromosome. (Adapted from 

















1.2 Long-range cis regulation: spatial, temporal and tissue-specific 
control of transcription by regulatory elements 
Over forty years ago (Britten & Davidson, 1969) theorised that the orders-of-
magnitude differences in genome size from viruses to mammals could in large part 
be explained by the proliferation of regulatory sequences that drive increased 
biological complexity. Britten and Davidson’s model proposed that there are five 
classes of elements required for spatial, temporal and tissue-specific coordination of 
gene expression: sensor genes (cis-regulatory elements), integrator genes (non-
coding RNAs), receptor genes (gene promoters), activator RNA (transcription 
initiation complexes, including RNA polymerase – the proteins involved in 
transcription initiation had yet to be elucidated, although the authors do suggest that 
their proposed activator RNA may code for active proteins), and producer genes 
(protein-coding genes) [terms in italics as used in the paper, with the present terms in 
parentheses] . Five classes of elements, they suggest, are the minimum necessary to 
establish specificity of gene control over a genome shared by every cell of a 
multicellular organism: to respond to an external signal; to produce a second signal; 
transmit the second signal to receptors that are unable to respond to the first signal; 
reception of the second signal; and activation and transcription of the producer 
(protein-coding) gene.  
Since its publication much of the conceptual framework about gene 
regulation by distal genomic elements envisaged by Britten and Davidson has proven 
to be sound. However, a great deal has still to be determined as to the functional 
roles of these elements. I will now review what is currently known about the active 
fields of research into distal cis-regulatory elements, describing current hypotheses 
on regulatory mechanisms and the experimental techniques being used. I also discuss 
the pre-genomic and genomic methods of identifying distal regulatory sequences, the 
evidence for these regulatory elements being crucial in evolution and development, 





1.2.1 Functional classification of cis-regulatory elements 
Genomic regulatory elements other than the promoter have been assigned to one of 
three functional classes: enhancers, repressors and insulators (enhancer/repressor-
blocking and /or barrier/boundary elements). The regulatory mechanisms that 
employ the first two are similar, whereas insulators have been described as more 
static genomic elements that establish regulatory domains (Gaszner & Felsenfeld, 
2006). Moreover, combinations of regulatory elements that control multiple gene 
activity within discrete genomic regions have been identified and have been termed 
locus control regions. These cis-regulatory sequences are ~200 – 1000 base pairs 
(bp) in size and contain multiple transcription factor binding sites (TFBS). 
1.2.1.1 Enhancers and repressors 
DNA regulatory elements classified as enhancers and repressors regulate target genes 
in a manner autonomous of location and orientation to transcription start sites; the 
former having a positive effect on transcription whereas the latter negatively regulate 
gene activity (Fig. 1.5). Sequences identified as distal regulatory regions do not in 
themselves regulate gene transcription; rather they form nucleoprotein structures in 
complex with trans-acting DNA-binding factors and co-factors which modify 
chromatin structure and interact with the basal transcriptional machinery (Arnosti & 
Kulkarni, 2005). Therefore, whether a distal regulatory element functions as an 
enhancer or repressor is determined by the active or repressive qualities of the bound 
factors and co-factors. As enhancer structure and function is covered in greater detail 
below (sections 1.2.3 and 1.2.4) I will focus on repressor properties. Repressors can 
be discrete regulatory elements or be contained within a proximal promoter or a 
distal enhancer (Maston, Evans & Green, 2006). Possible functional models include 
preventing the binding of a transcriptional activator, as elucidated at the interleukin-4 
promoter when the repressor element is bound by the transcriptional repressor BCL-6 
(Harris et al., 2005), and instigating a repressive chromatin state through the 
recruitment of histone-modifying complexes such as polycomb (Srinivasan & 
Atchison 2004). In Drosophila polycomb binds at polycomb response elements 
(Pirrotta 1997) (Francis & Kingston 2001), conserved DNA elements that apart from 
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a putative site within the HoxD cluster with similar characteristics (Woo et al., 2010) 
have yet to be widely characterised in mammals.  
Classifying many regulatory elements, which are part of complex 
transcriptional responses to developmental cues and environmental stresses, as either 
enhancers or repressors is somewhat arbitrary and simplistic. The reality is more 
likely to be a range of functional elements from purely active to purely repressive. 
For instance, the response of regulatory elements to environmental stimuli such as 
diet, steroid hormones and hypoxia is dependent not only on the cell type but also the 
transcription factors induced by the stimulus, which subsequently bind to and 
influence the transcriptional response (Semenza et al., 1991; Katzenellenbogen, 
1996; McGrane, 2007).  
1.2.1.2 Insulators 
In contrast to enhancers/repressors, the activity of an insulator element is position 
dependent. Insulators possess enhancer-blocking and/or barrier properties (the latter 
mechanism establishes a boundary between active and repressive chromatin), and 
have been postulated to have a role in maintaining discrete regulatory domains (Fig. 
1.5) (boundary elements involved in the segregation of chromosomes into 
topologically associating domains (Dixon et al., 2012; Nora et al., 2012)). Insulation 
is widely accepted as playing an important role in the epigenetic control of gene 
expression, particularly at imprinted loci (Gaszner & Felsenfeld 2006). Most of our 
knowledge of insulator function has been derived from transgenic studies, initially in 
Drosophila (Geyer et al., 1986; Bownes, 1990). The HS4 element of the chicken -
globin region was the first vertebrate insulator to be characterised: a compound 
element with both enhancer-blocking and barrier activity (Chung et al., 1993; Ma et 
al., 2011).  
Although the functional mechanisms of enhancer-blocking elements have still 
to be fully elucidated, these insulators do need to lie between an enhancer/repressor 
and gene promoter(s) (Fig. 1.5). One aspect of enhancer-blocking activity may be the 
formation of chromatin loops that result in the positioning of enhancers and 
promoters in different chromatin domains, a mechanism common to vertebrates and 
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invertebrates (Yusufzai et al., 2004). In Drosophila the key component of loop 
formation is the suppressor of hairy wing (Su(Hw)) protein (Gerasimova et al., 
2000). In mammals, CTCF proteins have been identified at many enhancer-blocking 
sites (Chung et al., 1993; Bell et al., 1999; Filippova et al., 2001; Chao et al., 2002). 
Like Su(Hw) CTCF is a large zinc finger protein and is proposed to possess similar 
properties: the capability to form clusters and create closed loops, or possibly to 
tether chromatin fibre to the nucleolar surface. Furthermore, there is evidence of a 
role for cohesin – a component of the structural maintenance of chromosome (SMC) 
complex that is essential for chromosome mechanics – in facilitating 
intrachromosomal loops between CTCF-binding elements at several loci of the 
mammalian genome (Hadjur et al., 2009; Mishiro et al., 2009; Nativio et al., 2009; 
Hou et al., 2010). 
               Barrier elements prevent stochastic, meta-stable, heritable silencing of 
genes situated in euchromatic domains by the advancement of heterochromatic 
regions – a process known as position-effect variegation (PEV) (Gaszner & 
Felsenfeld, 2006). In yeast, barrier activity has been linked to nucleosomal removal 
(Bi et al., 2004) and the recruitment of HATs and ATP-dependent nucleosome-
remodelling complexes (Oki et al., 2004). Analysis of the chicken HS4 insulator 
suggests a similar mechanism operates in vertebrates: the element is situated at a 
nuclease-hypersensitive site with adjacent histones heavily marked with euchromatin 
modifications (H3K4 methylation, H3 and H4 acetylation) due to the recruitment of 
HATs and HMTs (Litt et al., 2001a; Litt et al., 2001b). Ubiquitination of H2B 
(H2Bub1) is also required to maintain the barrier properties of HS4; depletion of the 
E3 ligase RNF20/BRE1A (which mediates H2B ubiquitination at HS4) results in loss 
of the active chromatin modifications at the insulator and a consequent encroachment 









Figure 1.5. Functional classes of cis-regulatory elements. Transcription initiation at 
promoters (blue DNA) may be activated by enhancers (green DNA) or repressed by 
silencers (red DNA). Enhancer and silencer activity may be restricted by position-dependent 
insulator elements (yellow DNA), which also form barriers that prevent the spreading of 
repressive heterochromatin. Blue ovals are transcription factors, activating and repressing 
proteins are green and red ovals respectively and yellow ovals are insulating proteins. (From 

















1.2.2 Methods of Enhancer Identification 
Up until the availability of comparative genomic methods and genome-wide 
identification of histone modification marks and bound factors /cofactors associated 
with enhancers, the identification of cis-regulatory elements was restricted to 
individual genes or gene clusters and the surrounding genomic region; time-
consuming and labour-intensive efforts that in many cases were initiated following 
the establishment of non-coding deletions/chromosome rearrangements/single 
nucleotide polymorphisms (SNPs) as causes of human disorders (Section 1.2.6). 
Translocations at the -globin locus that displaced non-coding regions causing -
thalassemia (Kioussis et al., 1983; Semenza et al., 1984), identified distal sequences 
that were subsequently shown to have enhancer functions in transgenic mice 
(Grosveld et al., 1987). Similarly, a translocation breakpoint mapped to a locus 1 Mb 
from the sonic hedgehog (Shh) gene in a human patient with the congenital limb 
malformation preaxial polydactyly (PPD) corresponded to the transgenic insertion 
point in a polydactylous mouse known as Sasquatch (Ssq) (Lettice et al., 2002). 
Analysis showed that both chromosomal lesions occur in a similar location within 
the Lmbr1 gene and genetic analysis revealed that the Ssq mutation interrupts a long-
range cis-acting  regulator of Shh (Fig. 4.5 top left-hand panel shows the Shh-Lmbr1 
region on mouse chromosome 5, and the bottom second panel from the left shows the 
highly conserved regulatory element (ZRS) located within intron 5 of Lmbr1). A 
highly conserved element was identified and further sequence analysis identified 
point mutations within this regulator and transgenic assays confirmed the regulatory 
sequence as a limb-specific enhancer that drives Shh expression (Lettice et al. 2003; 
Sagai et al., 2005).  
The availability of sequenced genomes for an ever-expanding number of 
organisms has facilitated the search for regulatory elements on a genome-wide scale. 
This comparative genomic strategy assumes that functional non-coding elements are 
under selection, just as coding sequences are. One of the first papers using 
comparative genomics focussed on identifying enhancers in two large gene deserts (a 
genomic environment in which a large proportion of developmental genes reside, 
section 1.2.5) adjacent to the human DACH1 gene (Nobrega et al., 2003). Thirty two 
27 
 
genomic regions conserved across to pufferfish (Fugu rubripes) were identified, and 
7 of the 9 sequences tested in mouse transgenic assays were able to drive reporter 
gene expression in the same tissues as endogenous DACH. In a whole genome study 
comparing human and pufferfish genomes, 1400 highly conserved non-coding 
elements (HCNEs) were identified; the majority situated in and around 
developmental genes (Woolfe et al., 2005). The authors tested twenty five of these 
elements, located within the genomic regions of four developmentally important 
genes, 23 of which showed enhancer activity in transiently transfected zebrafish 
embryos (Ancora http://ancora.genereg.net; Engstrom et al., 2008). 
Comparative genomic strategies alone cannot identify all enhancers (Blow et 
al., 2010). Transgenic assays can show that HCNEs have the potential to function as 
enhancers but at the present time can only be used to test a small number of 
sequences. Furthermore, those sequences that do not drive reporter expression cannot 
be discounted as enhancers as they may be active at other stages in development. A 
further note of caution in presuming that all conserved sequences are crucial for 
viability was raised by the deletion of four ultraconserved elements (sequences of 
>200 that show perfect conservation in the human, mouse and rat genomes) within 
sequences that show enhancer activity in transgenic assays (Ahituv et al., 2007). All 
four resulting mouse lines showed no severe phenotypic effects and were viable. 
To complement these strategies, ChIP combined with arrays (ChIP-chip) or 
deep sequencing (ChIP-seq) has been used to profile histone modifications and 
variants that mark enhancers, indicate an open chromatin state, or identify regions 
bound by transcription factor or co-factors associated with enhancers. As described 
in sections 1.1.1.1 and 1.1.1.3, H3K4me1/2, H3K27ac, H2A.Z, DNase I sensitivity 
and loss of nucleosome occupancy are all markers of active enhancers (Heintzman et 
al., 2007; Barski et al., 2007; ENCODE Project Consortium, 2007; Xi et al., 2007; 
Heintzman et al., 2009; He et al., 2010). These studies all demonstrate that enhancer 
activity is tissue or cell-type specific. Moreover, two recent studies propose that the 
H3K27ac modification marks active enhancers, whereas H3K4me1 is present at both 
active and poised enhancers (Creyghton et al., 2010; Rada-Iglesias et al., 2011). And 
28 
 
enhancers have been suggested to be switched off in development by the histone 
demethylase LSD1 (Whyte et al., 2012). 
 Although potential non-coding regulatory elements have been identified 
through specific transcription factor-binding (Johnson et al., 2007; Chen et al, 2008; 
Wederell et al., 2008), this is not a practical strategy for identifying enhancers 
genome-wide due to the sheer number of mammalian transcription factors, many of 
which are tissue-specific and are activated at specific temporal stages during 
development. Transcriptional co-regulators, such as chromatin remodelers and 
mediators, are less numerous and many have been shown to be recruited specifically 
to enhancer sequences (Heintzman and Ren, 2009). Genome-wide occupancy of the 
transcriptional co-factor p300 (an acetyltransferase component of enhancer-
associated protein complexes, Section 1.1.1) was assayed in several tissues from 
E11.5 mouse embryos and was shown to have a 5-16-fold better enhancer prediction 
rate compared with comparative genomics (Visel et al., 2009). The advantages of this 
approach are illustrated by the identification of > 3000 heart enhancers in E11.5 
embryos, a large proportion of which are only weakly conserved (Blow et al., 2010). 
Although multiple species comparisons and chromatin profiling has enabled 
the identification of many putative regulatory sequences and the testing of a selection 
of these in transgenic assays, the functional capability of the vast majority of these 
novel regulatory elements awaits confirmation in vivo, for instance by their targeted 
disruption in the genome. And, of course, these studies do not tell us anything about 
how enhancers function that is, how they target and activate specific genes, 
particularly for very distal enhancers that work over large genomic distances 
(Sections 1.1.2, 1.2.4, 1.2.5). 
 
1.2.3 Enhancers in Evolution and Development 
How did such cis-regulatory sequences evolve? Although speculative, their rise 
alongside the evolution of multicellular life is a reasonable proposition. There are 
several scenarios as to how non-coding regions arose.  Whereas simple elements that 
bind few factors may have arisen de novo by small base changes, it seems unlikely 
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that complex enhancers could have arisen this way. Other possible routes are; the 
exaptation of retroposons to form clusters of protein-binding motifs at new genomic 
locations (Santangelo et al., 2007; Sasaki et al., 2008), or the acquisition of novel 
regulatory functions by promoters of archaic genes whose coding sequences have 
been subsequently lost. Existing enhancers may also evolve to acquire new functions 
in development. 
What are the evolutionary consequences of mutation/deletion of existing 
enhancers? Ever since the first characterisation of a cis-regulatory sequence – the lac 
operon (Monod and Jacob, 1961) – evolutionary biologists have argued that 
regulatory mutations have had a major impact on phenotypic evolution (Wray, 2007). 
Whereas alteration of coding regions may have quite blunt effects on protein 
function, alterations at enhancers have the potential to subtly adjust levels of gene 
expression – a situation required for the evolution of quantitative traits and response 
to environmental stresses (Williamson et al., 2011). Moreover, the phenotypic effects 
of mutating enhancers can be confined to discrete tissues or developmental stages 
and so could allow a pre-existing gene to be harnessed to a new developmental 
scenario (Reibez et al., 2009). For instance, neural-specific activation of Lunapark 
and Evx2, situated between the HoxD cluster and the global control region (GCR), is 
regulated by enhancer elements within the GCR (Fig. 1.10). Co-option of the GCR to 
then facilitate Hoxd13-10 expression during limb development (discussed further in 
Sections 1.3 and 1.5) may have been due to the accrual of mutations to produce an 
element able to function in the developing limb (Gonzalez et al., 2007).  
A limb-specific enhancer of Prx1 – which promotes bone elongation in the 
forelimb – is responsible for higher levels of transcription and more extensive 
expression domains at key limb bud locations and embryonic stages in the fruit bat 
(Cretekos et al., 2008.). Replacing the endogenous mouse enhancer with the bat 
enhancer culminated in mouse embryos with longer forelimbs but no morphological 
effects in other organs where Prx1 is expressed. Similarly, in transgenic mouse 
assays human-specific point mutations within a highly conserved non-coding 
element (HACNS1) confer a limb expression pattern, including the presumptive 
anterior wrist and proximal thumb, that appears human-specific compared to that 
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conferred by orthologous sequences from non-human primates (Prabhakar et al, 
2008). These studies highlight the significance of cis-regulatory mutations for the 
divergence of morphological traits in closely related species. Morphological 
differences can also result from the loss of tissue-specific enhancers. Human-specific 
deletions of mostly non-coding sequences that are highly conserved between 
chimpanzees and other mammals include regions near the androgen receptor locus 
and the neural-specific GADD45G (Mclean et al., 2011). These contain tissue-
specific enhancers whose loss correlates with human-specific traits – the loss of 
secondary sexual characteristics associated with androgen hormone signalling and 
the expansion of specific brain regions respectively. 
An intriguing aspect of the cis-regulation of many developmental control 
genes is the role of ‘shadow’ enhancers. These are regulatory sequences that each 
can drive expression of the same gene in overlapping domains. Although mostly 
characterised in Drosophila larval development, several mammalian genes (e.g Shh 
and Sox10) have been described with redundant enhancer activity (Jeong et al, 2006; 
Werner et al, 2007.) Enhancer redundancy likely ensures that the control of gene 
expression is robust, even in conditions of genetic or environmental stress. 
 
1.2.4 The genomic context of enhancers 
A sizeable proportion of enhancers are situated tens-to-hundreds (even thousands) of 
kilobases from their target genes, often in stable gene deserts: expansive gene-poor 
regions that tend to resist chromosomal rearrangements (Ovcharenko et al., 2005). 
Indeed, many genes with tight spatial and/or temporal expression domains – such as 
developmental genes – tend to be located adjacent to gene deserts. The absence of 
other neighbouring genes could help ensure regulatory specificity between enhancer 
and promoter. An example of problems that can arise from the promiscuous action of 
enhancers placed within gene-rich domains is illustrated by the ectopic activation of 
neighbouring genes when the -globin locus control region (LCR) is integrated into a 
gene-rich domain of housekeeping genes (Section 1.1.2) (Noordermeer et al., 2008).  
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However, there must be specificity between some enhancers and promoters. The 
sonic hedgehog gene (Shh), which codes for a morphogen directing cell fate in 
several tissues during organogenesis, is adjacent to a large gene desert containing at 
least three enhancers that are active only within Shh-expressing tissues of the 
embryonic brain (Fig. 1.6A) (Jeong et al., 2006). But, Shh expression during limb 
development is regulated by another enhancer, known as the ZRS (zone of polarizing 
activity regulatory sequence), situated about one megabase away, beyond the neural 
enhancers and within an intron of another gene (Lettice et al., 2003) (Fig. 1.6A). The 
ZRS bypasses both the gene in which it is located and a neighbouring gene in order 
to activate only Shh. 
 
1.2.5 How do long-range enhancers activate target genes?  
Enhancers are clusters of cognate binding sites for transcription factors (TFs). There 
have been three, not entirely mutually exclusive, mechanisms proposed for enhancer-
gene communication (Figure 1.6B). In the first, sequence-specific factors bound to 
the enhancer and/or promoter, recruit further factors – perhaps even including RNA 
polymerase itself – to reorganise chromatin throughout the intervening region as the 
signal for gene activation (Bulger and Groudine, 2010). Due to the large genomic 
distances involved, and even intervening promoters, this seems unlikely to be a 
feasible mechanism for very long-range control, such as that at Shh.  
The second mechanism of action also involves reorganizing the intervening 
chromatin, but to allow for direct enhancer-promoter interaction – possibly by 
formation of a series of “mini” chromatin loops (Montavon et al., 2011).  
The third mechanism invokes the spatial co-localisation in the nucleus of 
enhancer and promoter, which can then directly interact with each other if the 
necessary factors are bound, looping out the intervening chromosomal region. This 
looping may involve the delivery of RNA polymerase to the promoter, or even the 
delivery of factors to de-repress the target gene, for instance a histone demethylase to 
remove polycomb (Vernimmen et al., 2011). One attractive feature of these models is 
that it ensures that an enhancer can activate the expression of only one gene at a time. 
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However, enhancer-promoter mediated looping may be insufficient for gene 
activation. Spatial co-localisation of the ZRS and Shh is reported to occur in nuclei in 
both expressing and non- expressing halves of the developing limb-bud, but on the 
posterior side of the limb-bud the active Shh locus is, in addition, also extruded out 
from its chromosome territory (Amano et al., 2009). A similar looping out from 
chromosome territories is induced by an ectopic -globin LCR (Noordermeer et al., 
2008). 
Does there even need to be direct physical interaction between enhancer and 
promoter? It is feasible that the clustered binding sites for transcription factors at 
enhancers act to reduce the effective nuclear search space of these proteins for a gene 
promoter by diffusion/non-specific binding. (Elf J et al., 2007). In this model, 
enhancer-promoter specificity would rely upon shared high affinity binding sites for 
the same set of factors.  Moreover, enhancers themselves often bind RNA 
polymerase II (De Santa et al., 2010) and are transcribed to produce short non-coding 
RNAs (Kim et al., 2010). Whether these RNAs have a functional role has still to be 
determined.  A long non-coding RNA (lncRNA) has been described that influences 
the neural-specific activity of a developmental enhancer.   Evf2 is a ncRNA that is 
transcribed across an ultraconserved enhancer situated between the Dix5 and Dix6 
homeodomain genes and cooperates with the Dix2 protein to increase the activity of 
the enhancer in a target and homeodomain specific manner (Feng et al., 2006). The 
authors speculate that the role of Evf2 is to enable Dix2 to bind the enhancer and 
suggest that developmentally regulated ncRNAs may function in trans to regulate the 
transcriptional activity of homeodomain proteins. The lncRNA HOTAIR is located in 
the HOXC locus and has been shown to have a repressive influence on the 5′ HOXD 
genes in human fibroblasts (Rinn et al., 2007).  
 







            
Figure 1.6. The sonic hedgehog regulatory region and possible mechanisms of 
enhancer activity. A, Linear representation of the Shh locus showing the location of long-
range  neural-specific and limb-specific enhancers. B, Models of enhancer-promoter 
communication. Factors bound to the enhancer and promoter recruit chromatin-modifying 
factors that reorganise the intervening chromatin with the factors themselves being the signal 
for gene activation or enabling direct enhancer-promoter interaction by the formation of 
chromatin “mini-loops”; or, spatial co-localisation of the enhancer and promoter, which can 









To initiate the transcription of target genes enhancers must integrate and 
process cellular signalling information. Two models of information processing have 
been proposed: “enhanceosome” and “billboard” (Arnosti & Kulkarni, 2005). In the 
former there is a high level of cooperative and coordinate action between the bound 
transcription factors to give unitary outputs; while in the latter the proteins do not 
operate as a single unit, but rather form multiple functional units that independently 
regulate gene expression. So, whereas mutations to individual enhanceosome binding 
sites may ablate enhancer function, the more flexible characteristics of  billboard 
style enhancers suggests that alteration to individual binding sites would be less 
drastic to overall enhancer function and therefore more amenable to evolutionary 
adaptation.              
 
1.2.6 Enhancers and disease 
Mutations associated with -thalassaemia were what first led to the identification of 
the -globin LCR and deletions that affect an enhancer’s function, or translocations 
that separate enhancers from their cognate promoters, have been identified as the 
cause of several simple Mendelian human genetic diseases (Noonan & McCallion, 
2010). Deletion of a bone-specific enhancer of SOST (a negative regulator of bone 
formation) has been identified as the cause of the homozygous recessive disorder 
Van Buchem’s disease (Loots et al., 2005). Similarly, the deletion of a regulatory 
sequence around 1Mb upstream of POU3F4 is responsible for some cases of the 
Mendelian disorder X-linked deafness type 3 (Noonan & McCallion, 2010). 
Translocations over a > 1Mb genomic region that cause disruption of SOX9 
expression are associated with several congenital skeletal malformations and 
implicate the loss of enhancers that regulate tissue-specific expression of the gene 
(Gordon et al., 2009). Point mutations in the Shh ZRS result in a gain of function of 
enhancer activity and ectopic activation of Shh expression in the anterior limb-bud – 
the underlying cause of PPD (Lettice et al., 2003). Human limb abnormalities can 
also result from translocations around HOXD (Spitz et al., 2002). A balanced 
translocation 60 kb from the cluster is associated with mesomelic dysplasia, which is 
a shortening of the forearms and forelegs.  
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Almost a half of single nucleotide polymorphisms (SNPs) that show 
statistical associations with common or complex human disease in genome-wide 
association studies (GWAS) are within non-coding regions and gene deserts and so 
potentially involve enhancers (Noonan and McCallion, 2010). For example, a SNP 
within an intronic enhancer of the RET gene confers a greater risk of Hirschsprung 
disease than the major allele (Emison et al., 2005). SNPs in a gene desert 330kb 
upstream of the c-myc protooncogene are associated with greater risk of several 
cancers (Wasserman et al., 2010). Two studies (Tuupanen et al, 2009; Pomerantz et 
al, 2009) established the mechanism by which one of the SNPs in this gene desert 
results in colorectal  cancer, revealing that it is located within an enhancer and 
increases its binding affinity for the TCF4 transcription factor, which activates genes 
through the Wnt signalling pathway. This enhancer was shown to physically interact 
with the MYC oncogene in colorectal cancer cell lines but not in fibroblast (control) 
cells. A SNP within an enhancer for the pigment gene OCA2 reduces the capacity of 
the enhancer to interact with the OCA2 promoter which directly influences 
melanocyte pigmentation (Visser et al, 2012).  Why might so much of the genetic 
variation apparently associated with complex human disease be in enhancers? 
Whereas point mutations in protein coding regions can completely ablate gene 
function and so result in strong and penetrant phenotypes, point mutations in an 
enhancer may alter binding affinity for a specific TF and so could result in only 
subtle changes in the level, time, or place of gene expression. The resulting 
phenotype could therefore be more modest and subject to interaction with other 
genes and with the environment. 
 
1.2.7 Mechanisms of long-range enhancer function have still to be fully 
elucidated 
Section 1.2.5 makes clear that a comprehensive understanding of the mechanisms of 
long-range regulation has yet to emerge, although several possible mechanisms have 
been proposed based on the available evidence. Our current lack of mechanistic 
understanding about how enhancers regulate temporal and spatial patterns of 
expression from the correct target gene is impeding the exploitation of the massive 
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investments being made in GWAS and the functional analysis of human disease. 
What needs to be done to better understand how enhancers work? The dearth of 
knowledge on enhancer biochemistry needs to be addressed in order to gain a more 
complete understanding of how enhancers integrate and process signalling 
information that promotes transcription. Enhancer elements function as nucleoprotein 
complexes, with multiple associated sequence-specific and sequence non-specific 
binding proteins. What are these proteins and how do they act together? There could 
be a high level of cooperative and coordinate action between the bound TF to give 
unitary outputs to the transcriptional machinery, or they may rather form multiple 
functional units that each independently regulate gene expression. (Arnosti and 
Kulkarni, 2005).  
The precise chronological sequence of chromatin events at enhancers is also 
still to be elucidated. Does any direct physical enhancer-promoter interaction only 
occur once factors are bound to both elements, or does the interaction itself 
contribute to the loading of TFs or transcriptional machinery to the promoter? 
Current assays for long-range physical interactions – fluorescent in situ hybridization 
(FISH) and chromosome conformation capture (3C) and its derivatives – only give 
snapshots or cell population averaged information, respectively. There is a need for 
dynamic assays of chromosome organisation; to capture long-range interactions as 
they occur in real time and for these to be coupled to methods for quantifying levels 










1.3 Growth and development of the vertebrate distal limb 
Digits are the main anatomical feature of the distal vertebrate limb (autopod). The 
patterning of the digits, and the processes that regulate the growth and form of the 
autopod, are a paradigm of organogenesis. Polarisation of the distal vertebrate limb 
across the anterior-posterior (A-P) axis (thumb/radius to the minimus/ulna) is a 
morphologically recognisable consequence of the signalling interaction of two 
organising centres, backed up by several inter- and intra-cellular systems, that ensure 
limb asymmetry. Indeed, the establishment of the vertebrate body plan relies on the 
control of polarity. The signaling molecule sonic hedgehog (Shh) is involved in 
regulating the polarity of many tissues during development (Echelard et al., 1993; 
Haraguchi et al., 2001). During organogenesis, activation of Shh is tightly regulated 
and expression is restricted to specific spatio-temporal patterns (Masuya et al, 2006). 
Early work on limb development revealed that the posterior mesenchyme of the early 
limb bud is the location of one of the organizing centres, known as the zone of 
polarizing activity (ZPA) (Fig. 1.7B) (Saunders and Gasseling, 1968). Shh was 
subsequently identified as the secretory protein responsible for activating the 
polarizing activity (Riddle et al., 1993).  
Although the early work that identified the ZPA – and how these cells were 
the source for A-P patterning instructions – was carried out in chick limb buds, much 
of the more recent work has utilised the powerful new tools of mouse molecular 
genetics (Robert and Lallemand, 2006). These tools include fine-tuned modulation of 
gene expression, intra-chromosomal deletions and duplications, and lineage analysis. 
As the model for this project is mouse limb bud cell lines, the following description 
of distal limb development is mostly based on the mechanisms and timing that occurs 
during mouse limb growth. 
 
1.3.1 Early limb outgrowth and the defining of the A-P axis   
At embryonic day (E) 9.0 limb budding occurs, and the limb A-P axis is initially 
determined by two mutually antagonistic patterns of gene expression (Fig. 1.7A). 
Pre-patterning of limb asymmetry depends on the expression of Hand2 in the 
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posterior limb bud and the truncated form of Gli3 (Gli3R) in the anterior (Robert and 
Lallemand, 2006; Hill, 2007). Hand2 induces Shh expression either along with or 
through the 5′ Hoxd genes, thereby positioning the ZPA at the posterior margin of the 
limb bud. In the anterior half of the developing limb bud Gli3R is involved in the 
activation of Alx4, which inhibits the expression of Shh-activating genes and is 
therefore crucial to the asymmetrical pre-patterning of the developing limb (Hill, 
2007).  
Early onset Hoxd expression in the limb culminates in the most 5 genes 
(Hoxd11-13) having restricted, posterior expression domains (Fig. 1.8). Through a 
series of deletions and duplications within the HoxD cluster that re-located individual 
genes – thereby altering their order and spatial position within the cluster – Tarchini 
and Duboule (2006) elucidated the collinear mechanism of spatial and temporal 
control of this initial wave of Hoxd expression. Two regulatory elements – an 
enhancer located at the telomeric end of the Hoxd cluster (ELCR) and a repressor 
element (POST) at the centromeric end  – combine to ensure that the 5′ genes are 
spatially restricted to the posterior limb bud, and temporally restricted to between 
E9.5 and E10.0, the location and time of Shh activation. The ELCR defines the 
timing of activation: 3′ genes such as Hoxd1 are closest to the enhancer and are 
expressed earliest – at E9.0 and throughout the limb bud – followed in a temporal 
collinear manner by successive genes within the cluster. Meanwhile, the POST 
element also influences expression in an asymmetrical manner: only the 5′ genes 
have posteriorly restricted expression domains and the extent of restriction depends 
upon position within the cluster relative to the 5′-located repressor. Gli3R may 
mediate this repression as the 5′ genes are activated in the anterior limb upon 
inactivation of Gli3 (Zuniga and Zeller, 1999; te Welscher et al., 2002). A hitherto 
unknown role for the polycomb methyltransferase subunit Ezh2 in limb bud pre-
patterning was recently established. The conditional inactivation of Ezh2 resulted in 
the posteriorization of limb bud identity with the loss of Gli3 and Alx4 and ectopic 
expression of Hand2 and the 5′Hoxd genes in the anterior limb (Wyngaarden et al., 
2011). Posterior-restricted expression of Hoxd11, Hoxd12 and Hoxd13 is crucial to 
ensuring limb A-P polarization: when their expression domains are anteriorized they 
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can induce ectopic Shh expression, which leads to the loss of limb asymmetry 
(Knezevic et al., 1997; Zakany et al., 2004; Tarchini et al., 2006).  
The mutual antagonism of the Hand2 and Gli3 (R) expression domains then 
ensures that 5′Hoxd gene activity is confined to the posterior margin of the limb bud 
during the initial phase of outgrowth and A-P polarization (E9.0 – E10.0). This 
polarity consequently ensures that activation of Shh and generation of the ZPA 
occurs at the posterior limb bud only. However, Shh has the potential to be anteriorly 
expressed, and Fgf-regulated Etv4/5 (two members of the PEA3 sub-family of Ets 
transcription factors that have redundant activity in the limb) have been identified as 
direct repressors of Shh in the anterior limb bud (Mao et al., 2009; Zhang et al., 
2009). This implicates the proximal-distal (P-D) organizing centre the apical 
ectodermal ridge (AER) in not only interacting and mutually maintaining the ZPA 
(see below) but also actively preventing anterior Shh expression. In the latter study 
conditional inactivation of Etv4/5 in mesoderm-derived cells had no effect on P-D 
development but all the resulting embryos exhibited a preaxial polydactyly (PPD) 
phenotype. PPD is a congenital abnormality that affects the digits on the anterior side 
of the distal limb (I discuss the link between Shh and PPD further in Section 1.4); 
and ectopic, anterior expression of Shh was detected at E11.0 in mutant embryos. 
Both papers provide evidence that Etv4/5 inhibition of Shh is required at the 
beginning of limb bud development. Activation of the Etv inhibitory form at E9.0 
Mao et al. (2009) resulted in ectopic expression of Shh, whereas upon its activation 
at E10.0 Shh expression remained restricted to the posterior margin. And in Zhang et 
al (2009) complete Etv inactivation was not observed until E10.0, the likely 
consequence of ectopic Shh activity and PPD only occurring in the mutant hindlimbs 









Figure 1.7. Genetic interactions during limb bud development. A, At E9.0 mutual 
antagonism between Hand2 and Gli3 (both encode transcription factors) determines the 
anteroposterior axis. Gli3 is expressed in the anterior half, mostly in its processed Gli3R form 
and controls the expression of Alx4. Hand2 either directly induces Shh expression or 
indirectly through the 5′ Hoxd genes in the posterior half of the limb bud. B, At E11.0 Shh 
maintains Hand2 expression, plays a role in instigating a second wave of 5′ Hoxd gene 
expression crucial for digit patterning, and regulates Gli3R levels. The Bmp antagonist 
Gremlin, which is repressed by Gli3R, is expressed only in the posterior limb bud, and this 
prevents the down-regulation of the Fgfs at the AER. This indirect interaction of Shh with the 
Fgfs completes a feedback loop which also involves the maintenance of Shh expression by 













1.3.2 Development of the vertebrate autopod 
In the mouse initial growth and patterning of the distal handplate takes place from 
E10.0 - E12.5. This period of limb development is defined by the expression of Shh 
and a second wave of 5′ Hoxd gene expression under the control of long-range 
enhancers that both determine levels of expression and influence spatio-temporal 
expression domains (I discuss both enhancers in more detail in Sections 1.4 and 1.5). 
At the end of this crucial period the digits have been specified and can be identified 
within the distal limb bud. Subsequent development involves mostly chondrogenesis 
and the growth of pre-patterned limb structures. A multifaceted interplay of 
regulatory and signaling networks direct autopod specification and development, the 
complexity of which has still to be fully unravelled. However, I will briefly describe 
the salient aspects of the role played by the key players.   
A signaling feedback loop between the ZPA and the AER maintains Shh 
expression (Fig. 1.7B). Signals that emanate from the AER are required for 
outgrowth of the limb along the P-D axis. The AER is situated in a strip of epithelial 
cells at the distal tip of the limb bud and is the source of fibroblast growth factor 
(Fgf) signaling in the limb, with Fgf4 and Fgf8 being the major factors involved in P-
D patterning (Sun et al., 2002, Mariani et al., 2008). Fgf signaling is also required for 
the maintenance of Shh expression, while Shh indirectly maintains Fgf expression 
(Fig. 1.7B). Gli3R levels are regulated by Shh repression of Gli3 transcription in the 
posterior limb bud and by restricting the processing of Gli3A to Gli3R to the anterior 
(Hill, 2007). Shh maintains Hand2 expression in the posterior limb, and also 
Gremlin, a Bmp antagonist, to prevent the inhibition of Fgf signaling and the Bmp-
induced regression of the AER (Laufer et al., 1994; Niswander et al., 1994; Zuniga et 
al., 1999; Benazet et al., 2009). Therefore, this feedback loop, linking the epithelium 
and the mesenchyme, co-ordinates A-P and P-D patterning and ensures correct distal 
growth.   
Shh plays a direct role in digit specification and growth. The classic 
concentration morphogen model posits that digit identity is dependent on distance 
from the ZPA through the formation of a Shh concentration gradient across the 
presumptive handplate, with only digit 1 (thumb) not specified in some way by Shh. 
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However, experiments that identified the fate of Shh-expressing cells and cells 
responding to Shh signalling suggest a temporal dynamic needs to be included in a 
model that accounts for digit identity (Ahn and Joyner, 2004; Harfe et al., 2004). In 
these studies digit 2 condensation is specified by Shh signalling, whereas digits 3, 4 
and 5 (most posterior) derive from the ZPA and their identity is established from 
progressively increasing periods of exposure to Shh.  
More recent findings, in the mouse and chick, have revealed a direct link 
between Shh-mediated growth and patterning: the growth-morphogen model. In the 
chick, both inhibition of Shh signalling and blocking of cellular proliferation reduced 
limb bud width and, as a consequence, the number of digits (Towers et al., 2008). 
Crucially, though, whereas inhibition of Shh resulted in the formation of anterior 
digits, blocking of cellular proliferation (with Shh expression maintained, albeit at 
slightly lower levels) led to posterior digit formation (digits 3 and 4, or 4 alone). 
These results suggest that Shh-dependent limb bud expansion across the A-P axis is 
necessary to separate digit primordia for normal specification in the chick, and 
therefore correct Shh expression is crucial for digit specification and proliferation of 
limb mesenchymal cells. Studies in the mouse corroborate the chick study 
conclusions; nonetheless with some salient disparities (Zhu et al., 2008). In mouse 
limb development each digit has a distinct temporal requirement for Shh signalling: 
early (E9.5) inactivation culminated in the condensation of digit 4 only; inactivation 
at subsequently later stages allowed the condensations of digits 2 then 5. Therefore, 
the order of digit development is opposite to the susceptibility of digit loss (digit 3, 
then 5, 2, 4). Shh controls cell proliferation (and survival) and as a consequence 
signalling duration influences digit number, as in the chick. However, unlike in the 
chick, reduced exposure time does not result in the anteriorization of digit identity, 
but rather the digits maintain their identity; an outcome that the authors argue is due 
to digit specification in the mouse occurring at an early developmental stage. So 
these data imply that, in the mouse, Shh specifies A-P patterning early on in limb 
development and is required at later stages to promote cell cycle progression to 
ensure there are enough cells for complete formation of the digits.    
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Late onset expression of the 5′ Hoxd genes (Hoxd13 to Hoxd10), by a process 
termed “reverse collinearity” (Nelson et al., 1996), is initiated in the Shh-expressing 
region of the posterior limb bud from around E10.5 until E12.5 (Fig. 1.8). The most 
5 Hoxd gene, Hoxd13, has the strongest expression then levels progressively 
decrease down to Hoxd10, and this varying level of expression ensures correct digit 
morphogenesis (Kmita, et al., 2002; Montavon, et al., 2008). Late onset 5′ Hoxd gene 
expression is controlled by enhancers located centromeric of the cluster, namely the 
GCR and Prox (Spitz et al., 2003; Gonzalez et al., 2007), and position within the 
cluster determines the strength and extent of each gene’s expression domain across 
the distal plate (Tarchini and Duboule, 2006) (Fig. 1.8) Hoxd13 is the only Hoxd 
gene that is expressed at the extreme, anterior, distal plate within the cells that give 
rise to presumptive digit 1 (thumb in humans) (Montavon et al., 2008). 
My research has focussed on how Shh and the 5′Hoxd genes are regulated 
during this phase of mouse distal limb development, and in particular the role of the 
two long-range enhancers – ZRS and GCR. Therefore, I will end this introduction to 
my thesis by describing what is known about both these elements in more detail 













Figure 1.8. Hoxd expression occurs in two waves during limb development. The first 
wave (from E9.0 to E10.0) is temporally and spatially controlled by two regulatory elements 
either end of the cluster (ELCR and POST). Expression occurs in a collinear (Hoxd1 to 
Hoxd13) manner. Late onset expression involves the 5′ genes only and is under the control 
of the GCR and Prox enhancers. Hoxd13 is expressed first and to the greatest extent, with 
Hoxd12, 11 and 10 expressed in decreasing levels. This process has been termed “reverse 












The zone of polarizing activity regulatory sequence (ZRS) is the long-range cis-
regulator of sonic hedgehog (Shh) in the limb. The enhancer lies up to 1Mb away 
from its target in an intron of the Lmbr1 gene, and an 800bp sequence of the 
enhancer is evolutionary conserved across to chondrichthyans (Dahn, et al, 2007). 
Transgene assays demonstrated that the highly conserved ZRS sequence from Fugu 
is able to induce a ZPA in mouse (Lettice, et al, 2003). Intriguingly, the ZRS exerts 
no control over either Lmbr1 or Rnf32, which lie an order of magnitude closer to the 
enhancer than Shh. Therefore, the active ZRS bypasses the gene it is located within 
and an adjacent gene and is able to traverse an 800kb gene desert to induce Shh 
expression (Figure 1.9). 
              The ZRS has a functional role in the instigation of Shh expression along the 
distal posterior mesenchyme of the limb bud to create the ZPA, as limb-specific Shh 
expression is abrogated upon its deletion (Sagai et al, 2005). Moreover, point 
mutations across the whole conserved sequence of the enhancer induce anterior, 
ectopic Shh expression that can cause PPD (Lettice et al, 2003; Sagai et al, 2004; 
Lettice et al, 2008). These point mutations occur within dissimilar DNA sequences, 
indicating that different DNA-protein interactions are being disrupted but with the 
same regulatory outcome. However, point mutations in two families with PPD result 
in the formation of protein-binding motifs associated with the ETS family of 
transcription factors, which include ETV4 and ETV5 (Fig. 3.1A) – factors with a 
known role in Shh regulation in limb development (Section 1.3.2). In Silico analysis 
by the Hill lab identified multiple ETS binding motifs, which suggests a possible role 
for these factors in Shh limb expression through the ZRS (I will discuss this further 
in the introduction to Chapter 3, the results chapter based on research into ETS factor 
binding at the ZRS).  
Recent analysis of Silkie (Slk) chickens (an ancient breed with naturally 
polydactylous feet) revealed causative links between the mutated ZRS – both ectopic 
anterior Shh expression and more extensive Shh signaling in the posterior leg bud – 
and extension of the digit-forming leg bud field; all resulting in morphogenic 
variability of anterior digits: from an extra phalanx in digit 1 to two extra digits with 
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either digit 1 or digit 2 morphology (Dunn et al., 2011). Based on their results, the 
authors propose a mechanism based on the growth-morphogen model with the 
mutated ZRS driving increased Shh expression in an expanded posterior domain. 
Consequently, Shh signaling is intensified, which extends the digit-forming field. 
When the posterior domain is then surgically removed at this stage ectopic activation 
of Shh fails to occur and the result is the condensation of an additional anterior digit 
but the loss of the most posterior digit 4. Abnormal levels of Shh signaling causes the 
anterior expansion of ectodermal Fgf signaling which then acts upon anterior 
mesenchyme tissue that is receptive to Shh-activating signals through the mutated 
ZRS. Ectopic expression of Shh then ensures the growth of additional digit(s) with a 
more posterior morphology.     
The length and conservation of the ZRS suggests a high degree of complexity 
in controlling the spatial-temporal expression of Shh in the limb. Its size – ~800bp – 
is at the upper end of well defined regulatory elements, and so an intriguing question 
is: does the regulatory sequence contains information that not only enables enhancer-
promoter interaction and subsequent Shh expression but also endows the activated 
enhancer with the capability to function over large distances? Work on the 
elucidation of how the ZRS activates Shh suggests that there is a physical co-
localisation of the enhancer and gene in both the anterior and posterior margins of 
the mouse limb bud at E10.5; however, a looping out of the Shh locus from the CT 
could only be detected at the posterior margin where Shh is expressed (Amano et al., 
2009). This study indicates that higher-order chromatin conformation has a role in 
ZRS activity, and the multiple point mutations identified within the enhancer 
suggests that its functional capability is dependent on the dynamic interplay between 
activating and repressive binding factors. What remains to be addressed are the 
identity of activating and repressing factors and the mechanism by which they 
interact to constrain ZRS activity to the posterior limb bud. In addition, what are the 
motive forces behind the ZRS-Shh interactions? Is it a looping mechanism? gross 
compaction of the intervening region through irregular folding of the chromatin 
fibre? or is this whole region a discrete genomic locus (a “regulatory landscape”, as 
has also been proposed for the gene desert adjacent to HoxD, see below) being held 
in a tight conformation that reduces the nuclear search space for tissue-specific 
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enhancers of Shh to find and activate the gene? Each of these scenarios rely upon a 
deterministic, biochemical manipulation of the higher-order chromatin structure, 
























Figure 1.9. ZRS/Shh regulatory region. The arrows indicate that the enhancer only 
















The global control region (GCR) is a series of cis-regulatory elements within a 
~50kb region located around 200kb upstream of the HoxD cluster. These regulatory 
elements are highly conserved in vertebrates and are active in the developing nervous 
system, regulating Lnp and Evx2 expression – two genes that lie between the GCR 
and HoxD (Spitz et al., 2003). However, one of these elements has been co-opted 
along with the 5′ genes during evolution of the tetrapod limb. The GCR, then, is 
active in the limb and genital buds and the CNS during development, but only Evx2 
and Lnp are expressed in the CNS (Fig. 1.10); possibly due to the activity of a 
boundary element located between Evx2 and Hoxd13 (Yamagishi et al, 2007).  
The GCR is highly conserved between humans and mice and sequence 
identity is quite high compared with the Fugu sequences.  However, the Fugu GCR 
does not drive reporter gene expression in mouse limb buds, but does drive 
expression in neural tissue (Spitz et al, 2003). These results suggest that late-phase 
cis regulation of Hoxd genes is unique to tetrapods. However, further transgenic 
analysis of GCR activity in fish species whose genomes have not undergone a 
duplication event (the authors propose that the additional set of Hoxd genes and GCR 
in Fugu could have culminated in enhancers with divergent functions) demonstrated 
that conserved sequences from tetrapods, zebrafish and skate can drive appendage 
expression in transgenic mice and zebrafish (Schneider et al., 2011). The authors 
suggest that development of the autopod during tetrapod evolution arose through 
modification of ancient gnathostome regulatory elements that led to an expansion of 
late phase Hoxd expression, possibly further enhanced by the acquisition of the Prox 
enhancer that has no orthologous sequence in fish (Gonzalez et al., 2007).     
Although the molecular mechanisms that underlie GCR regulation of the 5′ 
Hoxd genes are unknown, the decreasing levels of expression from Hoxd13 to 
Hoxd10 indicate that positioning within the cluster is important. The use of deletion 
and duplication alleles confirmed the importance of gene position, the more 5′ the 
gene the greater its expression levels (Kmita et al, 2002; Tarchini and Duboule, 
2006). Nevertheless, Montavon et al. (2008) identified some promoter-specific 
responses, with Hoxd13 the most responsive. This quantitative colinearity 
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mechanism, then, with progressively weaker expression of Hoxd genes the further 
they are located away from the GCR, suggests direct promoter-enhancer interactions, 
possibly through a chromatin looping mechanism. Moreover, transgene experiments 
and genetically induced rearrangements of Hox loci suggest that progressive opening 
of the chromatin structure from 3 to 5 has a role in sequential gene activation 
collinear with the order of the genes (Kmita and Duboule, 2003; Soshnikova and 
Duboule, 2009). This model is supported by work done in the Bickmore lab, which 
showed there is chromatin decondensation followed by activation of Hoxb and Hoxd 
genes (Chambeyron and Bickmore, 2004; Chambeyron et al, 2005; Morey et al., 
2007; Eskeland et al., 2010). So, with regard to late phase Hoxd activation in the 
limb are the same regulatory processes involved in addition to the activity of cis-
regulatory elements? That is, does polycomb have a role and, as a consequence, does 
the HoxD locus undergo decompaction? 
 
















    
 
Figure 1.10. The 5′ HoxD regulatory region. The arrows indicate the genes that are 
activated by the Prox and/or GCR enhancers, solid arrows for genes regulated in the limb, 
















The aim of my research is to delineate the chromatin structure and conformation at 
the Shh and Hoxd loci, including the long-range enhancers, in a model of the 
developing limb bud, and to determine whether chromatin modelling and structural 
alterations to chromosome territories have a role in the functional mechanisms of the 
ZRS and the GCR. Furthermore, I aim to characterise DNA-protein interactions at 
conserved and mutant binding motifs identified in silico, and subsequently to identify 
transcription factors that bind to the active ZRS. 
To do this I made use of immortalised cell lines derived from the developing 
mouse limb bud, as well as dissected limb tissue and tissue sections, and genomic 
tiling arrays that span the genomic regions under study. I used chromatin 
immunoprecipitation (ChIP), fluorescence in situ hybridisation (FISH), expression 
microarrays and quantitative PCR to try and answer the following questions: 
 Are modifications to chromatin structure necessary for the activation of 
limb-specific Shh and 5Hoxd expression? 
 Does polycomb regulate limb-specific Hoxd expression? 
 Are alterations to chromatin conformation in each regulatory region enabling 
physical interaction between the enhancers and gene promoters? 
 
For determining DNA-protein interactions at the ZRS ETS-binding sub-regions, 
various biochemical techniques in addition to ChIP-chip have been used to answer 
the following questions: 
 Which protein or proteins bind(s) to the conserved and mutant binding sites? 
 What is the mechanism that determines ZRS activity and how can point 











Anterior-posterior differences in HoxD 











 2.1 Introduction 
Regulated expression of Hox genes is crucial for anterior-posterior (A-P) patterning 
of the primary embryonic body axis, with Hox genes being first activated at 
gastrulation (Deschamps and van Nes, 2005). The HoxD cluster has also been co-
opted more recently in evolution into regulating the growth and patterning of the 
limb and digits.  
Polycomb repressive complexes (PRC1 and PRC2) are required to maintain 
Hox genes in a silent and compact chromatin state in embryonic stem (ES) cells 
(Boyer et al., 2006; Lee et al., 2006; Endoh et al., 2008; Stock et al., 2007; Eskeland 
et al., 2010). Whereas the roles of polycomb-mediated gene silencing and chromatin 
compaction at Hox loci have been well established in both early embryonic 
development and differentiation along the primary embryonic axis (Voncken et al., 
2003; Faust et al., 1998; Chambeyron et al., 2005; Soshnikova and Duboule, 2009), 
whether polycomb-mediated histone modifications and chromatin changes are 
involved in Hox gene regulation in the secondary body axis is unclear.  
There are two separate phases of Hoxd gene expression important in limb 
development and patterning (Zakany and Duboule 2007), with each phase regulated 
by two different groups of global regulatory elements situated either side of the 
cluster (Spitz et al., 2005). An early phase of temporal regulation results in 
expression of 3′ Hoxd genes (Hoxd1-9) earlier than the 5′ genes, due to collinear 
activation by an as yet undefined 3′-located enhancer (ELCR, Section 1.3) (Tarchini 
and Duboule, 2006). Combined with a proposed repressor element situated 5′ of the 
cluster, this restricts 5′ Hoxd expression to the posterior side of the distal limb bud 
and is required for limb outgrowth, proximal limb development, limb A/P polarity 
and the posterior expression of Sonic hedgehog (Shh) (Figs. 1.7, 1.8). This 3′-5′ 
temporal and spatial colinearity is reminiscent of regulation in the main embryonic 
axis, which is accompanied by progressive loss of histone H3 lysine 27 tri-
methylation (H3K27me3) – the histone modification catalysed by PRC2 (Soshnikova 
and Duboule, 2009).  
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The early phase of limb Hoxd expression is followed by a later phase (E10.5) 
in the distal limb which is required for digit morphogenesis (Spitz et al., 2003). This 
is characterised by “quantitative colinearity” in which expression of the most 5′ gene, 
Hoxd13, is initially strongest in the posterior mesenchyme of the distal limb, with 
progressively less strong expression of Hoxd12 to Hoxd10. The expression domains 
of all the 5′ genes (Hoxd13-10) then spread anteriorly, so that by E12.5 they are 
being transcribed across the handplate but with only Hoxd13 gene expression robust 
enough to be detectable on the most anterior side of the distal limb – the position of 
the presumptive thumb (Fig. 1.8) (Montavon et al., 2008). This expression is driven 
by enhancer elements including; a ~40kb global control region (GCR) centromeric of 
the cluster, ~200kb 5′ of Hoxd13 beyond Evx2 and Lnp, and the Prox enhancer that is 
located between Evx2 and Lnp (Fig 1.10) (Spitz et al., 2003; Tschopp and Duboule, 
2011). This late phase of HoxD regulation in the distal limb is a more recent 
adaptation (Schneider et al., 2011) and given its distinct regulatory characteristics it 














2.2 Cell lines retain distal limb identity 
2.2.1 Cell lines derived from the mesenchyme of E10.5 limb buds  
The activity of limb enhancer elements in the HoxD GCR first becomes apparent in 
posterior mesenchyme cells of the distal forelimb bud at E10.5, followed later by 
anterior extension of this expression zone across the distal limb (Spitz et al., 2003). 
Therefore I restricted my analysis to E10.5 limb buds to capture the initiation of this 
second wave of HoxD regulation.  
Analysing chromatin structure in the small number of cells dissected from 
regions of the mouse embryo is challenging (Soshnikova and Duboule, 2009). 
However, conditionally immortalised cell lines can be derived from the transgenic 
“immortomouse” that expresses a temperature sensitive SV40 T antigen H-2Kb-
tsA58 (simian virus 40 (SV40) large tumour (T) antigen (TAg)) (Jat et al. 1991). The 
temperature sensitive gene was used for producing the transgenic mice to prevent the 
expression of the antigen in vivo as it has been associated with tumourigenesis and 
improper development. By culturing the cells derived from the transgenic embryos at 
33°C the antigen is activated and consequently restricts further differentiation (Jat et 
al, 1991). Such cell lines appear to retain many biological properties of the cells from 
which they were derived, including gene expression patterns and response to 
signalling pathways (Kohn et al., 2010). Two sets of cell lines were derived from 
dissected E10.5 forelimb buds (by A. Hill) to represent the most posterior third of the 
distal limb (cell lines P1 and P2) or the anterior two-thirds (A1 and A2) (Fig. 2.1). 
The embryonic limb bud consists of two main cell types, mesenchyme and a 
layer of surface ectoderm which at the most distal limb margin forms the apical 
ectodermal ridge (AER). The morphology of the cell lines indicated that they were 
likely to be mesenchymal in origin. I confirmed this by RT-PCR analysis of RNA 
isolated from all four cell lines (Fig. 2.2A). Fgf10 is expressed in limb bud 
mesenchyme and signals to the Fgfr2b receptor expressed in the AER to induce 
expression of Fgf8 there. In contrast, Fgfr2c is expressed in both the mesoderm and 
ectoderm of the developing limb bud (Lizarraga et al., 1999; Duboc and Logan, 
2011). The detection of mRNAs from Fgf10 and Fgfr2c, but not Fgf8 or Fgfr2b in 
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immortomouse derived limb bud cell lines indicates their derivation from the limb 
mesenchyme (Fig. 2.2A). The origin of these cells from the distal, rather than 
proximal, margin of the limb is indicated by the expression of Etv4 (Mao et al. 
2009). I conclude that the 4 cell lines retain developmental specific functions 














                  
Figure 2.1. Schematic of E10.5 mouse forelimb bud.  The cross-lines show where the 
limb buds were dissected into anterior vs posterior distal regions and used to generate cell 













Figure 2.2. Characterisation of cell lines derived from distal posterior and anterior 
forelimb. A, RT-PCR to detect the expression of mesenchymal markers (Fgf10, Fgf2cR, 
Etv4) and epithelial markers (Fgf8, Fgf2cR) in the A1/P1 and A2/P2 cell lines. B, Selection of 
genes showing greater anterior or posterior expression or similar levels of expression in the 
A2/P2 cell lines from expression microarray analysis. Genes are categorized according to 
their function in limb development. y-axis: log2 scale showing greater anterior expression 
upper, greater posterior lower (A/P). C, Schematic of gene ontology (GO) pathway analysis 





To provide further insight into the differences between the anterior and 
posterior derived cell lines (A2 and P2) I analysed RNA prepared from these cell 
lines on mouse expression microarrays (Illumina). Array hybridisation was 
conducted by the Wellcome Trust Clinical Research Facility and the data were 
analysed in R using the limma (Smyth et al. 2005) and beadarray (Dunning et al. 
2007) bioconductor packages. Probes were assessed for differential expression using 
limma’s lmFit, eBayes and topTable function. Levels of Etv4 and Etv5 mRNAs – 
encoding transcription factors known to be expressed in the distal limb mesenchyme 
and important for the posterior restriction of Shh expression (Mao et al., 2009) – 
were higher in the anterior cells than posterior, whereas members of different groups 
of ETS factors that define the spatial boundary of Shh (Chapter 3) were higher in the 
posterior cells (Ets1) or expressed at similar levels (Gabp)  throughout the distal 
limb bud (Lettice et al., 2012) (Fig. 2.2B). Genes involved in mesenchymal-epithelial 
signalling and patterning of the distal limb bud were upregulated in anterior (Bmp4, 
Spry4) and posterior (Twist1) cells or expressed evenly across the A-P axis (Fgf10). 
Amongst the genes with the highest ratio of expression in the posterior cells were 
those involved in retinoid signalling (Cyp26a1, Crabp2, Raet1b, Rbp1), and in 
chondrogenesis, osteogenesis or myogenesis (Sox9, Pdzrn3, Dlk1, Col2a1, Col4a2) 
(Fig. 2.2B). However, some genes associated with retinoid signalling (Rarg) and 
skeletal morphogenesis (Fzd5) were more highly expressed in the anterior cells or 
showed similar levels of expression (Sulf1). 
Gene Ontology analysis (GOrilla) indicated that the genes with the most 
significantly different A/P expression levels were most highly enriched for GO 
Biological Process terms (P < 10
-9
) including anterior/posterior axis and pattern 
specification, anatomical structure morphogenesis and embryonic skeletal system 
morphogenesis – categories that reflect the cell lines’ origins from mesenchymal 





2.2.2 Immortomouse cell lines reflect differential 5′ Hoxd gene expression in 
distal posterior limb bud  
The spatial expression domains of Hoxd genes in E10.5 limb buds are well 
characterised (Spitz et al., 2003; 2005; Tarchini and Duboule, 2006; Zakany and 
Duboule, 2007). To determine how relevant the limb cell lines are for analysis of 
HoxD spatial regulation in the distal limb I carried out RT-PCR and qRT-PCR on 
both sets of cell lines and on tissue dissected from E10.5 anterior and posterior 
forelimb buds. 
Hoxd1 mRNA was not detected in any of the cell lines and only very faintly 
in anterior limb tissue (Fig. 2A). Hoxd3 expression was detected at levels that are 
generally low (Fig2A)  and similar between the anterior and posterior limb tissue and 
the corresponding cell lines – except for even lower levels  in P2 cells (Fig 2B). 
There was no significant anterior/posterior difference in Hoxd3 expression in either 
cell line pairs or limb tissue (Fig. 2C). Conversely, at the 5′ end of HoxD the levels 
of Hoxd13 expression are 17 fold higher in posterior limb and limb-derived cell lines 
than in the anterior equivalents (Fig. 2C). A2 and P2 cell lines showed similar 
expression levels as detected in dissected anterior and posterior tissue, but A1 and P1 
lines showed proportionally similar decreases in expression levels (Fig. 2B). I 
observed slightly higher Hoxd12 expression in the posterior limb tissue than the 
anterior, and higher Hoxd11 in P1 compared to A1 cells, but their expression levels 
were too low for reliable quantification. Hoxd10 expression shows a high P/A 
difference in both cell line pairs – the apparent large difference (Fig 2C) measured in 
the A1/ P1 cell lines is due to the very low levels of expression in A1 – and Hoxd8 
expression shows a P/A differential (3 fold) in the second cell line pair only due to 
increased expression of this gene in the P2 cells, expression levels in A2, A1 and P1 
being similar to limb tissue levels (Fig. 2B and C). No P/A difference in Hoxd8 
expression was detected in the E10.5 limb tissue samples. This suggests that both cell 
line pairs capture cells that have activated 5′ Hoxd genes specifically in the posterior 
compartment at the start of the second wave of HoxD activation in the distal limb 
and that Hox gene activation has a greater extension 3′ in the P2 cell line (to Hoxd8) 
than P1 (Hoxd10). Gene activation extends more 3′ in the posterior derived cell lines 
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than in the dissected limb tissue. This could be due to the outgrowth of cells from the 
posterior limb that have more extensive gene activation than the average or, more 
likely, that the regulatory mechanisms driving progressive 5′-3′ HoxD activation 
continued to operate for some time after tissue dissection and during cell 
immortalisation.  
 Upstream of Hoxd13, Evx2 expression could not be detected in the E10.5 cell 
lines by PCR (data not shown) suggesting that the cells likely originate from outside 
of the small domain at the extreme distal margin of the E10.5 forelimb bud to which 
Evx2 expression is restricted (Tarchini and Duboule, 2006). Shh expression was also 
not detected, suggesting that it is not required for maintenance of the second wave of 
HoxD activation, at least in cell lines, as has been previously proposed (Harfe et al., 
2004).  
Whilst both immortomouse derived distal limb cell line pairs show a posterior 
-anterior difference in 5′ HoxD activity, the P2/A2 pair show a more extensive 
domain of activation (Hoxd13 to Hoxd8) and so were chosen for most of the 
subsequent study.  
  










                        
Figure 2.3. Comparison of Hoxd expression in the distal anterior and posterior limb 
cell lines with distal anterior and posterior forelimb tissue A, RT-PCR to detect the 
expression of 3′ (Hoxd1, Hoxd3, Hoxd4, Hoxd8) and 5′ (Hoxd10, Hoxd11, Hoxd12, Hoxd13) 
Hoxd genes and the adjacent Lnp in both sets of cell lines (A1 & P1, A2 & P2) and in E10.5 
distal forelimb tissue (A & P). Primer pair sequences for each gene are indicated in Table 
6.1. B and C, Quantitative (q)RT-PCR to compare expression levels of 3′ (Hoxd3, Hoxd8) 
and 5′ (Hoxd10, Hoxd13) Hoxd genes in both sets of cell lines and anterior or posterior distal 
forelimb tissue. In B, expression in each cell line is compared to the corresponding limb 
tissue. C, Log2 P/A expression in both sets of cell lines (white and grey bars) and in distal 
forelimb tissue (black bars). The y-axis has a Log2 scale due to the large difference in 




A model for late phase HoxD activation in the distal limb bud proposes a reciprocal 
activation pathway involving the restriction of early phase 5′ Hoxd gene expression 
to the posterior margin of the limb bud that then ensures posterior-only activation of 
Shh, which in turn effects the initiation of secondary 5′ HoxD expression in the distal 
posterior limb bud (Harfe et al., 2004; Robert and Lallemand, 2006). I did not detect 
Shh expression in either the P1 or P2 posterior derived cell lines, which nonetheless 
maintain upregulated 5′ Hoxd gene expression – especially of Hoxd13 (Fig. 2.3). 




 mice, and only 
at reduced levels in Shh
-/- 
mice (Litingtung et al., 2002). Shh expression prevents 
Gli3 repression of the 5′ Hoxd genes, both by repressing Gli3 expression posteriorly 
and antagonizing Gli3 processing to Gli3R, as Gli3R has been suggested to be the 
repressor of 5′ Hoxd gene expression in anterior limb (Tarchini and Duboule, 2006). 
It is likely that posterior Shh expression in the embryonic limb, up to the point of cell 
immortalisation, was sufficient to activate late phase HoxD expression. The 
subsequent strong maintenance of Hoxd13 expression in the posterior limb-derived 
cell lines suggests that Shh is not required for maintaining HoxD activity. Loss of 
Shh expression in the cell lines could be due to the loss of interaction between the 
mesenchyme of the zone of polarizing activity (ZPA), which maintains A-P polarity 
and is defined by Shh expression, and the overlying AER which regulates proximal-











2.3 A-P difference in polycomb over the HoxD cluster 
2.3.1 Loss of H3K27me3 over the HoxD cluster in posterior cells 
The polycomb complex PRC2 is fundamental to regulation of Hox gene clusters 
during ES cell differentiation and early embryogenesis and is responsible for 
blanketing HoxD with H3K27me3 (Boyer et al., 2006; Lee et al., 2006). Polarised (3′ 
- 5′) loss of H3K27me3 accompanies 3′ Hoxd gene activation during ES cell 
differentiation (Eskeland et al., 2010) and in the tail bud of the main embryonic axis 
during early embryogenesis (Soshnikova and Duboule, 2009). PRC2 function in the 
limb is required for cell survival and for proximodistal elongation of the limb 
(Wyngaarden et al., 2011), but whether differential polycomb-mediated chromatin 
changes are involved in regulating anterior-posterior Hoxd gene expression during 
the late phase of distal limb patterning is unclear.  
From my analyses in Figure 2.2, the limb cell lines are composed of, what 
appears to be, a relatively homogenous mesenchymal cell population. In contrast, 
more heterogenous cell populations are inevitably present in dissected limb tissue, 
where AER- and mesenchyme- derived cells expressing different cohorts of Hoxd 
genes may mask differences in H3K27me3 levels between the anterior and posterior 
mesenchyme. Immunoblotting shows that total levels of H3K27me3 are similar 
between A2 and P2 cells (Fig. 2.4A). Using native ChIP combined with custom high-
density tiling arrays covering multiple regions of the mouse genome, including 
670kb encompassing HoxD, I determined the H3K27me3 profile of the A2/P2 distal 
forelimb-derived cell lines (Fig. 2.4B).  
H3K27me3 is pervasive over HoxD in anterior cells, with both the 5′ and 3′ 
(Hoxd1 – d4) genes densely covered (Fig. 2.4B). The dip in H3K27me3 between 
Hoxd4 and Hoxd8, is similar to that seen in ES cells (Eskeland et al., 2010). Whilst 
H3K27me3 still blankets Hoxd1 - d3 in posterior (P2) cells, it is largely absent over 
the 5′ genes (Fig. 2.4B, upper two tracks and higher resolution tracks below 
displaying the Hoxd13  and  Hoxd12 genomic region). Low levels of H3K27me3 at 
the HoxA and HoxB  loci where observed, with only Hoxa11-13 and Hoxb13 highly  
enriched (Hoxa13 expression is restricted to the extreme distal margin of the limb 
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bud and temporal activation occurs at around E10.5 (Lehoczky et al., 2004)). The 
polycomb target Pax6 was blanketed with H3K27me3, however no change in 
anterior versus posterior cells was observed. H3K27me3 is absent over Brd3, a gene 
that codes for a bromodomain protein with a role in histone acetylation. 
Analysis of all regions of the genome covered by the tiling array, which 
includes the other paralogous Hox clusters, showed that extensive A-P differences in 
H3K27me3 are specific to HoxD. Of those probes significantly enriched in 
H3K27me3 in anterior cells (log2 H3K27me3/input ≥ 1) (Fig. 2.5, Upper Pie chart) 
only 8% are from HoxD. Yet 93% of these probes with an at least two-fold (log2 ≥ 
1) A/P difference in H3K27me3 enrichment are from this locus –  88% from 5′ 
HoxD, and 5% from 3′ HoxD (Fig. 2.5, Lower Pie Chart). In contrast, any 
differences of H3K27me3 coverage over the entire HoxA locus between anterior and 
posterior cells at stage E10.5 is minimal: the HoxA locus contains 4% of the probes 
significantly enriched for H3K27me3 in anterior cells but only 2% of probes with at 
least two-fold A/P difference in H3K27me3.  
Despite their cellular heterogeneity, I also analysed H3K27me3 in E10.5 
anterior and posterior dissected distal forelimbs (Fig. 2.4B, lower two tracks) by 
native ChIP, using an amended protocol for low cells numbers (see Chapter 6: 
Methods and Materials). In both limb regions a block of H3K27me3 covered the 3′ 
end of HoxD (d1-d4). Both anterior and posterior limb samples also show a second 
block of modification over the 5′ end of HoxD, from Hoxd9 through to Evx2, but this 
was at a significantly higher level in anterior compared to the posterior region 
(Hoxd13 – Hoxd10 p < 0.0001) (Fig. 2.6A and B). Whereas in the anterior distal 
limb H3K27me3 remains high from Evx2 to beyond Hoxd12, in the posterior 
H3K27me3 declines from the Evx2 - Hoxd13 intergenic region up to Hoxd11 (Fig. 
2.6A). This A-P difference in H3K27me3 levels in limb tissue is specific to the 5′ 
HoxD region (Fig. 2.6C), being significantly greater (p < 0.0001) than the A-P 
difference for all Hox loci combined. The A-P difference for the 3′ HoxD region is 
not statistically significant (p = 0.57). 
Quantitative PCR (qPCR) confirmed the lower H3K27me3 levels in P2 vs A2 
cells at Hoxd10 (Fig. 2.7A), with a less dramatic decrease at Hoxd1. There was no 
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significant A-P difference in H3K27me3 at the polycomb target Olig2 (positive 
control) or housekeeping gene -actin (negative control). A decrease in H3K27me3 
at the Hoxd10 promoter in the posterior compared with anterior limb tissue cell 
population was confirmed by qPCR, whereas H3K27me3 levels at the Hoxd1 
promoter were similar in both distal limb samples (Fig. 2.7B). These data are 
consistent with a role for polycomb-mediated repression in regulating posterior-
anterior differences in Hoxd gene expression during the patterning of the distal limb. 
 
2.3.2 PRC1 levels are reduced over HoxD in distal posterior cells 
The switch over from early to late phase HoxD expression in the posterior 
mesenchyme of the E10.5 distal forelimb, involving the switching off of 3′ Hoxd 
genes as the 5′ genes are being activated in reverse order, suggests that regulatory 
factors are operating in a highly dynamic milieu. Therefore, snapshots of H3K27me3 
profiles at this crucial developmental time point may not fully capture this dynamism 
if there were a time lag in the removal of this histone modification. The PRC1 
complex recognizes and binds to H3K27me3-modified chromatin to bring about 
chromatin compaction and gene repression (Eskeland et al., 2010). To determine 
whether there is differential PRC1 binding related to limb-specific Hoxd gene 
expression, I analysed the distribution of the PRC1 component Ring1 by ChIP in 
E10.5 anterior and posterior dissected limb bud tissues.  
The Ring1profile at HoxD shows a correlation with that of H3K27me3 in limb bud 
tissues (Fig. 2.8A, H3K27me3 profile over the HoxD locus from Fig. 2.4 shown 
above). There is a block of Ring1 from Evx2 up to Hoxd9 in distal anterior limb 
cells, whereas in posterior tissue this block reaches Hoxd10 and only sparsely covers 
the genomic region encompassing Hoxd13-11. The A-P difference in Ring1 levels 
was significant throughout the 5′ HoxD (promoters, genes and intergenic p < 
0.0001). Over 3′ HoxD A-P differences were only significant over the genes 
themselves (p < 0.0001) and not over the gene promoters (p = 0.68) nor the 
intergenic regions (p = 0.07) (Fig. 2.8B). A-P difference at the 5′ HoxD region was 
greater than at all the Hox loci combined (p < 0.0001) (Fig. 2.8C).  
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At the HoxB locus, Hoxb13 has high coverage of Ring1B in anterior and posterior 
cells, similar to H3K27me3. Ring1B-binding over the rest of the HoxB cluster was 
similar in anterior and posterior tissue, except over Hoxb9 and the adjacent intragenic 
region where Ring1B levels were more extensive in the anterior cells (Fig. 2.8A). As 
for H3K27me3, Ring1B covered the Pax6 locus but was absent at the Brd3 locus in 


































































































































































































































































































































Figure 2.5. The majority of highly enriched H3K27me3 probes in A2 cells compared to 
P2 cells cover the 5′ HoxD genomic region. Pie charts showing the genomic distribution of 
different categories of probes enriched for; (top) H3K27me3 in A2 cells (log2 





















Figure 2.6. Comparison of H3K27me3 levels over 5′ and 3′ HoxD in E10.5 distal 
anterior and posterior limb tissue. A, Mean (+/- S.E.M.) log2 H3K27me3/input at HoxD 
and neighbouring genes and promoter regions in distal forelimb anterior and posterior tissue. 
Average log2 values were calculated from each individual probe value that covered the 
genomic locations of the genes and promoters. The significance of differences in H3K27me3 
enrichment in anterior compared to posterior cells over each gene and promoter were 
examined by 2-sample t-test (* p < 0.01, ** p < 0.0001). B, Median log2 H3K27me3/input at 
the HoxD locus in distal anterior and posterior cells. The whole locus, 5′ and 3′ ends and 
promoter, gene and intergenic loci within each region were compared; and the statistical 
significance of anterior-posterior differences was examined by Mann-Whitney U tests. C, A-P 
difference in median log2 H3K27me3/input at all the Hox loci combined and the 5′ and 3′ 
ends of the HoxD locus. The statistical significance of differences between the combined 
Hox clusters and either end of the HoxD region were examined by Mann-Whitney U tests (5′ 
HoxD : Hox p < 0.0001,  3′ HoxD : Hox p = 0.57). 
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Figure 2.7. Loss of H3K27me3 at 5′ Hoxd promoter in posterior cells. A, ChIP for 
H3K27me3 at the Hoxd1, Hoxd10, Olig2 and -actin promoters by qPCR in A2 (white) and 
P2 (black) cells. Enrichment is shown as mean percent input bound ± SEM over 3 biological 
replicates. B, ChIP for H3K27me3 at the same gene promoters as (A) in E10.5 distal anterior 
(white) and posterior (black) forelimb tissue. Enrichment is shown as mean percent input 





































































































































































































































































































































































































































































































































































































































2.4 Anterior-posterior differences in chromatin compaction at HoxD in 
the distal limb bud  
2.4.1 Chromatin decompaction in both posterior cell lines specifically over 
HoxD  
Polycomb, and particularly PRC1, brings about a chromatin compaction at target loci 
that is detectable by measuring the spatial separation of fluorescence in situ 
hybridization (FISH) signals from closely apposed probe pairs (Eskeland et al., 2010) 
(Fig. 2.9). Using these approaches, a decompaction of HoxD is seen as Hox genes 
are activated during ES cell differentiation and in the tail-bud of the embryo (Morey 
et al., 2007). I first used 2D FISH to assay chromatin compaction (d
2
) across HoxD 
in limb bud cell lines. Any difference in inter-probe distance (d) due to variation in 
nuclear size between the cell lines was also assessed by normalising d
2
 by the nuclear 
radius (r
2
). However, in practice the exact same conclusions were reached when 
considering interprobe separation without normalization to nuclear size (Table 2.1). 
I found that chromatin across HoxD (Hoxd3 – Hoxd13) was significantly less 
compact in distal posterior cell lines compared to the distal anterior (p = 0.0002 and 
p = 0.03 for A1/P1 and A2/P2 respectively) (Fig. 2.10 and 2.11, and Table 2.1). This 
was restricted to the region with differential H3K27me3, as there is no significant A-
P difference in chromatin compaction of the GCR-Lnp region 5′ of HoxD where the 
low levels of H3K27me3 detected are the same between A and P cell lines (Fig. 
2.4B). Nor was there differential compaction at a control region near the Pax6 locus 
(Rcn – Rpl10) on the same chromosome (MMU2) as HoxD, and which contains 
genes with no known role in limb development and no differential expression 









Figure 2.9 Schematic of the genomic region around HoxD. The grey boxes above the 
genomic region depict the probes used for FISH experiments. Highly conserved regions 
within the GCR locus, the position of the limb-specific Prox enhancer and the recently 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table  2.1. Normalised interprobe distance for A1 & P1 and A2 & P2 cell lines 
Cell line Hoxd3-Hoxd13 (93 kb) GCR-Lnp (89 kb) Rcn-Rpl10 (166 kb) 





A1                                                               
P1                                                             
0.0056
0.0084 (p = 0.0002) 
0.0021 
0.0024 (p = 0.05) 
0.0039 
0.0030 (p = 0.11) 
A2                                                              
P2                                                             
0.0060
0.0084 (p = 0.03) 
0.0025 
0.0027 (p = 0.90) 
0.0054 
0.0038 (p = 0.08) 





A1                                                            
P1                                                           
0.16
0.25 (p < 0.0001) 
0.066 
0.073 (p = 0.34) 
0.11 
0.09 (p = 0.14) 
A2 
P2                                                                                                                          
0.20 
0.27 (p = 0.02) 
0.09 
0.08 (p = 0.88) 
0.18 
0.12 (p = 0.10) 
Statistical analysis of data for Fig. 2.10 and 2.11. Interprobe distances are median values, p-
values from Mann-Whitney U Tests. 
 
2.4.2 Chromatin decompaction at HoxD is specific to the distal posterior limb 
bud in E11.0 embryos 
I sought confirmation of differential HoxD compaction by FISH analysis in tissue 
sections cut through the anterior and posterior regions of the forelimbs of 
paraformaldehyde-fixed E10.5 – E11.0 embryos  (Fig. 2.12).  Here, not only was I 
able to compare the distal anterior and posterior regions, but also more proximal limb 
regions and indeed the flank region adjacent to the forelimb bud tissue where Hoxd 
genes are not expressed. As observed in the cell lines, HoxD chromatin was 
significantly less compact (d
2
) at the distal posterior forelimb bud compared to the 
distal anterior (p = 0.0008) but also compared with other limb and non-limb regions 
analysed (proximal posterior, p = 0.02; proximal anterior, p = 0.0002; flank, p = 
0.0002) (Fig. 2.13 and Table 2.2). There was no significant difference in HoxD 
chromatin compaction between any of the other limb regions or even between these 
other limb regions and the flank tissue. Likewise, no significant differences in 
chromatin compaction could be identified between any of the tissue regions, 
including the distal forelimb bud, at the GCR-Lnp and the Rcn-Rpl10 control regions 
(Fig. 2.13 and Table 2.2). Therefore, an unfolding of chromatin at HoxD 





Table 2.2. Interprobe distances for E11 limb bud sections 












0.116 (p = 0.0008) 
0.153 (p = 0.02) 
0.098 (p = 0.0002) 
0.130 (p = 0.0002) 
0.076 
0.076 (p = 0.93) 
0.076 (p = 0.46) 
0.074 (p = 0.45) 
0.078 (p = 0.49) 
0.080 
0.081 (p = 0.10) 
0.090 (p = 0.06) 
0.112 (p = 0.05) 
0.112 (p = 0.17) 
Statistical analysis of data for Fig. 2.13. Interprobe distances are median values, p-values from 
































































































































































































































































































































           
 
 
Figure 2.13. Decompaction of HoxD is specific to the distal posterior region of E11 
forelimbs. Box plots show the distribution of interprobe distances (d
2
) at the HoxD, GCR 
and control loci for the proximal and distal anterior and posterior forelimb bud and the 
adjacent flank. Shaded boxes show the median and interquartile range of the data; asterisks 
indicate outliers. Number of loci: HoxD = 100, GCR > 80, control > 80. Probe positions as 
indicated in Fig. 2.8. The statistical significance of differences between each of the limb 
regions and flank were examined by Mann-Whitney U tests: Hoxd3-Hoxd13 – distal posterior 
- distal anterior, p = 0.0008; - proximal posterior, p = 0.02; - proximal anterior, p = 0.0002; - 
flank, p = 0.0002. GCR-Lnp – distal posterior - distal anterior, p = 0.93; - proximal posterior, p 
= 0.46; - proximal anterior, p = 0.45; - flank, p = 0.49. Rcn1-Rpl10 – distal posterior - distal 













2.5 Nuclear co-localisation of the GCR and 5′ HoxD in distal posterior 
cells 
Developmental stage E10.5 marks the start of the later phase of distal limb 
development, characterised by quantitative colinearity in which strong expression of 
Hoxd13 is initiated in the distal margin of the posterior mesenchyme. This is driven 
by enhancer elements located 5′ of HoxD, the best characterised of which is the GCR 
~200kb centromeric of Hoxd13 (Figs. 2.4B and 2.9) (Montavon et al., 2008).  
One possible mechanism for long-range cis-regulation invokes the spatial co-
localisation in the nucleus of the enhancer and target promoter (Williamson et al., 
2011). Indeed, modelling of the changes in gene expression in the distal limb bud 
that occur as a consequence of 5′ HoxD deletions led to the suggestion that the first 
step in 5′ Hoxd gene activation in the distal posterior limb bud might be a long-range 
interaction (looping) between regulatory sequences such as GCR and Hoxd13 
(Montavon et al., 2008). To test this model, I analysed FISH signals for probes from 
the GCR and Hoxd13 regions and determined the proportion that co-localised (d < 
200nm). I analysed multiple areas within the E11.0 limb bud (Fig. 2.14A); including 
those where late phase gene activation initiates (distal posterior), where it is poised 
for activation at later embryonic stages (distal anterior), where the early phase of 3′-
5′ Hoxd gene activation – that does not depend on the GCR – has occurred (proximal 
limb) and then in the control flank mesoderm.  
Average GCR - Hoxd13 interprobe distance (d
2
) were significantly smaller in 
nuclei of the posterior distal limb bud compared to distal anterior (p = 0.04, Mann-
Whitney U analysis) (Fig. 2.14B; Table 2.3). This was also true for comparison of 
GCR - Hoxd13 interprobe distances (d
2
) measured in the flank, proximal anterior and 
posterior (Mann-Whitney U analysis of distal posterior versus proximal posterior, p 
= 0.002; proximal anterior, p = 0.02; or flank, p < 0.0001). This was not seen for 
distances between GCR and a probe at the 3′ end of Lnp (Fig. 2.13) indicating that 
there is not a simple compaction of the whole region 5′ of Hoxd13. Moreover, the 
proportion of alleles where GCR and Hoxd13 probe signals were spatially co-
localised was far higher in posterior distal limb (> 30%) than in all other areas tested 
(Figs. 2.14C and 2.15A; Table 2.4). These data are consistent with the formation of a 
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chromatin loop between Hoxd13 and the GCR regulatory module at the time and 
place of distal limb bud development when the GCR is required to initiate HoxD 
reverse co-linearity and Hoxd13 expression (Fig. 2.16).  
Recently, the 4C technique was used to identify sequences that could be 
captured together with Hoxd13 in tissue from across the distal limb at E12.5 – a later 
stage of limb development and 5′ HoxD activation than studied here (Montavon et al. 
2011). This identified multiple new potential regulatory regions in the extensive gene 
desert centromeric of HoxD and located far beyond the GCR. It was suggested that 
these elements might simultaneously interact with each other and with 5′ HoxD in 
the distal limb to form a compact regulatory hub (Figs. 2.9 and 2.16). One of these 
new regulatory elements, island III (Fig. 2.9), is located ~200kb centromeric of the 
GCR and was shown to interact with Hoxd13 in limb and brain tissue (Montavon et 
al. 2011). To test this model, we measured the physical separation between the island 
III region and the GCR – a genomic distance that is equivalent to that separating 
GCR from Hoxd13 (~200kb) – and also between island III and Hoxd13 (Fig. 2.9). In 
E11.0 limb buds, we did not detect any significantly increased co-localisation 
frequency between island III and Hoxd13 or between island III and GCR in posterior 
distal limb, compared to other forelimb regions (Figs 2.14C and 2.15B & C, Table 
2.4). However, average interprobe distances (d
2
) between Hoxd13 and island III are 
similar to those between Hoxd13 - GCR and GCR - island III despite the former 
being double the genomic distance (Fig. 2.14B, Table 2.3). These data suggest that 
the ~400kb genomic region from the 5′ end of HoxD into the centromeric gene desert 
is configured in a relatively compact, yet flexible, conformation (Fig. 2.16).  
I did not assess the co-localisation of the Prox regulatory element (Fig. 2.9) as 












Table 2.3. Interprobe distances for HoxD regulatory regions in E11 limb bud sections 
 
Limb region Hoxd13-GCR  
 (231 kb) 
Island III-GCR  
(201 kb) 













0.098 (p = 0.04) 
0.107 (p = 0.002) 
0.098 (p = 0.02) 
0.171 (p < 0.0001) 
0.084 
0.087 (p = 0.43) 
0.098 (p = 0.99) 
0.094 (p = 1.00) 
0.098 (p = 0.77) 
0.072 
0.067 (p = 0.96) 
0.085 (p = 0.11) 
0.099 (p = 0.005) 
0.081 (p = 0.04) 
Statistical analysis of data for Fig. 2.14B. Interprobe distances are median values, p-values from 
Mann-Whitney U Tests. 
 
 
Table 2.4. Co-localisation frequency of Hoxd13 and enhancer probes for E11 limb bud 
sections 
Limb region Hoxd13-GCR   
(231 kb) 
Island III-GCR  
(201 kb) 
Hoxd13-island III  
(432 kb) 







14 (p = 0.01) 
5 (p < 0.0001) 
8 (p = 0.0001) 
7 (p < 0.0001) 
13 
11 (p = 0.83) 
11 (p = 0.839) 
13 (p = 1.00) 
12 (p = 1.00) 
19 
14 (p = 0.30) 
16 (p = 0.61) 
13 (p = 0.22) 
10 (p = 0.07) 
Statistical analysis of data for Fig. 2.14C. p-values from Fisher’s Exact Tests 
 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































          
 
Figure 2.15. Frequency distributions of the interprobe distance (d) between the GCR 
enhancer, Hoxd13 and island III probes. Frequences were calculated for every 0.m 
distance interval (x-axis) between A, GCR – Hoxd13, B, Hoxd13 - island III and C, GCR - 
island III in nuclei derived from proximal and distal E11 forelimb bud regions and the 
adjacent flank region. The location and plane of the tissue sections are shown in Figure 2.11. 




                            
 
Figure 2.16. Possible higher-order chromatin conformation of the 5′ HoxD regulatory 
region. Hoxd13 expression at E10.5-11 initiated following interaction with the GCR and Prox 
enhancers. Measurement of interprobe distance between Hoxd13 – GCR, Hoxd13 – island 
III and GCR – island III indicates that the nuclear distances separating all three regions are 
similar. FISH data presented here and 4C data from E12.0 embryos (Montavon et al., 2011) 
suggest that the locus has a compact conformation that may result from multiple chromatin 
mini loops enabling direct interaction between the enhancers and their target genes. But in 
this study, only the GCR showed significantly greater co-localisation with Hoxd13, implying 
that the island enhancers identified in the previous study, although situated within the 
regulatory region, are not yet active but are required for 5′ Hoxd expression at later 
developmental stages and/or across more anterior limb regions. (islands I & II not shown but 
located beyond the island III – V locus (Fig. 2.8). Prox previously shown to drive limb 5′ 













2.6 Poised/active enhancer histone modification H3K4me1 marks 
conserved GCR and Prox loci in distal limb anterior and posterior cells 
The histone modifications H3K4me1/3 are well-established markers of regulatory 
elements (ENCODE consortium, 2007; Barski et al., 2007; Heintzman et al., 2007; 
Wang et al., 2008) with H3K4me1 the dominant modification over enhancers in most 
cell types (Robertson et al., 2008; Heintzman et al., 2009) (section 1.1.1.3). Although 
widely accepted as being an “active mark”, H3K4me1 has also been identified over 
“poised” enhancers in human ES cells, mouse ES cells and several adult tissues 
(Rada Iglesias et al., 2010; Creyghton et al., 2010.; Zentner et al., 2011).  
In order to try and identify active and poised enhancers that might have a role 
in regulating gene expression in the developing limb, I used the native ChIP protocol 
modified for small numbers of cells combined with custom high-density tiling arrays, 
to determine the H3K4me1 profile of cells dissected from the distal anterior and 
posterior forelimb buds of E10.5 embryos. 
The HoxD cluster, and indeed the other three Hox clusters, are pervasively 
covered with the H3K4me1 mark in both anterior and posterior limb bud cells 
(Figure 2.17, upper panels, HoxA also shown), similar to H3K4me2/3 coverage in 
mouse primary lung fibroblasts (Bernstein et al., 2005). However, there is a dip in 
levels in promoter regions immediately adjacent to transcription start sites (TSSs) of 
the 5′ Hoxd genes and Evx2, likely to be a consequence of histone H3 lysine 4 being 
modified by the tri-methylation mark here (Fig. 2.17, lower middle panel) (Barski et 
al., 2007, Heintzman et al., 2007). In contrast the -globin genomic region, including 
enhancer elements, is free of H3K4me1; as expected from limb bud cell populations 
composed of non-erythroid precursors.  
Similar H3K4me1 modification in anterior and posterior cells at the promoter 
regions of 3′ and 5′ Hoxd genes was confirmed by qPCR (Fig. 2.18), although levels 
are greater at Hoxd1 compared to Hoxd10 which may be due to the progressive loss 
of the H3K4me3 mark at this silenced gene (Fig 2.3A).   The ubiquitously-expressed 
-actin gene’s promoter has high levels of H3K4me1 in both cell populations, 
whereas levels are minimal at the ES cell pluripotency marker Nanog (Fig. 2.18). 
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The chromatin at both the GCR and Prox loci is also marked by H3K4me1, 
with no A-P difference (Fig. 2.17, upper left panel) – an indication of the capability 
of these enhancers to activate the 5′ Hoxd genes across the distal handplate at later 
developmental stages (> E11.0 up to E12.5). Analysis of these loci at a higher 
resolution (Fig 2.17, lower left and centre panels) revealed that the modification is 
present over highly conserved regions in particular, comparable to the coverage in 
E12.0 distal limb tissue (Montavon et al., 2011). Closer analysis of the 5′ HoxD 
region also shows that H3K4me1 is pervasive mostly over intergenic regions, largely 
correlating with conserved sequences (for example the punctate blocks immediately 
upstream of the Hoxd12 and Hoxd10 promoters), and a further block over a cluster of 
highly conserved sequences centromeric to the adjacent Evx2 gene: which may be 
indicative of more proximal regulatory elements known to be located in and around 
the HoxD cluster.  
Analysis of other genes that are expressed in the distal limb: Shh (Chapter 4), 
Fgf10 and Hoxa13 provided further evidence for the presence of H3K4me1 at 
enhancers active in limb development. H3K4me1 is present not only immediately 
upstream of the Fgf10 promoter – the location of regulatory elements previously 
shown to be capable of driving reporter gene expression on the limb (Sasak et al., 
2002) – but also at several conserved intergenic and 3′ loci of this large gene (Fig. 
2.17, upper, second from the right, panel). The HoxA cluster is considered 
orthologous to HoxD and is also active in the limb. Hoxa13 is expressed in a spatio-
temporal manner similar to the late phase of 5′ Hoxd expression, and analysis of the 
genomic region upstream of the HoxA cluster identified a regulatory region similar 
to the GCR that controls expression of Hoxa13 and upstream genes – but not the rest 
of the Hoxa genes – in the developing distal limb bud (Lehoczky et al., 2004; 
Lehoczky and Innes, 2008). This region has been located to intron 4 of the Hibadh 
gene, with further elements centromeric to this gene, and again – similar to the GCR 
– H3K4me1 is pervasive specifically over regions containing highly conserved 
sequences (Fig. 2.17, lower right panel). Further array analysis is presented and 
discussed in Chapter 4, including for the active limb genes Hand2 and Grem1 as well 
as Shh. But of note, all the known and potential regulatory elements of these genes 
and of the 5′ HoxD genes and Hoxa13 do not show any anterior-posterior difference 
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in H3K4me1 modification, despite all having posteriorly-restricted domains at this 
developmental stage (E10.5).   
Extensive analysis of genomic regions containing genes that are active during 
the development of the distal handplate has identified the H3K4me1 modification at 
both proximal and distal enhancers. In E10.5 distal limb buds, long-range elements 
that drive late phase 5′ Hoxd and Hoxa13 expression are extensively marked by this 
histone modification in tissue where they are active (posterior) and in which they will 
be subsequently activated (anterior). Therefore,  the H3K4me1 histone modification 































































































































































                         
 
Figure 2.18. Similar H3K4me1 levels at 3′ and 5′ Hoxd genes in anterior and posterior 
limb tissue. ChIP for H3K4me1 at the Hoxd1, Hoxd10 and -actin promoters, and Nanog 
gene by qPCR in distal anterior (white) and posterior (black) forelimb tissue. Enrichment is 


















2.7 Discussion  
Limb-specific secondary activation of HoxD is initiated in the distal posterior 
forelimb bud at ~E10.5 in the mouse. I have confirmed that 5′ Hoxd gene expression 
levels are significantly greater in distal posterior E10.5 cells relative to distal anterior 
(Fig. 2.3), commensurate with the spatial and temporal aspects of late phase reverse 
co-linearity (Spitz et al., 2003). This A-P difference in expression levels is lost by 
E11.5-E12.5 as the 5′ genes are activated in more distal anterior regions, but with 
Hoxd13 still the most strongly expressed (data not shown) (Montavon et al., 2008).  
I have shown that immortalised cell lines derived from the anterior vs 
posterior E10.5 distal limb recapitulate global expression patterns consistent with 
their mesenchymal origin from the limb during anterior-posterior axis specification 
and skeletal morphogenesis (Fig. 2.2). Moreover, these cells maintain the differential 
Hoxd gene expression pattern of the temporal developmental stage from which they 
are derived (Fig. 2.3).  
I identified differential H3K27me3 over 5′ Hoxd genes between anterior and 
posterior derived limb cell lines. In anterior cells, I found extensive H3K27me3 over 
Hoxd13 towards Hoxd10 that is absent from posterior cells (Fig. 2.4). That this 
contributes to the repression of 5′ Hoxd genes in the anterior distal limb is consistent 
with the ectopic anterior expression of Hoxd11 and Hoxd13 in E10.5 limb buds after 
ablation of the PRC2 component Ezh2 (Wyngaarden et al., 2011). Since Hoxd genes 
have been transcriptionally active during the earlier phase of limb development, I 
cannot determine whether this represents an active removal of H3K27me3 from the 
5′ HoxD in cells derived from the posterior distal E10.5 limb, or whether this pattern 
results from the re-establishment of H3K27me3 by the PRC2 complex over this 
region in anterior distal cells. The presence of H3K27me3 over 3′ HoxD in both 
anterior and posterior derived cells and in dissected limb tissue most likely represents 
a re-imposing of this repressive histone mark after the initial phase of Hoxd gene 
expression in early, proximal limb bud development (Fig. 2.4).  
The late phase 5′ Hoxd gene expression in the posterior distal limb bud is also 
accompanied by a reduction of Ring1binding, as expected in a model where PRC1 
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binding is directed by recognition of H3K27me3 Fig. 2.8) (Ku et al., 2008), 
although a low level of PRC1 binding is thought to be mediated by Rybp1 and is 
independent of H2K27me3 (Tavares et al., 2012). Enrichment for PRC1 was 
detected across the Lnp – GCR locus but levels were low and therefore likely to be 
background ‘noise’. PRC1 is required to maintain Hox clusters in a silent, compact 
chromatin state in ES cells (Eskeland et al., 2010). Consistent with this I found 
differential chromatin compaction at HoxD both between the anterior and posterior 
derived limb cell lines and in limb tissue (Figs. 2.10, 2.11 and 2.13), with a greater 
degree of decompaction in cells from the posterior distal region than in cells 
measured in any other region of the limb bud at this stage of development (Fig. 
2.13). These data suggest that dynamic polycomb-mediated control of HoxD 
expression and higher-order chromatin structure, previously described occurring 
along the main anterior-posterior body axis (Morey et al., 2007) (Spitz et al., 2003) is 
recapitulated during limb-specific Hoxd gene expression.  
 I also observed co-localisation of the GCR regulatory region and 
Evx2/Hoxd13 specifically at the distal posterior limb bud (Figs. 2.14 and 2.15A); 
consistent with the formation of a chromatin loop between enhancer elements of the 
GCR and the 5′ HoxD at the time and place of distal limb bud development when the 
GCR is required to initiate HoxD reverse co-linearity and Hoxd13 expression (Spitz 
et al., 2003) (Montavon et al., 2008). My analysis at single cell resolution is 
consistent with average interaction frequencies captured between the 5’ HoxD region 
and GCR by 4C analysis in the limb bud (Montavon et al., 2011). However, there 
was no analysis of anterior vs posterior regions of the limb in that latter study. By 
contrast I did not find co-localisation of 5′ HoxD and a more distal regulatory region 
(island III) (Fig. 2.14C and 2.15B), previously identified by 4C (Montavon et al., 
2011). However, that study was conducted from across limbs from a later 
developmental stage (E12) and therefore the co-localisation might occur later than 
E11. My analysis of nuclear distance does indicate that the ~400 kb region extending 
out from the 5’ HoxD locus into the adjacent gene desert is in a generally compact 
chromatin conformation in all the limb regions tested (Figures 2.14A & B Table 2.3). 
Thus the entire regulatory domain may be configured to minimize the nuclear search 
space for enhancer-gene interactions to then occur at the correct time and place (Fig. 
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2.16). Further analyses over the entire temporal stage of late phase HoxD activity 
(E10.5 – E12.5) and across the A-P distal axis should clarify the spatial and temporal 
specificity of the multiple regulatory elements.  
I found that both the conserved regions of the GCR and the Prox enhancer of 
HoxD have similar levels of H3K4me1 in the distal anterior and posterior limb bud 
(Fig. 2.17); and that HoxD itself is covered with H3K4me1, particularly intergenic 
regions that contain proximal regulatory elements (Figs. 2.17 and 2.18). Therefore, 
H3K4me1 is not only present at the enhancers of the 5′ Hoxd genes in limb bud 
tissue in which they are being activated (posterior) but also where they will be 
activated at a later developmental stage (anterior): in other words, where the 
enhancers could be described as being in a poised state (Creyghton et al., 2010; Rada 
Iglesias et al., 2010). 
I have also shown that H3K4me1 marks long-range regulatory elements 
orthologous to the HoxD GCR (Lehoczky et al., 2004; Lehoczky and Innes, 2008) 
that activate Hoxa13 in a similar spatial and temporal manner as the second phase of 
5′ Hoxd expression (Zakany and Duboule, 2007). Moreover, analysis of other 
genomic regions covered by the high density arrays reveals that H3K4me1 is present 
at the long-range regulatory elements of many non-Hox genes active during distal 
limb bud development; including Fgf10 (Fig. 2.17), Shh and proposed elements 
associated with Grem1 and Hand2 (discussed in Chapter 4). This extensive analysis 
of the H3K4me1 mark in distal limb bud tissues suggests that it is prevalent over 
both proximal and distal regulatory elements of genes that are expressed during the 
growth and patterning of the hand plate. An examination of H3K27ac (a proposed 
mark of active enhancers (Creyghton et al., 2010; Rada Iglesias et al., 2010)) across 
these genomic regions may differentiate between tissues where the enhancers are 
active (posterior) and poised (anterior). 
I have demonstrated that complex higher-order chromatin dynamics is 
implicated in the regulation of Hoxd gene expression during distal limb development, 
with two different processes occurring – chromatin decompaction and looping. This 
is the first demonstration of differential chromatin compaction and enhancer-gene 
co-localisation across the anterior-posterior axis of the developing limb, as a 
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previous study analysing the spatial co-localisation of Shh and its limb enhancer 
reported similar co-localisation in both posterior (Shh expressing) and anterior (no 
Shh expression) limb regions (Amano et al. 2009). 
Before presenting (preliminary) data on the chromatin conformation of the 
Shh regulatory region in limb and neural tissue (Chapter 4), in the next chapter I will 
describe work carried out by myself and others into the competing regulatory 
activities of two different sets of ETS transcription factors at the limb-specific 


























The ETS family have opposing 
functions in the limb that determine 












Anterior-posterior (A-P) polarisation of the developing distal limb bud is determined 
by the zone of polarising activity (ZPA), a limb organising region spatially defined at 
the distal posterior margin by Shh expression and the polarising function of which is 
mediated by SHH (Tickle, 2006; Hill, 2007). Several models have been proposed to 
explain how Shh activity defines digit number and identity (Towers and Tickle, 
2009), and recent studies have established that the protein acts as both a diffusible 
morphogen and mitogen to coordinate digit development by integrating growth with 
digit specification (Towers et al., 2008; Zhu et al., 2008; see Section 1.3). All models 
of Shh function in directing distal limb asymmetry across the A-P axis are predicated 
on spatial expression being restricted to the ZPA (Yang et al., 1997; Ahn and Joyner, 
2004; Harfe et al., 2004). 
Regulation of the spatiotemporal pattern of Shh expression in the developing 
limb bud is encoded by the ZPA regulatory sequence (ZRS) long-range enhancer, 
located up to 1 Mb from its target gene (Fig. 1.7) (Lettice et al., 2002; Lettice et al., 
2003). Point mutations within the highly conserved ~800 bp sequence have been 
shown to generate ectopic anterior expression of Shh in several species (Lettice et al., 
2003; Sagai et al., 2004, Gurnett et al., 2007; Lettice et al., 2008; Furniss et al., 
2008), which is the underlying cause of the preaxial polydactyly (PPD). The severity 
of this skeletal malformation is variable, ranging from triphalangial thumb (three 
phalanges instead of two and rotation of the thumb digit to the same plane as the 
fingers) to the duplication of digits and tibial aplasia. PPD is a heritable abnormality 
that occurs in about 1:2000 human births (Hill, 2007), and has been additionally 
identified in mice, cats, dogs and chickens. The human congenital conditions 
collectively referred to as ZRS-associated syndromes (Wieczorek et al., 2010) 
include preaxial polydactyly type 2 (PPD2), triphalangeal thumb polysyndactyly 
(TPTPS), syndactyly type IV (SD4) and Werner’s mesomelic syndrome (WMS) 
(Lettice et al., 2003; Gurnett et al., 2007; Lettice et al., 2008; Furniss et al., 2008; 
Semerci et al., 2009; Farooq et al., 2010). Other limb abnormalities that map near to 
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the ZRS include the recessive condition achieropodia (Ianakiev et al., 2001) and 
acropectoral syndrome (Dundar et al., 2001). 
The concept of “homotypic clustering” posits that within cis-regulatory 
sequences important transcription factors will have multiple binding sites (Wagner, 
1999; Lifanov et al., 2003; Gotea et al., 2010). The ZRS contains a highly conserved 
7 bp motif (AGGAA
G
/AT) repeated five times (Fig. 3.2A), a sequence that is 




/AT) identified at 
proposed distal regulatory elements in T cells (Hollenhorst et al., 2009). ETS 
proteins form a large family of DNA-binding transcription factors related by their 
highly conserved ETS binding domain (Sharrocks, 2001). The 28 human ETS genes 
are divided into subfamilies based upon function that can be further classified into 
four groups defined by differences in binding motifs preferentially recognised in 
vitro (Fig. 3.1) (Wei et al., 2010; Hollenhorst et al., 2011). Nevertheless, all in vitro 
ETS motifs tested contain an invariant GGA core (Oikawa and Yamada, 2002). 
Many ETS factors are oncogenic and are involved in regulating gene expression by 
expediting the assembly of transcriptional machinery at specific promoters and 
enhancers (Hollenhorst et al., 2011). Two members of the PEA3 subfamily – ETV4 
and ETV5 – have been identified as components of an Fgf-induced pathway that 
inhibits anterior expression of Shh in the mouse developing limb (Zhang et al., 2009; 
Mao et al., 2009; see also Section 1.3.1).  
In addition to ETV4 and ETV5, several other ETS factors have been detected 
in the distal mesenchyme of early-stage mouse limbs. Ets1 and Ets2 are expressed in 
the distal posterior limb at E10.5 (see Fig. 2.2B and Section 2.2.1 for Ets1 expression 
in the P2 E10.5 posterior cell line) and by E11.5 can be detected across the distal 
mesenchyme (Fig. 3.2C, L. Lettice) (Ristevski et al., 2002). In situ hybridisation 
analysis also detected Etv4 and Etv5 expression across the distal mesenchyme at 
E11.5 (Fig. 3.2C, L. Lettice). In addition Gabp mRNA in the distal mesenchyme 
(Ristevski et al., 2004) and Elf1 expression throughout the limb (Richardson et al., 
2010) have previously been reported in the developing murine limb bud. 
Immunoblotting showed that these proteins are present in both the anterior and 
posterior limb bud regions at E11.5, and are enriched in nuclear extracts (Fig. 3.2D, 
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S.Peluso). Of all the known point mutations within the ZRS that engender PPD, none 
are located within the ETS consensus sites; but mutations that cause PPD2 in two 
families – Family A & C (AC) (Gurnett et al., 2007) and an Australian family (AUS) 
(E. Da Graaff, personal communication) – convert the surrounding sequence at the 3′ 
end of the ZRS into additional ETS binding sites (Fig. 3.2A). Transgenic analyses by 
the Hill lab and others (Lettice et al., 2003; Furniss et al., 2008; Lettice et al., 2008) 
have demonstrated that the ZRS can drive LacZ reporter gene expression in the 
expected posterior domain of the limb. The ZRS with the AUS mutation can also 
drive reporter expression in the anterior margin of E11.5 limb buds, and the mutation 
engendered an increase in the posterior expression domain deeper into the middle of 
the limb (Fig. 3.2B, L. Lettice). 
So, the ZRS contains multiple ETS binding motifs, the ETS factors ETV4 
and ETV5 have been shown to prevent ectopic anterior Shh expression, and yet point 
mutations within the ZRS that give rise to additional ETS sites results in anterior 
activation of Shh and as a consequence PPD2. In this project I was part of a lab effort 
to delineate whether and how the ETV factors, and possibly other ETS proteins 
expressed in the limb, exert control over Shh expression through binding to the ZRS.  
 












Figure 3.1. Several ETS factors are expressed in the early limb bud and point 
mutations within the ZRS that result in additional ETS motifs cause ectopic 
expression of Shh. A, Schematic showing the location and conserved sequences of the 
ETS motifs (numbered 1-5, green boxes) and the two non-canonical ETS sites we have 
termed ETV motifs (A & B, blue boxes). The sequence in and around ETV site B is the 
location of the AC and AUS mutations that create additional ETS motifs. Site A is the 
location of another point mutation that causes PPD in a Belgian family (Belg2). B, In situ 
hybridisation analysis for Etv4, Etv5, Ets2 and Ets1 in E11.5 embryos (insets show forelimb 
buds). C, Western blot analysis using antibodies raised against ETV4, ETV5, ETS2, ELF1, 
ETS1, GABP, histone H3 and Actin, with nuclear extracts from E11.5 anterior and posterior 
limb buds. For comparison, whole limb nuclear and cytoplasmic extracts are shown. H3 and 
Actin are loading controls. D, E11.5 forelimbs from transgenic animals carrying either wild-
type or mutant (AUS) ZRS reporter constructs show that the mutation results in expansion of 
posterior activity and ectopic anterior expression. (Modified from Lettice et al., 2012. B & D 
done by L. Lettice, C done by S. Peluso.) 
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Figure 3.2. Dendogram showing relatedness of human ETS factors. Length of each 
horizontal line is an indication of estimated evolutionary distance. Branches labelled in red 
separate sub-families based on function and classes based on DNA binding motifs derived 
from in vitro analysis are indicated by background colours. Factors highlighted in yellow are 
expressed in early limb bud development and were analysed in this study. (Modified from 















3.2 Differential binding at the wild type and mutant sites of the ZRS and 
identification of binding factors in vitro 
3.2.1. Cell line analysis identifies differential protein-binding profiles at WtB 
and AUS/AC mutation sequences  
Using an immortilised cell line derived from the posterior limb buds of E11.5 
embryos (termed 14fp) I delineated the protein-binding profile associated with the 
WtB, AC and AUS 7 bp motifs, and two of the five highly conserved ETS motifs (1 
& 3). Binding profiles were determined by electrophoretic mobility shift assays 
(EMSAs) using biotinylated double-strand oligonucleotide (ds-oligos) probes and 
nuclear extracts from 14fp cells. Initial analysis focussed on the AUS and AC sites 
with 24 bp ds-oligos spanning the WtB or mutant sequences (Fig. 3.2A). The WtB 
sequence produced a single gel-shifted specific band (band1, Fig. 3.3A), with a lower 
non-specific band (NS) observed for most ds-oligos. The ds-oligos with the AC 
mutation produced a strong higher migrating band (band 2), although band 1 was still 
present albeit at very low levels (Fig. 3.3A). In contrast, ds-oligos with the AUS 
mutation produced strong band1 and band 2 shifts, therefore exhibiting a binding 
profile that is a combination of the WtB and AC (Fig. 3.3A); a characteristic that 
may be due to the positions of both point mutations within the DNA sequence with 
regard to the ETV site (Fig. 3.2A, see below).  
To determine whether the proteins binding to the AC and AUS probes are the 
same, I ran a series of competition assays using unlabelled AC and AUS ds-oligos 
with a molar ratio of 1:50 labelled to unlabelled. Unlabelled AC and AUS oligos 
competed with labelled AUS probes for the proteins that cause both band 1 and band 
2 (Figs. 3.3B & C, first two lanes, and previous work done during my master’s 
project). These assays demonstrate that the same proteins are causing the band shifts. 
And during my Master’s project I carried out a series of EMSAs based on the AUS 
ds-oligos with contiguous 3 bp mutations. The protein responsible for the upper band 
shift (band 2) binds to the ETS motif of the AUS ds-oligos as this high migrating 







Figure 3.3. Point mutations that result in additional ZRS ETS motifs bind to the same 
proteins as endogenous sites. A-C EMSA analysis of nuclear extracts from an 
immortalised cell line (14fp) derived from E11.5 embryo posterior forelimbs. A, Protein-
binding profiles produced by ds-oligos containing WtB, AUS, or AC sequence. WtB produced 
a specific band (1), AC generated a higher migrating band (2), and AUS produced a 
combination of the two. A non-specific band (NS) was generated by all ds-oligos in most 
assays. B & C, Competition by EMSA of the binding for ZRS sites 1 and 3, showing that 
unlabelled AUS and AC ds-oligos compete for the band 2 generated by both ds-oligos 
containing the endogenous sites. D, Schematic representation of ETS factor binding to ZRS 
sequences with canonical and non-canonical ETS motifs. In vitro analysis identified ETV4 as 
being able to bind a core AGAAA motif (sites A and B) while ETS1 binds the AGGAAGT 
motifs at sites 1, 2, 3 and the AUS and AC mutation sites. Whereas the AC mutation 
changes the ETV site B to an ETS motif, the AUS mutation creates an additional ETS motif 
adjacent to the ETV site which may result in competition between the two factors for the 
binding site; as suggested by the different band shift profiles of the ds-oligos containing 
either mutation site (schematic figure summarises data from Lettice et al., 2012).     
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I also analysed two of the five endogenous AGGAA
G
/AT sites within the 
ZRS: sites 1 and 3 (Fig. 3.2A). Labelled oligo probes for both generated a band that 
migrated to the same position as band 2 generated by the AUS and AC ds-oligos; and 
showed specificity for binding by competition with both AUS and AC unlabelled ds-
probes (1:50 labelled to unlabelled) (Fig. 3.3B & C). Moreover, previous work 
showed the protein(s) that cause the band 2 shift binds the ETS motif of both probes 
as contiguous 3 bp mutations specifically within these sites resulted in the reduction 
(site 1) or loss (site 2) of this higher migrating band. A weak band that migrates to 
the same position as band 1 generated by WtB and AUS ds-oligos was generated by 
the site 1 sequence; and again was competed for by the AUS and, with a lower 
affinity, the AC unlabelled ds-oligos. 
EMSA analysis of the posterior forelimb 14fp cell line suggested that both 
the AUS and AC mutations disrupt DNA-protein interactions at the WtB locus of the 
ZRS; the former enabling an additional protein to bind while the latter abrogates the 
binding of a protein normally present at WtB, which is replaced by the same protein 
that also binds the Aus AGGAAGT motif. Moreover, this same protein can be 
detected at two of the endogenous AGGAA
G
/AT ETS sites tested and therefore imply 
that the AUS and AC point mutations do indeed result in additional ETS binding 
sites recognised by factor(s) that bind the conserved ETS motifs. To confirm this 
analysis and identify the factors, further EMSA analysis was undertaken on anterior 
and posterior forelimb tissue dissected from E11.5 embryos. 
 
3.2.2. Confirmation of differential binding at mutant and wild-type sites and 
identification of the binding ETS factors in anterior and posterior limb tissue 
This section is a summary of the EMSA analysis on nuclear extract from tissue 
dissected from E11.5 anterior and posterior limbs carried out by other lab members 
(J. Wiltshire and C. de Angelis) covered in the Lettice et al (2012) (Appendix B). I 
discuss this work here as it was a continuation of the analysis described in the 
previous section and feeds into the subsequent in vivo analysis that I undertook to 
confirm the EMSA data (section 3.3). Both this section and section 3.4 shows the 
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collaborative effort that went into this work and need to be summarised in order give 
context to the analysis that I specifically carried out. 
Briefly, upon confirming the binding profiles originally identified in the 
posterior cell line for WtB, AC, AUS and endogenous sites 1and 3 (and 
demonstrating binding of protein(s) that cause the band shift 2 at site 2), ETS1 was 
identified as causing band shift 2 while ETV4 caused band shift 1 (Fig.3.3A). The 
depletion of the protein that causes the WtB band shift following the addition of the 
anti-ETV4 antibody therefore indicates that this ETS factor binds to a non-canonical 
AGAAAAT site, the AGAAA core of which is present at the 5′ end of the ZRS that 
was also shown to bind ETV4 (Figs. 3.2A and 3.3D, sites A and B). This second 
motif is located at the position of a previously published Belg2 mutation site (Lettice 
et al., 2003), and analysis of the Belg2 sequence shows that it binds an additional, 
unidentified factor that generates an upper band (see Fig.2 of Lettice et al., 2012, 
included with this thesis). So, as Fig. 3.2A shows, whereas the AC mutation changes 
this site to a canonical AGGAAGT and therefore allows the replacement of ETV4 
with ETS1, the AUS mutation leaves the AGAAA sequence intact, which may 
explain why this mutation could enable ETS1 to bind in addition to ETV4 (Fig. 
3.3D).     
Extensive EMSA analysis of both canonical and non-cannonical ETS motifs 
within the ZRS, both endogenous and mutant, suggests that ETS factors do bind to 
and therefore regulate the ZRS in the limb. These in vitro assays have shown that at 
least two factors from different subfamilies – ETS1 and ETV4 – are capable of 
binding to specific sequences within the enhancer. Consequently, I sought to 
determine whether ETS factors are indeed bound to the ZRS in vivo. 
 
    





3.3. Identification of ETS factors that bind the ZRS in vivo 
To ascertain that Ets proteins bind to the ZRS in the early limb bud I performed 
chromatin immunoprecipitation (ChIP) on nuclear extracts derived from whole 
autopods dissected from E11.5 limbs. An initial screen of the ETS factors expressed 
in the limb by qPCR failed to detect at appreciable levels either ELF1 or ETS2 at the 
ZRS (data not shown, J. Wiltshire). Therefore, further investigations using high 
density tiling arrays did not include ETS2, but ELF1 was analysed as a negative 
control. The arrays were the same as those described in the previous chapter, 
containing not only the genomic regions in which the Hox clusters are located, but 
also regions containing genes crucial to early distal limb bud growth and patterning: 
Hand2, Grem1, Fgf10 and of course a 1.2 Mb region covering both Shh and the ZRS. 
In this section I will focus on ETS factor binding to the ZRS but in section 3.5 I 
describe in more detail the binding patterns of each of the factors tested over all the 
genomic regions covered by the arrays. 
Previous genome-wide in vivo analysis of ETS1 binding revealed co-
occupation of GABP and ELF1 at a significant subset of sites in Jurkat T cells 
(Hollenhorst et al., 2007; Hollenhorst et al., 2009). Microarray analysis showed that 
only GABPwas bound along with ETS1 at the ZRS (Fig. 3.4, first panel, fifth and 
fourth tracks respectively). The GABP binding profile suggests that it is present 
throughout the ZRS, whereas ETS1 binding overlapped but was more skewed to the 
3′ end. Although the arrays are not of a sufficient resolution to allow the 
identification of specific binding sites for each of these factors, the more 3′ 
endogenous ETS sites contain the sequence AGGAAAT, while the rest are 
AGGAAGT motifs. Binding of ETS1 to the ZRS was confirmed by qPCR, showing 
over two-fold enrichment over IgG (Fig. 3.6). Neither GABPnor ETS1 is bound at 
an appreciable level at the Shh gene or promoter (Fig. 3.4, third panel). ELF1 binding 
could not be detected at the ZRS on the arrays (Fig. 3.4, third track, first panel), 
corresponding to the initial qPCR screen and confirmed by qPCR on the same 
samples as applied to the arrays (Fig. 3.6). Indeed, the array-wide analysis suggests 
that in the murine embryonic limb ELF1 does not co-occupy the same sites as ETS1 
and GABPbut is frequently bound at the same sites occupied by ETV5 (section 
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3.5, Fig. 3.9). The second panel in Fig. 3.4 shows the promoter region of an 
uncharacterised gene at the 3′ end of the Hba locus where there is an appreciable 
level of ELF1 partially overlapping a defined ETV5 peak. Moreover, this ELF1 peak 
corresponds to a clustering of ETS motifs (second bottom track showing the 
locations of ETS motifs). Both GABP and ETS1 are completely absent from this 
site, as is ETV4, a pattern that develops from a more general analysis of the array 
data (section 3.5). Although ELF1 enrichment can be detected broadly across Shh, 
most is at background levels, with the possible exception of a minor peak within the 
first intron that may correspond to a cluster of ETS sites, and unlikely to be 
significant (Fig. 3.4, third panel, third track). 
ETV4 and ETV5 have recently been shown to prevent ectopic activation of 
Shh in the anterior limb bud (Mao et al., 2009; Zhang et al., 2009). Accordingly, both 
ETV4 and ETV5 were enriched over the probes covering the ZRS locus (Fig. 3.4 
first panel, first and second tracks respectively). ETV4 binding was characterised by 
two peaks either end of the ZRS, reflecting the location of the two predicted ETV 
sites (Fig. 3.2A). ETV5, by contrast, was enriched over a >5 kb region, with a peak 
over the whole of the ZRS. The extent of this enrichment is not due to non-
specificity binding; as revealed when considering the whole 1 Mb Shh/ZRS region 
(Fig. 3.5) and, more generally, the rest of the regions on the array – many of which 
are largely free of ETV5. ETV5 binds the ZRS directly; the broad enrichment 
domain – which can also be observed, to a lesser extent, for ETV4 – may be due to 
the high density of ETV sites within this region (Fig. 3.4, first panel, bottom track 
showing locations of ETV motifs). Enrichment of ETV5 at the ZRS was confirmed 
by qPCR (Fig. 3.6). Both ETV4 and ETV5 were absent from the Shh gene, 
nevertheless a small, discrete ETV5 peak was detected at the promoter region and 
similar small, discrete ETV5 and ETV4 peaks were located immediately 3′ of the 
gene; both regions containing clusters of  ETV motifs (Fig. 3.4 third panel). 
However, as for the other ETS factors analysed, the levels of enrichment at the Shh 




         
Figure 3.4. ETS factors bind to the ZRS in the distal limb buds of E11.5 embryos. ChIP 
using antibodies for five different ETS proteins (ETV4, ETV5, ELF1, ETS1 and GABP) 
analysed by hybridising equal quantities of enriched and input labelled DNA to high density 
tiling arrays. Three panels displaying the binding profiles of each factor are presented: the 
ZRS region and two control regions containing the Shh gene plus promoter and a region 3′ 
of the -globin locus (3′Hba). The y-axis is Log2 for each ChIP/Input DNA and the x-axis 
represents a segment of DNA from the array. The positions of potential ETS1/GABP 
(AGGAA
G
/A) and ETV4/ETV5 (AGAAA
G




                  
   
   
Figure 3.5. Discrete ETV5 enrichment peaks throughout the Shh/ZRS genomic region. 
Panel displaying the ETV5 binding pattern over the entire Shh region on chromosome 5 
covered by the microarray. Enrichment peaks are specifically high over the ZRS and an 
intronic region at the 3′ end of the Lmbr1 gene. Smaller, clustered peaks can also be 
observed in and around the genes 3′ of Shh and upstream of the gene itself, whereas the 




















              
Figure 3.6. ETS1 and ETV5 binding at the ZRS confirmed by qPCR. Enrichment of ETS1 
and ETV5 at the ZRS was detected by qPCR of enriched samples compared to ChIP 




















3.4 Transgenic assays define the mechanisms by which the opposing 
ETS factors regulate Shh expression through the ZRS in the developing 
limb 
The transgenic experiments and analysis described in the following two sub-sections 
were done by L. Lettice. 
3.4.1 Two mechanisms can induce ectopic Shh expression 
There are two possible explanations for ectopic expression of Shh induced by the 
AUS mutation: the displacement of (possibly) ETV4/ETV5 at site B reduces the 
level of these factors, or the creation of an additional AGGAAGT (ETS) site directly 
drives ectopic expression (Figure 3.2A). Neither deletion nor contiguous 3bp 
mutation (AGAAAAT → AGAGCGT) of the ETV site caused ectopic expression in 
transgenic embryos (Lettice et al., 2012). Nonetheless, the loss of both sites A and B 
did result in ectopic reporter gene expression (Fig. 3.7D). However, the insertion of 
an additional AGGAAGT site within a putative neutral position of the ZRS – a 
variable stretch of Ts that differ in mammalian species – (Fig. 3.7A) generated 
ectopic expression (Fig. 3.7C); whereas the insertion of seven additional Ts (control) 
did not (Fig. 3.7B). Therefore, the creation of an additional ETS site (possibly bound 
by GABP/ETS1) is sufficient on its own to drive ectopic expression of Shh.   
3.4.2 Endogenous ETS sites define the Shh expression boundary 
To study further the consequences for ZRS function of having multiple endogenous 





its own or in combination with other sites and evaluated by transgenic assays (a full 
description of these results can be found in Lettice et al. (2012) enclosed at the end of 
this thesis). The wild type expression domain is shown in Fig. 3.7E. Loss of sites 1 
and 3 (the sites with the highest affinity for ETS1 binding in vitro) caused the most 
extensive reduction in reporter-gene expression (Fig. 3.7H). Loss of additional sites 
did not reduce the reporter gene’s expression domain further (Fig. 3.7I & J). The 
presence of either site 1 or site 3 on its own was sufficient to generate expression 
domains approaching the wild-type construct (Figs. 3.7K & L); whilst together the 
expression boundaries were indistinguishable from wild-type (Fig. 3.7M).  
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Disruption of site 1 in the transgenic construct containing the ZRS with the 
AUS mutation had little effect on the extensive posterior expression domain and did 
not prevent ectopic expression (compare Fig. 3.7N with Fig 3.2B). But ablation of 
sites 1 and 3 reduced the posterior expression domain to wild type boundaries (Fig. 
3.7O). Removal of other sites did not cause further appreciable changes in expression 
levels (Fig. 3.7P), indicating that a single high affinity site is capable of generating 
wild-type transgenic expression. Whereas the addition of the AUS mutation results in 
ectopic anterior expression in the limb, the removal of all five endogenous sites 
results in no ectopic expression, therefore suggesting that the wild-type sites assist in 

















     
 
Figure 3.7. Transgenic analysis of embryos carrying mutant ZRS sequences. A, 
Position of the run of Ts within the ZRS, with the changes shown in red. B, C, Expression 
due to the changes shown in A. Only the addition of the ETS motif (C) results in ectopic 
expression of the reporter gene. D, Disruption of sites A and B (-ETVA -ETVB) in 
combination results in ectopic anterior expression. E-M, Examples of transgenic embryos for 
endogenous ETS mutations. Remaining ETS sites are depicted in the lower left-hand corner 
of each image. N-P, Transgenic embryos representative of the addition of the Aus mutation 
with endogenous ETS site mutations. Each transgenic image has close-up of the forelimb in 




3.5 Binding profiles of ETS factors across the tiling array genomic 
regions 
3.5.1 ETS factors predominantly bind to intergenic and intronic regions 
Recent genome-wide analysis of ETS factor binding in Jurkat T-cells demonstrated 
that both ELF1 and ETS1 co-localise with GABP at a significant proportion of sites 
(Hollenhorst et al., 2009; Hollenhorst et al., 2011). To determine the binding patterns 
of each of the ETS factors analysed in this study, I quantified the proportion of 
significant enrichment levels located within discrete genomic territories. Thresholds 
were determined using the R/Bioconductor Ringo package (Toedling et al., 2007) 
and a previously published algorithm (Schwartz et al., 2006) (see Methods section 
6.6.3.2). To account for variation in antibody efficiency and noise levels due to 
differences in sample DNA quality, enrichment thresholds were calculated separately 
for each antibody. These thresholds are: GABP > 0.76, ETS1 > 0.64, ETV4 > 0.78, 
ETV5 > 0.85, ELF1 > 0.7 (Log2 values). Peaks were scored as containing at least 
three probes with enrichment above these thresholds within a block of continuous 
enrichment up to 500bp in size. 
Of the tiling array regions analysed, probes covered ~4.7 Mb of the mouse 
genome in which genes active in early distal limb development are included (Hoxa 
and Hoxd, Shh, Hand2, Grem1and Fgf10) and ~5.3 Mb containing genes belonging 
to multiple categories, including maintenance of ES cell pluripotency, ES cell 
differentiation, and early embryo development. Division of the array data into these 
two broad categories revealed that the proportion of ETV5 peaks (17%) in the 
defined limb regions of the array is significantly less than that of the other ETS 
factors (p < 0.0001 (Fishers Exact two tail tests); ETS1, 51%; GABP, 53%; ETV4, 
42%; ELF1, 43%) (Fig. 3.8B. 
  Each genomic region covered by the arrays were further sub-divided into 
intergenic, intronic, exonic (protein-coding) and promoter regions (as for the Chapter 
2 array analysis). Promoter regions were defined as the 2 kb region upstream of the 
TSS, therefore possibly encompassing sites that have been previously defined as 
proximal enhancers (Hollenhorst et al., 2009)); and the number of significantly 
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enriched peaks located within each of these categories were counted. ETV4 and 
ETV5 had significantly greater numbers of highly enriched binding sites across the 
full array compared to the other ETS factors (Table 3.1). Most peaks for all the 
factors are located in intergenic and intronic regions (from 69% of GABP peaks to 
84% of ETV5 peaks) (Fig. 3.8A, top row of pie charts). Surprisingly, the numbers of 
peaks located within promoter regions is very low for all factors but particularly 
GABP (2%), ETS1 and ETV5 (both 5%); especially considering a previous study 
on ETS1 that indicated that the majority of binding occurs near TSSs (Hollenhorst et 
al., 2009). The fourth panel of Figure 3.9 shows the solitary GABPpeak within a 
promoter from the array analysis (highlighted locus on the right), located at the 
active limb gene Hand2. However, array bias has likely contributed to this 
discrepancy. Hollenhorst et al. (2009) measured ETS1binding genome-wide by 
ChIP-seq and a large proportion of promoter-bound regions were adjacent to 
housekeeping genes, whereas the arrays used here cover genomic regions containing 
mostly developmental genes and genes involved in ES cell differentiation. Insofar as 
the genomic regions covered by the array, then, the ETS factors assayed 
predominantly bind to non-coding regions remote from gene TSSs in E11.5 mouse 
limb tissue.  
Focussing on the array regions that include the genes involved in distal limb 
growth and development only reveals that the proportion of binding sites located 
within intergenic and intronic regions is even greater for all the ETS factors assayed 
apart from ELF1 (Figure 3.8A, lower row of pie charts). Over 90% of GABP, 
ETS1, ETV4 and ETV5 peaks are located in non-coding regions remote from TSSs 
in genomic regions that include these active distal limb genes, an increase in 
proportion due to greater relative numbers of peaks situated within intergenic 
regions. These data clearly show the preponderance of bound distal non-coding sites 
over more proximal promoter and coding sites for all the ETS factors tested, 
particularly for the four ZRS-binding factors in regions covered by the array 




3.5.2. High correlation between significant binding peaks and ETS/ETV motifs  
The majority of enriched sites for GABP, ETS1 (65%) and ELF1 (69%) 
contained the ETS motif AGGAA
G
/A (Fig. 3.8C, Table 3.1), which forms the core of 
the ETS1-specific motif identified in human T cells (Hollenhorst et al, 2009). 
Likewise, ETV4 and ETV5 peaks show a high correlation with the non-canonical 
ETV motif AGAAA
G
/A identified within the ZRS: 84% and 73% respectively (Fig. 
3.8C and Table 3.1). These data further validate the characterisation of AGAAA
G
/A 
as a motif recognised and bound by members of the PEA3 sub-family in the mouse, 
and is especially robust due to the large number of peaks for both factors (255 and 
271 for ETV4 and ETV5 respectively).  
Peaks for all factors are less correlative with conserved loci (defined as 
sequences within factor peaks with high mammalian conservation (Fig. 3.9, bottom 
track)). Nevertheless for GABP, though the total numbers are relatively low, 56% 
of the peak sites contain conserved sequences (Fig. 3.8C, Table 3.1). Within intron 4 
of the Fmn gene on chromosome 2 there is a significant GABP peak over a locus 
containing a conserved region and a cluster of ETS and ETV motifs (Fig. 3.9, 
highlighted region in first panel). Also within the 15 kb region shown here is a more 
widespread enrichment of ETV4 and ETV5, with a significant peak of the latter co-
localised with the GABP peak. ETS1 is barely above background while ELF1 is 
largely absent. Panel three of Fig. 3.9 shows a 10 kb locus within a gene desert 
adjacent to the Hand2 gene that contains several conserved regions occupied by 
GABP. The most significant GABP peak (highlighted) covers conserved 
sequences with one ETS motif adjacent to but not within the peak. This conserved 
region does contain several ETV motifs; however, ETV4 enrichment does not reach 












GABP ETS1 ETV4 ETV5 ELF1 
All 45 88 255 271 98 
ETS/ETV sites 34 (76) 57 (65) 213 (84) 199 (73) 68 (69) 
Conserved regions 25 (56) 27 (31) 46 (18) 44 (16) 27 (28) 
Number and proportion (in parentheses) of ETS factor peaks containing ETS/ETV binding motifs 
and mammalian regions of conservation for Figure 3.8C. (Log2 enrichment: GABP> 0.76, ETS1 
> 0.64, ETV4 > 0.78, ETV5 > 0.85, ELF1 > 0.7; peaks scored as containing at least three probes 













































































































































































































































































































































































































































































































































































































































































































































Figure 3.9. Binding profiles of ETS factors at genomic regions associated with genes 
expressed in the distal limb buds of E11.5 embryos. ChIP using antibodies for five 
different ETS proteins (ETV4, ETV5, ELF1, ETS1 and GABP) analysed by hybridising 
equal quantities of enriched and input labelled DNA to high density tiling arrays. Five panels 
displaying the binding profiles of each factor are presented: promoter regions of Fgf10, 
Hoxb8 and Hand2; an intronic region of the Fmn gene adjacent to Grem1; and an intergenic 
region within the gene desert upstream of Hand2. The y-axis is Log2 for each ChIP/Input 
DNA and the x-axis represents a segment of DNA from the array. The positions of potential 
ETS1/GABP (AGGAA
G
/A) and ETV4/ETV5 (AGAAA
G
/A) binding sites are shown on the two 
tracks below the genes and regions of high mammalian conservation are shown on the 
bottom track (based on multiple alignments of 19 placental mammals and a further 11 non-
placental mammals and non-mammal vertebrates). Full genomic regions containing Grem1  
and Hand2 covered by the tiling arrays shown above.  
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3.5.3. Majority of each factors’ peaks are not co-localised with the peaks of the 
other ETS factors  
Redundant binding is a striking feature of several ETS factors (Hollenhorst et al., 
2011). Comparisons of GABP (Valouev et al., 2008) and ETS1 (Hollenhorst et al., 
2009) genome-wide data reveals that most GABP sites are also occupied by ETS1 
in Jurkat cells. Further comparisons of the GABP data and genome-wide ELF1 
occupancy in Jurkat cells (Wei et al., 2010) also showed an extensive overlap 
between these two factors from different subfamilies (Hollenhorst et al., 2011). 
Therefore, I analysed the peaks of each factor in turn to determine the extent of co-
localisation of other ETS proteins, in particular GABP, ETS1 and ELF1 at the same 
binding regions and the separate co-localisation of ETV4 and ETV5. Only where 
significant peaks of each factor overlapped were considered; however this highly 
stringent criteria excluded many sites bound by a significant peak of one factor that 
had continuous blocks of enrichment of other factors which – although above 
background levels – were not above the significance threshold set for each factor 
(Fig. 3.9).   
Surprisingly, given the redundancy of the two PEA3 sub-family proteins, 
ETV4 and ETV5 could only be detected at seven of the same binding sites (3% and 
2.5% of their total peaks respectively) (Fig. 3.10A). Of the two, ETV4 has a higher 
proportion of co-localised binding sites, most of which are co-occupied with ETS1 
(32, 12%) and to a lesser extent GABP (10, 4%) (Figure 3.10C). In the selective 
genomic regions covered by the microarrays only GABP(38%) and ETS1 (44%) 
had significant numbers of peaks co-localised with other factors – mostly with each 
other and ETV4 (Fig. 3.10C). In contrast to the analysis done on genome-wide data 
sets (Hollenhorst et al., 2011), ELF1 co-localisation with GABP and/or ETS1 was 
minimal (1 and 2 sites respectively, with no sites co-occupied by all three) (Fig. 
3.10B). The end panel of Fig. 3.9 shows an ELF1 peak within the promoter of 
Hoxb8. Apart from very sparse GABP enrichment at background levels, no other 
ETS factor is present in a locus on the edge of a highly conserved region and 
containing adjacent ETS and ETV motif clusters.  
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  Co-localisation in this study cannot be construed as co-occupation of the 
same site in the same cells, as the limb buds from which the tissue was dissected for 
these assays contain a heterogeneous cell population. But it does suggest that ETS1, 
ETV4 and to a lesser extent GABP may bind many of the same sites in the mouse 
genome during limb development, although probably binding to different motifs 
rather than motif redundancy, as has been shown to occur at the ZRS in this study. 
The second panel of Fig. 3.9 shows a binding site co-localised by ETV4 and ETS1 
~10kb upstream of Fgf10. A significant ELF1 peak and a below threshold GABP 
block were also detected over the same non-conserved genomic region containing 
ETS and ETV motifs located near an active limb regulatory gene.   
This extensive analysis of the binding patterns of the five ETS factors to the 
genomic regions covered by the tiling array suggests that GABPand ETS1 co-
localise at a substantial proportion of binding sites in mouse embryonic limb cells, 
though not to the same extent as has been previously shown to occur in more 
extensive, genome-wide, analysis of human T cells (Hollenhorst et al., 2009). 
However, the PEA3 sub-family member ETV4 also co-localised with these two at a 
significant number of sites, probably by binding to the ETV motif rather than 
redundantly competing for the same binding sequence recognised by GABP and 
ETS1. The majority of genomic locations of each factors’ binding peaks contained 
either the ETS or the ETV binding motifs, although conserved sequences were 
present in a majority of peak sites for GABPonly. Most locations of significant 













   
 
Figure 3.10. Co-localisation analysis at significant binding peaks. A – C, Venn diagrams 
representing the extent of co-localised ETS factors. The PEA3 sub-family factors ETV4 and 
ETV5 do not show an extensive overlap in binding sites (A). Of the three factors that 
generally bind to the ETS motif ELF1 does not co-localise with either GABP or ETS1 to a 
significant extent, in contrast to the co-occupancy of the latter two at the same genomic sites 
(B). ETV4 also co-localised with GABP and particularly ETS1 at a significant proportion of 
the latter two’s binding peaks (C). Values within each circle are the numbers of non-localised 
peaks for each factor, values within each overlapping portion the number of co-localised 
sites shared between different factors. Size of circle and extent of overlap between circles 







3.6.1 Opposing functions of two different groups of ETS factors at the ZRS 
defines Shh spatial expression in limb buds  
Extensive in vitro analysis has revealed that ETS1 binds to at least three of the five 
endogenous ETS motifs (sites 1, 2 and 3) and the two mutation sites (AUS and AC) 
within the ZRS (Figs. 3.2A, 3.4D) (Lettice et al., 2012). This AGGAA
G
/AT motif has 
been previously described as ETS1-specific in human T cell Jurkat cell lines and is 
predominantly located at distal regulatory regions (Hollenhorst et al., 2009). EMSA 
assays were highly suggestive that ETS1, and possibly other ETS factors expressed 
during mouse limb development – such as ETS2 from the same sub-family which has 
overlapping, redundant roles in mouse development (Wei et al., 2009), and two 
members of different sub-families (GABP and ELF1) previously characterised as 
co-occupying ETS1 binding sites – bind to and regulate the activity of the ZRS. 
Failure to detect GABPbinding to the ETS motif was likely due to the failure of 
GABP and GABP to form the heterotetramic complexes required for enhancing 
the DNA-binding affinity of the former (Batchelor et al., 1998) in a dilute in vitro 
environment.  
EMSAs also identified ETV4 as being capable of ZRS binding, however, this 
factor did not bind the ETS motif but rather to the non-canonical AGAAA
G
/A motif 
(Figs. 3.2A, 3.3D) (Lettice et al., 2012)). ETV4 and ETV5 have redundant activity in 
limb development and expression in the distal mesenchyme is maintained by FGF 
signalling from the AER that represses anterior expression of Shh in the limb (Mao et 
al., 2009; Zhang et al., 2009). The identification of binding sites recognised by one of 
these PEA3 sub-family members (Fig. 3.2A, sites A and B – site A corresponds to a 
point mutation that causes PPD in a Belgian family (Belg2)) suggested that this 
repressive regulatory activity may occur through the ZRS. 
Therefore, EMSA analysis is indicative of two possible mechanisms by 
which the ZRS AC and AUS mutations result in ectopic anterior expression of Shh. 
In the first, the additional ETS site created by the point mutations enables increased 
binding of active factors, possibly ETS1 alone or in concert with others, which 
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enables the ZRS to override repressive signals in the anterior limb and induce ectopic 
Shh expression. In the second scenario, the point mutations cause the abrogation of 
the ETV site B (AC) or the creation of an adjacent ETS motif and the partial loss of 
the ETV motif (AUS) that reduces ETV4 and/or ETV5 binding at the ZRS in the 
anterior limb (Fig. 3.3D), thus removing the factors repressing ectopic Shh 
expression.   
In order to establish the importance of the ETS and possible non-canonical 
ETV motifs in the regulation of ZRS activity, I performed a series of ChIP-chip 
assays to determine which ETS factors expressed in the developing limb bud bind to 
the enhancer in vivo. These assays identified four different ETS proteins: ETS1 and 
ETV4, previously shown to bind ZRS sequences in EMSAs, were confirmed along 
with GABP and ETV5, which could not be detected in vitro – thereby highlighting 
the limitation of the cell-free assays. GABP and ETS1 co-occupancy of the same 
binding sites has been previously characterised in human Jurkat cells at a genome-
wide scale (Hollenhorst et al., 2009), and the tiling arrays used in this study show 
that co-localisation occurs at the ZRS in murine E11.5 embryonic limb tissue.  
Although the ChIP-chip assays were not of a sufficient resolution to 
determine the specific binding sites of each of the ETS factors within the ZRS, the 
EMSA analysis indicates that ETS1, and by extension GABP are binding to the 
ETS motifs (1 - 5) and are activating factors, while ETV4 and ETV5 bind to the ETV 
sites (A & B) and have a repressive influence on ZRS activity. To establish the exact 
binding sites for each factor and whether GABP/ETS1 and ETV4/ETV5 compete 
for the same sites would require performing ChIP-chip on tissue or cells derived 
from mice with each site knocked out to identify which site(s) are necessary for each 
factor to bind the ZRS. These assays would be technically difficult and time 
intensive, but by using reporter constructs containing the ZRS with single and 
multiple deletions of the ETS/ETV sites and/or with the additional AUS site the 
importance of each binding motif in ensuring the correct activity of the ZRS could be 
established.   
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Through multiple binding sites within the ZRS, GABP/ETS1 determines the 
expression boundary of Shh that defines the posterior-restricted ZPA (Figs. 3.2B & 
3.7E). These AGGAA
G
/AT motifs are common to both factors, and both bind to the 
ZRS in vivo (Fig. 3.4). The EMSA and transgenic results presented in this chapter 
suggests that sites 1 and 3 (Fig. 3.2A) have the greatest input, with both acting 
cumulatively to produce a wild-type expression boundary (Fig. 3.7J). Nevertheless, 
other sites do participate: sites 2, 4 and 5 drive reporter expression at the extreme 
posterior margin (Fig. 3.7F) and expand the boundary established by site 3 alone 
(Lettice et al., 2012).  
The addition of the mutant AUS site highlights this combinatorial mechanism 
as it results in extension of the Shh expression boundary deeper into the centre of the 
limb bud (Fig. 3.2B). The AUS mutation is the most active site analysed in transgene 
assays: loss of site 1 still engenders posterior extension of expression and ectopic 
expression (Fig. 3.7K), while loss of both sites 1 and 3 is compensated for by the 
addition of the AUS site (Fig. 3.7L & M). The differential expression levels of 
GABP but especially ETS1 in the posterior compared to anterior limb (for instance 
see Fig. 2.2B), combined with the in vitro and in vivo binding data and the transgenic 
analysis, suggests that ETS factor levels and number of binding sites act together to 
regulate ZRS spatial activity and consequently the extent of Shh expression. This 
activating regulatory system works in tandem with the repressive activity of a second 
regulatory system that involves the PEA3 factors ETV4 and ETV5 (Fig. 3.11). Again 
building on the in vitro binding assays, two non-canonical ETS sites termed ETV 
motifs A and B (Fig. 3.2 A) were identified in the ZRS that are bound by 
ETV4/ETV5 (Fig. 3.3D). The abrogation of both sites results in ectopic anterior 
expression (Fig. 3.7D). 
As well as increasing the wild-type expression domain, the AUS mutation 
also drives anterior, ectopic expression; the known cause of PPD which is the 
pathogenetic outcome of this point mutation within the ZRS. A previous study 
suggests that the ZRS is poised for activity not only in the posterior but also the 
anterior limb bud margin (Amano et al., 2009). The activity of ETV4/ETV5 prevents 
ZRS-induced Shh expression in the wild-type anterior limb bud, but an additional 
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high affinity ETS site such as the AUS site disrupts the activating/repressing balance, 
overcoming the repressive influence of ETV4/ETV5 in the anterior limb to activate 
the poised ZRS and as a consequence effecting the loss of posterior-restricted Shh 
activation. 
 
3.6.2 ETS factor binding profiles suggest a more general limb-specific 
interaction at distal regulatory regions for GABP/ETS1 and ETV4 
Despite the focus of the tiling array on a selection of genomic regions containing 
genes involved in ES cell differentiation and early development, the binding profiles 
of each of the ETS factors analysed may be indicative of a more widespread role in 
distal cis-regulation. As the objective was to elucidate the genomic characteristics 
preferentially bound by each factor, and not to identify specific regulatory elements, 
then the likelihood of missing binding sites within possible bona-fide elements due to 
enrichment values lower than the threshold(s) should not be crucial to the analysis. 
For example, extensive ETV4 enrichment covers a highly-conserved region ~10 kb 
upstream of Hand2 (Fig. 3.9, left-hand highlighted region within panel 4), the 
location of a branchial arch-specific enhancer of Hand2 (McFadden et al., 2000). 
This site corresponds to a cluster of ETV motifs, the ETV4 protein has a known 
repressive function in the limb (Mao et al., 2009; Zhang et al., 2009; Lettice et al., 
2012) and this enhancer has no role in limb development, but enrichment was below 
the threshold and so this locus had been excluded from the set of ETV4 peaks. 
For all five ETS factors tested, the majority of significant enrichment sites are 
located within intergenic and intronic regions; particularly so for the four ZRS-
binding factors at the genomic regions involved in limb development (Fig. 3.8A). 
Only a small minority of enriched sites were located within promoters. Genome-wide 
characterisation of ETV4/ETV5 binding has yet to be done for any model system, so 
the binding profiles presented here await confirmation as to how representative they 
are of the genomic location of target sites. Human ETS1 binding has been 
characterised though, using both promoter-specific arrays (Hollenhorst et al., 2007) 
and whole genome ChIP-seq (Hollenhorst et al., 2009). These studies indicate that  
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Figure 3.11. Model demonstrating the opposing functions of the two ETS groups. 
Summary of how four of the transgenic constructs (shown on the left) may interact with ETS 
factors in the limb. Expression domains for each are shown in the middle, change in 









ETS1 predominantly binds to active promoter regions, in particular of housekeeping 
genes, containing the highly redundant ETS motif CCGGAAGT – the redundancy of 
this site may be indicative of different ETS factors regulating these genes in different 
cell types (Hollenhorst et al., 2011). However, the genome-wide analysis of the 
human T cells highlighted substantial binding of ETS1 at possible distal regulatory 
elements containing the more specific ACAGGAAGT motif (containing the 7 bp site 
clustered in the ZRS). Therefore, the predominance of distal binding sites identified 
by the array data could in large part be due to the bias in the regions covered and the 
lack of housekeeping genes. 
A striking feature of the array analysis is the high co-localisation of ETS1 and ETV4, 
and to a lesser extent GABP (Fig. 3.10C). Comparisons of two different data sets 
for ETS1 and GABP binding sites in Jurkat T cell lines identified extensive co-
occupation of the same sites by these factors (Hollenhorst et al., 2009), which has 
occurred to a lesser extent in the array data presented here (Fig. 3.10C). Intriguingly, 
GABP has a binding domain recognised by the co-activator histone 
acetyltransferase CBP/p300 (Kang et al., 2008), a protein complex frequently 
identified at enhancers (Chapter1, section 1.2). Therefore, GABPmay also be a 
marker of active regulatory elements. ELF1 does not co-localise with GABP/ETS1, 
in contrast to analysis of two different genome-wide sequencing studies of 
GABP(Valouev et al., 2008) and ELF1 (Wei et al., 2010) which revealed that 
nearly two thirds of ELF1-bound regions co-localise with GABP sites (Hollenhorst 
et al., 2011). ELF1, then, does not have a role in determining ZRS activity, nor, it 
seems, does it have a collaborative function with GABP/ETS1 in mouse limb 
embryogenesis. 
Co-localisation of ETV4 at a substantial proportion of GABP and 
particularly ETS1 peaks (and vice versa) may indicate that the opposing functions of 
these two groups elucidated at the ZRS occur at other regulatory elements. Although 
requiring further verification, the competing active and repressive dynamics co-
ordinating ZRS activity, of which these two sets of ETS factors are an intrinsic part 
of, may be a common mechanism in determining spatial and temporal enhancer 
activity during development. Of course, it is unlikely that these factors are working 
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in isolation. For larger enhancer elements such as the ZRS – that have greater scope 
to bind complex assortments of factors – spatio-temporal activity and the capability 
to correctly target and regulate genes over large genomic distances will involve the 
input of multiple factors. 
 
3.6.3 Conclusions 
Using electrophoretic mobility shift assays (EMSAs), chromatin 
immunoprecipitation combined with qPCR and tiling microarrays (ChIP-qPCR, 
ChIP-chip) and transgenic assays, we show that ETS1 and GABPoccupy the 
multiple ETS sites and regulate the position of the Shh posterior boundary and thus 
define the ZPA, while multiple binding of ETV4 and ETV5 at non-canonical ETS 
(ETV) motifs within the ZRS prevents ectopic anterior Shh expression. Further, the 
two PPD2 mutations that result in additional ETS sites disrupts the balance between 
the active and repressive ETS factors and results in activation of Shh in the anterior 
limb bud and an extension of the posterior domain. From extensive analysis of the 
microarray data, I show that the majority of significant peaks for each ETS factor are 
located in non-coding regions remote from TSSs.  Moreover, sixty five to eighty four 
percent of well defined peaks for each factor are associated with either ETS or ETV 
binding motifs.   
 
3.6.4 Future directions 
The ETS binding pattern at the ZRS identified by ChIP-chip cannot be considered as 
occurring within individual limb mesenchymal cells due to cell heterogeneity of the 
E11.5 dissected limb tissue. To determine the binding profile of Shh-expressing cells 
requires cell sorting, possibly by the knockin of GFP into the Shh locus. Subsequent 
analysis, either by ChIP-chip or Chip-seq, of  Shh-expressing and non-expressing 
distal limb cells will clarify whether the different ETS factors do indeed vary in their 
binding affinity to the ZRS depending on the spatial position within the distal limb 
bud. Analysis by ChIP-seq would also determine genome-wide ETS factor-binding 
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in the distal murine limb bud, thus revealing whether the genomic binding profiles 
identified in the present study  accurately reflect the binding patterns of these 























The Shh-ZRS regulatory region is held 
in a compact higher-order 
















Multiple tissue-specific enhancers regulate the expression of the sonic hedgehog 
gene (Shh), which codes for a morphogen directing cell fate during organogenesis. 
Proximal enhancers drive expression in the developing floorplate/neural tube, 
hindbrain and midbrain (SFPE1); distal enhancers (SBE4) located ~300-400 kb away 
control Shh activity in overlapping domains of the forebrain (Jeong et al., 2006), 
while the ~800 kb distant limb-specific ZRS enhancer drives expression within the 
distal, posterior limb bud (Lettice et al., 2003) (Fig. 4.1). Possible cis-regulatory 
elements in and around Rnf32 adjacent to the ZRS-containing Lmbr1 have been 
shown to drive reporter expression in Shh-expressing cells within oral, pharyngeal 
and lung-gut epithelium (Sagai et al., 2009). Unpublished data describes a further 
neural enhancer at the 3′ end of Lmbr1 (D. Epstein, private correspondence).  
Therefore, restriction of Shh activity to specific tissues at particular stages of 
embryogenesis requires regulation by several enhancer elements spread throughout a 
~1 Mb region defined by the near complete absence of other genes (Fig. 4.1): a 
genomic feature known as a gene desert (Chapter 1, section 1.2.4). This genomic 
environment is characteristic of many developmental genes, such as the HoxD cluster 
(chapter 2) and Hand2 (section 4.2.3). Prevention of promiscuous enhancer activity 
may explain why these enhancers are located in genomic regions largely devoid of 
protein-coding sequences but not why many are located at such large genomic 
distances from their target genes; although remoteness from the proximal promoter 
may ensure that promiscuous expression of the target gene itself does not occur. Of 
note, all known regulatory elements lie 5′ of Shh. A simple looping model enabling 
direct enhancer-promoter interaction (Fig. 1.6) would not require distal regulatory 
elements exclusively located to one side of the gene; the concept of topologically 
separate genomic domains, on the other hand, may account for the 5′ exclusivity of 
Shh enhancers (Dixon et al., 2012; Nora et al., 2012).  
How, then, do the limb, forebrain and epithelial enhancers of Shh target and 
activate the gene? Due to the large genomic distances some alteration of higher-order 
chromatin conformation is likely to be involved. A recent study showed that 
chromosome conformational dynamics enabled nuclear co-localisation of the ZRS 
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with Shh in murine E10.5 limb cells with the capacity to express Shh (Amano et al., 
2009). In Chapter 2 I showed that the GCR limb enhancer directly co-localises with 
the 5′ end of the HoxD cluster in E11.0 distal posterior limb tissue – i.e. the time and 
place in development where the enhancer activates 5′ Hoxd expression. Regulatory 
elements further into the gene desert centromeric of the HoxD locus have also been 
suggested to directly interact with Hoxd13 at a later stage in mouse limb 
development (E12.5) (Montavon et al., 2011), although unlike the case for the GCR I 
was not able to visualize co-localisation of one of these with 5′ HoxD (Figs. 2.13B 
and 2.14C) . These studies suggest that some sort of chromatin looping (described in 
Chapter 1, section 1.2.5) enables direct enhancer-promoter interactions to occur at 
the Shh and HoxD genomic regions.  
However, the mechanism whereby higher-order chromatin structure is 
manipulated in order for these enhancers to co-localise and possibly directly interact 
with the promoters of Shh/Hoxd13 has yet to be determined. My DNA FISH analysis 
of higher-order chromatin structure over HoxD and the 5′ gene desert indicates that 
this ~500 kb region is in a compact yet flexible conformation (Chapter 2) – which is 
in accord with 4C data on the same region (Montavon et al., 2011). Therefore, 
chromatin structure of what could be described as a regulatory region – 
encompassing several regulatory elements and their target genes – is being held in 
such a conformation as to optimize enhancer-promoter interaction and exclude the 
adjacent genomic territories. Could a similar mechanism be occurring at the Shh 
regulatory region? In a series of experiments aimed at elucidating what is required 
for the ZRS to work over such a large genomic distance, a -gal reporter cassette 
with a minimal promoter adjacent to the 5′ end of the ZRS (the minimum portion of 
the highly-conserved region of the enhancer able to drive reporter expression in the 
ZPA of transgenic mice) was inserted into the endogenous ZRS site (L. Lettice). 
Surprisingly, in mice heterozygous for the reporter construct, -gal expression could 
be detected throughout all the embryonic tissues where Shh is expressed and not just 
in the distal limb buds as expected. These results imply that the reporter gene is 
being activated not only by the adjacent limb-specific ZRS but also by all the other 
tissue-specific Shh enhancers. Therefore, during embryogenesis is the ~1 Mb 
genomic region – from Shh to the ZRS – in a similar compact chromatin state as the 
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HoxD regulatory region, enabling all receptive promoters to be bound and activated 
by active enhancers? Both the gene in which the ZRS is located and the adjacent 
gene – Lmbr1 and Rnf32 (Figure 4.1) – do not appear to respond to Shh enhancers. 
Rnf32 and Lmbr1 are expressed at low levels throughout the embryo and are not up-
regulated in the posterior limb (Hill, 2007). This lack of up-regulation in ZRS-active 
tissue suggests that the enhancer does not function as an alternative, tissue-specific, 
promoter to produce non-protein coding polyadenylated RNA transcripts reflecting 
Lmbr1 structure; a capability recently identified in erythroid-specific intragenic 
enhancers (Kowalczyk et al., 2012).        
In this chapter I will present the preliminary results from on-going research to 
answer the above question. This project is still in its infancy; therefore the data 
presented is not complete. I have focused on E11.5 limb and neural tissue to 
determine chromatin conformation state and possible enhancer-gene co-localisations 
by DNA FISH. I also present ChIP-chip data from E10.5 distal anterior and posterior 
limb tissue that reveals H3K27me3 and H3K4me1 histone modification states at the 
Shh and other regions containing genes active during limb development (Hand2 and 
Grem1). Conformation of the Shh region in ES cells, where the gene is not 
expressed, was also analysed by FISH and I discuss these results too. 
 












        
 
Figure 4.1. Shh genomic region indicating the position of fosmid probes. Bottom track 
shows gene locations with Shh situated in the middle. To the right of Shh is the ~800 kb 
gene desert with the locations of the proximal SFPE1 and distal SBE4 neural enhancers 
indicated, as is the location of the ZRS within Lmbr1 at the other edge of the gene desert. 
Below Lmbr1 the red box indicates the location of the -gal reporter with 5′ ZRS and minimal 
promoter insertion. The grey boxes in the top track show the locations bound by the fosmid 
probes used in the FISH assays. The probe over the Dpp6 gene is the equivalent distance 


















4.2. Chromatin topology of the Shh-ZRS regulatory region in E11.5 
forelimb buds 
4.2.1. Shh-ZRS region is maintained in what appears to be a highly folded 
chromatin state throughout the forelimb bud and the adjacent flank 
To determine the conformation of higher-order chromatin structure across the gene 
desert from Shh to the ZRS in Shh-expressing and non-expressing limb cells I carried 
out 3D FISH on tissue sections dissected from the anterior and posterior regions of 
E11.5 forelimb buds (Fig. 4.2). As for the HoxD analysis in Chapter 2 both distal and 
proximal regions of the limb bud were analysed, and I also measured compaction 
levels in the adjacent flank region where Shh expression does not occur at any time 
during embryogenesis. This was an important control as the anterior margin of the 
limb bud is also primed to express Shh (Lettice et al., 2003; Amano et al., 2009; Mao 
et al., 2009; Zhang et al., 2009). For each of these limb and flank tissues I also 
measured the nuclear distance (d
2
) between hybridisation signals for probes covering 
Shh and the Dpp6 gene situated the same linear genomic distance from Shh as the 
ZRS in the other direction (Fig. 4.1). This genomic region does not contain any 
known Shh regulatory elements. 
The bottom two rows of FISH images in Fig. 4.2 demonstrate the difference 
in chromatin conformation between the genomic regions 5′ and 3′ of Shh. The Shh-
Dpp6 probe pairs are separate from each other in all tissue sections (Fig. 4.2 lower 
row), while the majority of Shh-ZRS probe pairs are closely apposed or overlapping 
in Shh-expressing (distal posterior limb), -primed (distal anterior), and -non-
expressing (proximal limb, flank). Calculation of the median interprobe distances 
(d
2
) confirmed the initial visual analysis. Shh and Dpp6 regions have median d
2 
separation values of 0.22 - 0.27 m
2 
and a wide spread of inter-probe distances as 
revealed by the box plots (Fig. 4.3, Table 4.1). In contrast, median d
2
 values between 
the Shh and ZRS probes were 0.063 - 0.12 m
2
 (flank) and the range of interprobe 
distances much closer. The difference in interprobe distances between Shh- Dpp6 
and Shh-ZRS is highly significant for all tissues (p < 0.0001), whereas there are no 
significant differences in Shh-Dpp6 separation distance between the different limb 
tissues and flank tissue (Table 4.1). 
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 Analysis of the frequency of hybridisation signals separated by defined 
distance (d) intervals also demonstrates what appears to be significantly greater 
decompact chromatin conformation of the genomic territory 3′ of Shh compared to 
the 800 kb region up to the ZRS. The proportion of co-localized signals (< 200 nm) 
was less for Shh-Dpp6 than Shh-ZRS in all tissues (Fig. 4.4A). Conversely, the 
proportion of signal pairs ≥ 600 nm apart was greater for Shh-Dpp6 than Shh-ZRS: 
33 - 40% compared to 5 - 10% respectively (Fig. 4.4B and C, Table 4.2). The 
proportions of widely separate probe pairs spanning the adjacent genomic territories 
are highly significantly different in all the limb regions and Shh non-expressing flank 
tissue (Table 4.2). 
Comparison of overall interprobe distance (d
2
) between Shh and the ZRS 
revealed that the nuclear distance between gene and enhancer is significantly shorter 
in cells of the distal limb bud (both expressing (posterior) and poised (anterior) 
tissues) compared to the adjacent flank tissue (p = 0.04, Fig. 4.3 and Table 4.1). The 
difference between proximal anterior and flank is also significant (p = 0.005) while 
comparison of proximal posterior limb tissue and flank tissue reveals no significant 
difference. The proximal posterior nuclei were located nearer the flank due to these 
sections containing limb tissue up to the shoulder region, whereas the anterior 
sections were at the extremity of the limb bud where it forms a bulb type shape at 
this stage of development (Fig. 4.2, schematic showing position of dissected tissues). 
As a result the proximal anterior measurements may not be a true reflection of this 
limb region and therefore further analysis of tissue sections containing proximal 
anterior tissue up to the shoulder is required. The cells I have classed as proximal 
anterior are located in a region of the E11.5 limb bud likely to contribute to forearm 
(radius/ulna) development and therefore influenced by Shh activity. Finally, 
comparisons between proximal and distal limb tissues revealed no significant 
difference in overall Shh-ZRS interprobe distance throughout the E11.5 forelimb 
bud; in both Shh-expressing and non-expressing limb cells this regulatory region is 




In E11.5 murine embryos the Shh-ZRS ~800 kb region appears to be 
configured into a compact chromatin structure in the forelimb bud and adjacent 
flank. ChIP-chip analysis of E10.5 distal anterior and posterior tissue (a temporal 
stage when Shh expression is established in the distal forelimb bud) revealed that, 
although the Shh gene itself is coated by H3K27me3, the entire regulatory region 
located 5′ of Shh is largely free of this histone modification (Fig. 4.5, top left-hand 
panel) associated with a repressive and compact chromatin state (Chapter 2) 
(Soshnikova and Duboule, 2009; Eskeland et al., 2010). Similarities with the HoxD 
locus – key developmental genes with multiple enhancers spread throughout adjacent 
gene deserts – suggests, as for HoxD, the entire region up to the ZRS is being held in 
a compact yet flexible chromatin conformation that reduces the nuclear search space 
for the ZRS to interact with the Shh promoter. The surprising result in this context is 
the close conformation of the locus in the flank cells, where a range of interprobe 
distances similar to the region 3′ of Shh (compare boxplots in Fig. 4.3) would be 
expected (further analysis of neural tissues and adjacent non-neural cells suggests 
that this higher-order structure may be a general configuration during murine 
embryogenesis, see section 4.4.1).  
 
Table 4.1. Interprobe distances for E11.5  limb bud sections 












0.076 (p = 0.93) 
0.076 (p = 0.18) 
0.063 (p = 0.58) 
0.12 (p = 0.04) 
0.27 
0.23 (p = 0.47) 
0.22 (p = 0.43) 
0.27 (p = 0.54) 
0.26 (p = 0.98) 
 
Statistical analysis of data for Fig. 4.3. Interprobe distances are median values, p-values from 



















































































































































































































































































































































































Figure 4.3. The Shh-ZRS regulatory region is maintained in a compact chromatin 
structure in Shh-expressing, -primed and –non-expressing E11.5 murine forelimb 
buds and adjacent flank. Box plots show the distribution of interprobe distances (d
2
) at the 
adjacent Shh-Dpp6 and Shh-ZRS genomic regions for the proximal and distal anterior and 
posterior forelimb bud and the adjacent flank. Shaded boxes show the median and 
interquartile range of the data; asterisks indicate outliers. Number of loci: Shh-Dpp6 = 90, 
Shh-ZRS 90 - 97. Probe positions shown above. The statistical significance of differences 














Table 4.2. Frequency of Shh-ZRS and Shh-Dpp6 probes separated by ≥ 600nm for 
E11.5 limb bud sections. 
 









Frequency (%) ≥ 600 nm 
Shh-ZRS     
(847 kb)  




40                   
(p < 0.0001) 
10 
 
33.5                    
(p = 0.0002) 
10.5 
 
30.5                      
(p = 0.0008) 
5.5 
 
36.5                        
(p < 0.0001) 
11 
 
39          
 (p < 0.0001) 
 
Statistical analysis of data for Fig. 4.5 B and C. p-values from Fisher’s Exact Tests. 
 
4.2.2. Increased co-localisation of the ZRS and Shh in the distal posterior 
forelimb of E11.5 embryos 
Despite the compactness of the Shh-ZRS region throughout the forelimb bud and 
flank region of E11.5 embryos, differences in co-localisation frequency (defined as d 
≤ 0.2 m) of the gene and enhancer within the various limb regions and flank could 
be discerned. Co-localisation within the distal posterior limb bud (23.5%, averaged 
over measurements from three different sets of ~30 nuclei from different sections 
through the same embryo) was significantly greater than within the flank region 
(11%): p = 0.03 (Fig. 4.4 A, Table 4.3). In contrast, co-localisation within the distal 
anterior and proximal forelimb regions was not significantly greater than the flank 
(distal anterior 13.5%, proximal posterior 13%, and proximal anterior 13.5%). 
Comparison of co-localisation frequency within the distal posterior forelimb 
bud and the other limb tissues reveals that, although increased in the former, the 
difference is not quite significant: p = 0.09 for each (Fig. 4.4A, Table 4.3). However, 
further work is required to complete this analysis due to a possible skewing of the 
distal posterior data set in a manner that has lowered the proportion of co-localised 
probe pairs. Of the three sets of data, two had co-localisation frequencies of 30.5% 
and 23.5%, while the data set average for the other section was 16.5%. This latter 
frequency is closer to the other limb regions and could be due this section containing 
cells outside the ZPA and closer to the centre of the distal limb bud. The Shh 
expression domain is smaller than that of Hoxd13 which was analysed in the same 
way in Chapter 2. Therefore I will continue with this analysis on other posterior 
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sections taken from individual embryos to determine if, indeed, a change in co-
localisation across the distal limb can be identified. 
 
Table 4.3. Co-localisation frequency of the Shh probe with the ZRS and Dpp6 probes for 
E11.5 limb bud sections 
Limb region Shh-ZRS (847 kb) Shh-Dpp6 (831 kb) 







13.5 (p = 0.09) 
13 (p = 0.09) 
13.5 (p = 0.09) 
11 (p = 0.03) 
3.5 
4.5 (p = 1.00) 
0.5 (p = 0.62) 
4.5 (p = 1.00) 
0 (p = 0.25) 



















                   
 
Figure 4.4. Frequency distributions of the interprobe distance (d) between Shh and the 
ZRS and Dpp6 probes. A, Percentage of co-localised probe pairs (interprobe distance < 
200 nm) for each of the two genomic regions assayed in the distal anterior, distal posterior, 
proximal anterior, proximal posterior forelimb bud and the flank. The statistical significance of 
the differences in co-localisation between the limb regions and the flank were examined by 
the Fishers exact test (Table 4.3).  Frequences were calculated for every 0.m distance 
interval (x-axis) between B, Shh-ZRS, C, Shh-Dpp6 in nuclei derived from proximal and 
distal E11.5 forelimb bud regions and the adjacent flank region. The location and plane of 
the tissue sections are shown in Figure 4.2. Number of loci measured ≥ 90. Error bars 




4.3. Histone modification characteristics of similar genomic regions 
containing active limb genes 
4.3.1 H3K27me3 is largely absent from genomic regions encompassing Shh, 
Grem1 and Hand2   
The genomic territories that contain Shh and two other genes involved in anterior-
posterior specification and development of the distal handplate – Grem1 and Hand2 
(sections 1.3.1 and 1.3.2) – have many features in common. Hand2, like Shh, is 
expressed not only in the limb but also in other tissues during development 
(Srivastava et al., 1995; Fernandez-Teran et al., 2000; Ruest et al., 2003; Morikawa 
et al., 2005) and is also situated adjacent to a ~1 Mb gene desert containing many 
highly conserved loci, although they have yet to be characterised as possessing 
regulatory capabilities (Fig. 4.5, top right-hand panel). Grem1 is not located near a 
gene desert but the genomic region of chromosome 2 where it is situated is gene-
poor, with the large Fmn1 gene spread over ~400 kb adjacent to the gene (Fig.4.5, 
top centre panel). A global control region (GCR) containing multiple enhancer 
elements that regulates Grem1 and Fmn1 limb expression (Vokes et al., 2008) is 
located across the 3′ end of the Fmn1 gene (Fig. 4.5 bottom centre panel). Both 
Hand2 and Grem1, then, inhabit a genomic environment similar to Shh and both 
HoxA and HoxD clusters: all are crucial developmental genes with tissue-specific 
regulatory elements.  
I analysed H3K27me3 modification across the Shh, Grem1 and Hand2 loci 
by ChIP in dissected limb tissues and found that it is almost completely absent from 
the three genomic regions (Fig. 4.5 top panels, lower two tracks). Across the Grem1 
locus the only peaks are over an intergenic location 5′ of Fmn1, over a gene 
downstream of Grem1, and over the Grem1 promoter (Fig. 4.5 top and bottom centre 
panels, lower two tracks). Both Shh and particularly Hand2 are covered with the 
H3K27me3 modification but the chromatin over both adjacent gene deserts is 
virtually free of the mark (Fig. 4.5 top left-hand and right-hand panels, lower two 
tracks). Whereas an anterior-posterior difference in H3K27me3 levels can be 
discerned over Hand2, there is no difference over Shh (Fig. 4.5. bottom extreme left-
hand and right-hand panels, lower two tracks). As for the 5′ Hoxd genes, Shh and 
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Hand2 have posteriorly-restricted expression domains at E10.5. The extent of Hand2 
expression across the distal posterior limb is greater than for Shh, which is the 
probable reason for the anterior-posterior difference for the former and not the latter. 
Shh-expressing cells will account for only a minority within the posterior tissue 
samples. Interestingly, H3K27me3 covers a large ~40 kb block at Hand2 (Fig 4.5 
bottom extreme right-hand panel), extending beyond the limits of the annotated CpG 
islands which have been suggested to be involved in polycomb recruitment.  
 
4.3.2. H3K4me1 marks characterised and potential regulatory elements of the 
Shh, Grem1 and Hand2 genomic regions in distal posterior and anterior limb 
bud cells  
Apart from the widespread coverage over a ~40 kb block downstream of 
Hand2 that contains several highly conserved regions (Fig 4.5 bottom extreme right-
hand panel), H3K4me1 has a punctate coverage over the three regions displayed in 
Fig. 4.5 (top three panels, upper two tracks); most of the peaks being situated in 
intergenic and intronic sites rather than proximal promoters. Over the Shh-ZRS 
region discrete peaks occur over the ZRS and to a lesser extent the floorplate 
enhancer SFPE1, but the gene itself is extensively covered (Fig. 4.5, two bottom left-
hand panels, upper two tracks). The Grem1 and Hand2 genomic regions have greater 
coverage over the large Fmn1 gene adjacent to the former and the gene desert 
adjacent to the latter, with many peaks corresponding to conserved sequences. For 
instance, intron 4 of Fmn1, the location of GABP and ETV5 peaks, and a region in 
the middle of the Hand2 gene desert with highly conserved sequences, that also 
contains a significant GABP binding site in E11.5 limb tissue (Chapter 3, Fig. 3.9), 
also have blocks of H3K4me1 (Fig. 4.5 bottom panels 3 and 6, upper two tracks). 
Moreover, the highly conserved elements within the Grem1 GCR are also covered 
with this mark, as is an intergenic region at the far end of the Hand2 gene desert that 
intriguingly shows an anterior-posterior difference not only for H3K4me1 but also 
for H3K27me3 (Fig. 4.5 bottom panels 4 and 5). At none of the loci analysed is there 
a differential distribution of H3K4me1 between anterior and posterior limb tissue, 
despite the differential expression of these 3 genes in the limb region; supporting the 
147 
 
view that this modification cannot on its own be considered as a mark for active 
enhancers.  
As discussed briefly in section 4.2.1 the lack of H3K27me3 over the Shh-
ZRS region indicates that polycomb is not responsible for the compact state of this 
locus, but may have some role in the regulation of Shh as revealed by the array data 
displayed in Fig. 4.5. Likewise, Hand2 expression is probably also influenced by 
polycomb activity, but from the array data these repressive complexes may have less 
of a role in Grem1 regulation. Common to all three regions, though, is the general 
absence of this mark and the presence of the distal regulatory mark H3K4me1, often 
over non-coding conserved regulatory sequences. Further work to identify possible 
distal elements in the Hand2 and Grem1 regions and analysis of chromatin 
conformation will reveal whether regulation of these genes has a higher-order 
structure component similar to Shh and the 5′ Hoxd genes. 















































































































































































































4.4. Chromatin topology of the Shh-ZRS regulatory region in E11.5 
floorplate cells 
The objective of the preliminary experiments described in this section is to determine 
if the neural enhancers co-localise with the -gal cassette inserted into the 
endogenous ZRS locus in cells where they drive Shh expression. DNA FISH on 
tissue sections derived from E11.5 embryos heterozygous for the reporter construct 
was carried out, initially with the fosmid probe that binds the wild type region of 
Lmbr1 containing the ZRS. A 10 kb probe specific for the reporter construct (Fig. 
4.1, purple region within the ZRS fosmid) has been optimised in order to do 4-colour 
FISH to compare co-localisation frequency of the SFPE1 and SBE4 enhancers with 
the reporter construct allele to co-localisation frequency with the ZRS wild type 
allele in floorplate and forebrain tissues. Work presented here involves the SFPE1 
probe along with either the wild type ZRS probe or the Dpp6 probe as in the limb 
analysis. These experiments initially focussed on determining the extent of chromatin 
compaction over the Shh-ZRS regulatory region in floorplate cells and adjacent cells 
where Shh is not expressed. The results are based on two sections through the same 
embryo, and although the results are intriguing, I aim to validate the data by carrying 
out further analysis on sections from other embryos. The sections shown here (Fig. 
4.6B) have not been cut cleanly across the floorplate/notochord but rather at a more 
obtuse angle, making it more difficult to clearly identify Shh-expressing 
floorplate/notochord tissue (Fig. 4.6A). Therefore, I must again emphasise that 
results presented below can only be regarded as indicative of chromatin topology 
within neural cells; however the data is similar to what appears to be occurring in 
Shh-expressing and non-expressing tissues within – and adjacent to – the limb bud.   
 
4.4.1 Shh-ZRS region is maintained in a compact chromatin state in floorplate 
and Shh-non-expressing cells 
DNA FISH analysis in floorplate and adjacent cells suggests that the Shh regulatory 
region is in a highly compact conformation, similar to the limb bud at this stage of 
murine embryogenesis (Fig. 4.6). Interprobe distances (d
2
) between SFPE1 and ZRS 
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revealed no significant difference in chromatin compaction between the Shh-
expressing and adjacent non-expressing cells (p = 0.34) (Fig. 4.7A, Table 4.4). The 
region 3′ of Shh is in a decompact state in the cells adjacent to the floorplate similar 
to that in the limb and flank tissue (compare median interprobe distances in Tables 
4.1 and 4.4); however this region is very decondensed in the floorplate, significantly 
greater than in the adjacent tissue (p = 0.0008) (Fig. 4.7A, Table 4.4). Difference in 
compaction is also highly significant when comparing SFPE1-ZRS and SFPE1-Dpp6 
in both sets of cells (p < 0.0001) (Fig. 4.7A). 
Analysis of the frequency of hybridisation signals separated by defined 
distance (d) intervals also reveals the highly decompact chromatin state of the 
genomic territory 3′ of Shh. The proportion of signal pairs ≥ 600 nm apart was 
greater for SFPE1-Dpp6 than SFPE1-ZRS: 50% and 32% compared to 1.5% and 4% 
in the floorplate and adjacent tissue respectively (Fig. 4.7B, Table 4.5). In both 
groups of cells the difference in proportion was highly significant: p < 0.0001. The 
significantly greater decompaction of the SFPE1-Dpp6 region in floorplate compared 
to adjacent cells can be accounted for by the ~25% of the probe pairs in the former 
having an interprobe distance (d) greater than 800 nm (Fig. 4.7B).  
  
Table 4.4. Interprobe distances for E11.5  floorplate sections 










0.06 (p = 0.34 ) 
 
0.37 
0.24 (p = 0.0008) 
  
Statistical analysis of data for Fig. 4.7A. Interprobe distances are median values, p-values from 




Table 4.5. Frequency of SFPE1-ZRS and SFPE1-Dpp6 probes separated by ≥ 600nm for 
E11.5 floorplate sections. 
 
Probe pairs Floorplate Adjacent non-expressing 
 Frequency (%) ≥ 600 nm 
SFPE1-ZRS (816 kb)  
SFPE1-Dpp6 (866 kb) 
1.5 
50 (p < 0.0001) 
4 
32 (p < 0.0001) 
 
Statistical analysis of data for Fig. 4.7 B. p-values from Fisher’s Exact Tests. 
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Figure 4.6. Representative section and nuclei images. A, Shh expression in the floorplate 
and neural tube (Image from Jeong et al., 2006) (fp, floorplate; nc, notochord). B,  Image of 
floorplate tissue section for DNA FISH, counterstained with DAPI. Below are examples of 
nuclei from floorplate and the adjacent region from which interprobe distances were 
measured. Hybridisation signals are for SFPE1-Dpp6 and SFPE1-ZRS probe pairs. Scale 




          
 
Figure 4.7. The Shh-ZRS regulatory region is maintained in a compact chromatin 
structure in possible Shh-expressing floorplate cells and adjacent non-expressing 
cells but with significantly greater co-localisation of SFPE1-ZRS in the floorplate only. 
A, Box plots show the distribution of interprobe distances (d
2
) for the SFPE1-Dpp6 and 
SFPE1-ZRS probe pairs in floorplate and adjacent tissue. Shaded boxes show the median 
and interquartile range of the data; asterisks indicate outliers. Number of loci: SFPE1-Dpp6 = 
100, SFPE1-ZRS ≥ 100. Probe positions shown above. The statistical significance of 
differences between each tissue was examined by Mann-Whitney U tests (Table 4.4). B, 
Frequences were calculated for every 0.m distance interval (x-axis) between SFPE1-ZRS 
and SFPE1-Dpp6 in floorplate and adjacent Shh-non-expressing cell nuclei. The location of 
the tissue sections are shown in Figure 4.6. The statistical significance of the differences in 
co-localisation (< 200nm) of both probe pairs between Shh-expressing and non-expressing 
tissue were examined by the Fishers exact test (Table 4.6). Number of loci measured ≥ 100. 
Error bars represent SEM obtained from two different tissue sections. 
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4.4.2. Significantly greater co-localisation of SFPE1 and ZRS in floorplate 
tissue compared to the adjacent cells 
Co-localisation of the SFPE1 floorplate enhancer probe and the probe covering the 
ZRS region (32% averaged over measurements from two different sections) within 
the Shh-expressing cells of the floorplate was significantly greater than within the 
adjacent non-expressing region (17%): p = 0.02 (Fig. 4.7B, Table 4.6). Frequency of 
co-localisation between SFPE1 and the Dpp6 was minimal in both cell types and not 
significantly different (p = 0.72). 
These data suggest that the ZRS and Shh loci co-localise in neural cells of the 
floorplate (the SFPE1 fosmid probe binds to the region immediately upstream of the 
Shh TSS, Fig. 4.1), although the ZRS has been shown to have limb-specific activity 
(Lettice et al., 2003; Sagai et al., 2005). Increased frequency of co-localisation may 
be due to the allele containing the reporter cassette. These tissue sections are from 
mice heterozygous for the construct, -gal expression throughout the floorplate 
indicates that the floorplate enhancers (including SFPE1) are able to target and 
activate the reporter gene located at the endogenous ZRS locus. The compact higher-
order chromatin conformation of the Shh-ZRS region in cells of the floorplate 
reduces the nuclear search space for these proximal enhancers of Shh (SFPE2 is 
located within an intron of the gene, Fig. 4.1) that may enable them to act over this 
large genomic distance. Further analysis of the floorplate tissue sections will involve 
4-colour DNA FISH using the same probes in addition to the probe that binds to the 
reporter construct; in this way I will be able to discern whether the increased co-
localisation frequency is due to interactions specifically between the -gal 
endogenous knock-in and the floorplate enhancer.        
 
Table 4.6. Co-localisation frequency of the SFPE1 probe with the ZRS and Dpp6 
probes for E11.5 floorplate sections 
Tissue SFPE1-ZRS (816 kb) SFPE1-Dpp6 (866 kb) 




17 (p = 0.02) 
3 
5 (p = 0.72) 
Statistical analysis of data for Fig. 4.7B. p-values from Fisher’s Exact Tests. 
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4.5. Shh regulatory region is maintained in a compact chromatin 
structure in embryonic stem cells 
My initial analysis of the Shh regulatory region in murine E11.5 embryos by FISH 
has revealed that the chromatin is arranged into a compact chromatin state not only in 
cells where the Shh is expressed (distal posterior limb bud, floorplate) but also in 
non-expressing cells (regions adjacent to the limb and floorplate). Further tissues 
await characterisation but in this section I will describe 2D FISH experiments that 
determined the chromatin conformation of the regulatory region in undifferentiated 
ES cells, where Shh expression is repressed. (2D FISH experiments on ES cells were 
carried out by S. Boyle.) 
In these experiments the SFPE1 probe was used rather than the Shh probe but 
both recognise immediately adjacent regions, so for this analysis the SFPE1 probe 
was a legitimate proxy for the Shh genomic locus (Fig. 4.1). To account for 
differences in nuclear size, interprobe distance (d
2





), although the non-normalised results were also comparable (Table 4.7). As for 
the E11.5 tissues analysed, the 800kb SFPE1-ZRS region was highly compact 
compared to similarly sized SFPE1-Dpp6 interval (p < 0.0001) (Fig. 4.8, Table 4.7). 
However, the interprobe distance between SFPE1-ZRS (816 kb) is significantly 
shorter than that for SBE4-ZRS (515 kb) (p < 0.0001) (Fig. 4.8A, Table 4.7). So 
although the forebrain enhancer is ~300kb closer to the ZRS, their nuclear separation 
is greater than the distance from the Shh locus to the limb enhancer. Moreover, the 
interprobe distance between SFPE1 and SBE4 (286 kb) is also greater than the 
distance between SFPE1 and ZRS, though this difference is not quite significant (p = 
0.06) (Fig. 4.8A, Table 4.7).  
These data suggests that the compact nature of the Shh regulatory region is 
the result of a (small-scale) looping mechanism – possibly similar to the  formation 
of a series of mini-loops described in section 1.2.5, Fig. 1.6 – that maintains the locus 
containing Shh and the locus where the ZRS resides in close proximity, at least in ES 
cells (Fig. 4.8B). And as the box plots in Fig. 4.8 show, the range of interprobe 
distances for each of the sub-regions between Shh and the ZRS, though greater than 
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for SFPE1-ZRS, did not reach the levels indicative of an extensive unravelling of 
chromatin structure characteristic of a large looping mechanism.   
 
 
Table 4.7. Normalised and squared interprobe distances for OS25 ES cells 












SFPE1-ZRS (816 kb) 
SFPE1-SBE4 (286 kb) 
SBE4-ZRS (515 kb)  
SFPE1-Dpp6 (866 kb) 
0.0006 
0.0009 (p = 0.06) 
0.0014 (p < 0.0001) 
0.0097 (p < 0.0001) 
0.08 
0.14 (p = 0.15) 
0.22 (p = 0.0001) 
1.75 (p < 0.0001) 
Statistical analysis of data for Fig. 4.8. Interprobe distances are median values, p-values from 






















Figure 4.8. Chromatin structure of the Shh regulatory region is maintained in a 
compact conformation in ES cells. A, 2D FISH with probe pairs across the ~800 kb 
regions centromeric and telomeric of Shh, in MAA-fixed nuclei of OS25 ES cells. Probe 
positions for each experiment are shown above. Box plots show the distribution of interprobe 
distances (d
2
) normalized for nuclear radius (r
2
). The shaded boxes show the median and 
interquartile range of the data; asterisks indicate outliers. Number of loci: SFPE1-Dpp6 = 82, 
SFPE1-ZRS = 93, SBE4-ZRS = 86, SFPE1-SBE4 = 86. The statistical significance of 
differences between each probe pair were examined by Mann-Whitney U tests (Table 4.7). 
B. Schematic of a possible higher-order chromatin configuration over the Shh-ZRS 
regulatory region that accounts for the interprobe distances measured between the various 
probe pairs in ES cells and embryonic tissue. Factors that could be maintaining this structure 





4.6.1. Compact chromatin structure characterises the Shh-ZRS region in 
murine E11.5 limb and neural tissue and undifferentiated ES cells 
From the preliminary data of this on-going project the most surprising finding is 
what appears to be a highly compact chromatin structure across the Shh/SFPE1-ZRS 
genomic region. These probe pairs have significantly shorter interprobe distances 
separating them than the Shh/SFPE1-Dpp6 probe pairs that cover the adjacent 
genomic region; which is maintained in undifferentiated ES cells where Shh is not 
expressed (Fig. 4.8A) and in all the tissues so far examined in E11.5 embryos (Figs. 
4.3 and 4.7B). In the E11.5 limb bud no significant difference in compaction levels 
of the Shh-ZRS regulatory region could be detected between the distal posterior 
where Shh is expressed and the distal anterior and proximal limb bud where the gene 
is silent. In the adjacent flank region, though, the ~800 kb region was significantly 
less compact but – as the box plots reveal – not to the extent of the unfolded 
chromatin structure throughout the 800 kb region 3′ of Shh (Fig. 4.3). Floorplate and 
adjacent cells showed no difference in compaction. To determine whether this 
chromatin conformation is maintained throughout all embryonic tissues at E11.5 
requires further analysis of cells more remote from tissues where Shh is expressed. 
As for the HoxD locus, this compact conformation could be maintained to minimize 
the nuclear search space for the long-range enhancers to find the Shh promoter. So 
analysis of limb and neural tissue from embryos at a later stage in development, 
when the gene is no longer expressed, may reveal a more decompact chromatin 
conformation over the Shh-ZRS genomic region.    
ChIP-chip data from E10.5 distal limb bud tissue revealed that the PRC2-
catalysed H3K27me3 histone mark is absent from the Shh regulatory region, 
indicating that polycomb complexes do not have a role in the formation of this 
compact chromatin structure. In any case, the compact nature of the locus is more 
likely to signify an active or at least poised configuration; possibly similar to the 
conformation over the HoxD regulatory region described in Chapter 2 and in 
Montavon et al. (2011). My immediate focus in order to elucidate further the 
chromatin conformation of the locus is to measure the distances between Shh and the 
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forebrain enhancer SBE4 and between SBE4 and the ZRS in the limb and floorplate, 
as for the ES cell analysis. To determine whether the chromatin is forming a series of 
“mini loops” (Fig. 4.8B) I will use additional probes for loci between SBE4 and 
ZRS, including the Rnf32 fosmid (Fig. 4.1), and by 3- and 4-colour FISH look for 
increased interprobe distances between probe pairs that indicate looping across 
particular regions. Further studies would involve trying to establish the probable 
biochemical factors required to maintain the higher-order chromatin structure in this 
compact conformation. Possible proteins are CTCF and cohesion, which has been 
identified as a facilitator in the formation of intrachromosomal loops (Hadjur et al., 
2009; Mishiro et al., 2009; Nativio et al., 2009; Hou et al., 2010). 
The FISH data presented for both the Shh and HoxD regulatory regions 
suggests that they form what has recently been described as “topological domains”: 
up to megabase size genomic regions characterized by local chromatin interactions 
and separated by insulator elements bound by CTCF (Dixon et al., 2012). Indeed, 
both regions are identified as discrete topological domains in murine ES cells (Fig. 
4.9). In another recent paper chromatin conformation capture carbon copy (5C) 
(Dostie et al., 2006) and super-resolution microscopy was used to demarcate 
“topologically associating domains” within a 4 Mb region of the X chromosome 
containing the X-inactivation centre (Nora et al., 2012). Therefore, I intend to 
interrogate further both regulatory landscapes using 5C in conjunction with FISH 
assays (possibly using high resolution microscopy for the Shh locus) in order to 
clearly define the limits of each region and confirm the gene-enhancer co-localisation 
results (see below). For HoxD I intend to use the immortalised cell lines (Chapter 2) 
for the 5C assays but these cells may not be a good system for Shh as it cannot be 









          
 
Figure 4.9. Topologically interacting domains in murine ES cells. The Shh and 5′ HoxD 
regulatory regions correlate with chromatin interaction domains identified in ES cells. 
Domains are shown as coloured bars along the top track. The second track shows fosmid 
positions used in FISH analysis of both genomic regions, with the position of regulatory 
elements below. Bottom track shows gene locations. (Topological domains from Dixon et al., 










4.6.2 Frequency of ZRS-Shh interactions was increased in the distal posterior 
limb and floorplate 
In both Shh-expressing tissues analysed by FISH (limb bud and floorplate), the 
proportion of co-localised Shh/SFPE1-ZRS probes was greater than the adjacent 
tissue. Previous analysis of Shh-ZRS co-localisation in the limb, using the same 
criteria, found a co-localisation frequency of 18% of measured probe pairs in 
posterior cells compared to 10% in anterior cells dissected from E10.5 murine distal 
forelimbs (Amano et al., 2009). The difference in frequency was not significant 
between anterior and posterior cells, but co-localisation frequency in posterior cells 
was significantly greater than in cells dissected from the middle of the limb bud; a 
location where Shh is not normally expressed and where the authors present data 
showing over 40% of probe pairs separated by distances greater than 600 nm. This 
analysis was done on single cell suspensions, while the work I present here was done 
on dissected tissue sections; and in no tissues so far analysed have I found this level 
of probe separation. In the distal posterior and anterior tissue nuclei analysed here the 
frequency of co-localisation was 23.5% and 13.5% respectively, again not quite 
significantly different but this could be due to one of the posterior tissue sections 
measured (16.5% co-localisation) not containing ZPA cells. Further analysis of tissue 
sections across the entire forelimb will determine whether co-localisation of Shh-
ZRS significantly increases within the ZPA. Of course, for a more accurate 
comparison with the earlier study, and to determine if there are temporal differences 
in chromatin topology over the Shh-ZRS regulatory region, requires repeating this 
analysis on E10.5 forelimb tissue. To ensure only ZPA cells are analysed, embryos 
containing a Shh allele containing an endogenous GFP knock-in could be used; 
immunofluorescence analysis of alternate sections would therefore allow a more 
precise identification of Shh-expressing cells.  
Although expected in the distal posterior limb bud where the ZRS is active, 
co-localisation in the floorplate is not required to drive Shh expression there as two 
proximal enhancers have been shown to regulate expression throughout the 
floorplate/neural tube and hindbrain (Jeong et al., 2006). As explained in section 4.4 
the tissues analysed were derived from mouse embryos heterozygous for a reporter 
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construct inserted into the endogenous ZRS locus (Fig. 4.1), so increased co-
localisation may be indicative of the proximal enhancers having long-range 
capabilities and are actively driving reporter gene expression in the floorplate. 
Further analysis using a probe that is specific for the inserted reporter construct 
should be able to establish if these enhancers do have this capability and may provide 
insight into the intriguing question as to whether the capacity for long-range activity 
is inherent to all enhancers – that it is the presence of the right binding factors and/or 
the receptiveness of promoters within “topologically associating domains” that 
determine the extent of enhancer activity. However, co-localisation could also be 
caused by another, currently uncharacterised floorplate enhancer located near to the 
ZRS which is interacting with Shh. Or, indeed, both scenarios could occur. To 
determine if this proposed neural enhancer does co-localise with Shh in the floorplate 
requires FISH analysis on wild type embryos, ideally in conjunction with the 5C 
assays described above. However, collecting sufficient quantities of chromatin from 
floorplate tissue, and limb tissue, to carry out these assays would be technically 
challenging.        
4.6.3 Histone H3 lysine 4 mono-methylation marks known and potential 
enhancers of genes expressed during distal limb development 
The genomic regions displayed in Fig. 4.5 contain three genes – Shh, Grem1 and 
Hand2 – that play crucial roles in posterior specification of the distal limb bud and 
consequent development of the handplate (Robert and Lallemand, 2006; Hill, 2007). 
All three reside in chromosome regions that can be termed gene-poor (especially Shh 
and Hand2) and at least for Shh and Grem1, are regulated by long-range enhancers. 
The histone modification associated with distal regulatory elements, H3K4me1, 
covers discrete, often conserved, distal loci throughout each of these genomic 
territories; including the known limb enhancers ZRS and Grem1 GCR. However, 
these enhancers have the H3K4me1 mark in anterior cells also, which indicates that 
this modification is also present over poised enhancers during limb development (as I 
showed for the Hoxd and Hoxa enhancers in Chapter 2). Additional ChIP-chip 
analysis of other active enhancer markers, particularly H3K27ac and p300, may 
reveal differences in enhancer status between the anterior and posterior limb bud.  
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To establish if the conserved regions with the H3K4me1 peaks, that also had 
GABP peaks in the E11.5 ChIP-chip assays described in Chapter 3, are possible 
enhancers (at the centre of the gene desert centromeric of Hand2 and within intron 4 
of Fmn1 (Fig. 4.5)) I intend to interrogate both regions by DNA FISH. Furthermore, 
I would like to establish whether Grem1 and Hand2 also reside in regulatory regions 
as suggested by their surrounding genomic landscape; in the first instance by FISH to 
determine chromatin conformation and then at greater resolution by the 5C 





























A wealth of data has provided clear evidence that dynamic manipulation of higher-
order chromatin structure impacts upon gene expression (Dostie and Bickmore, 
2012). The capacity of distal enhancer elements to activate target genes in a tissue-
specific manner requires modification to, and very likely altered conformation of, 
chromatin structure (Amano et al., 2009; Montavon et al., 2011; Cotney et al., 2012). 
However, specificity may be more reliant upon the binding of factors necessary to 
activate an enhancer; for large regulatory sequences such as the ZRS competing 
active and repressive factors are likely to bind in varying ratios that depend on their 
cellular levels or the levels of co-factors, which will determine subsequent activity 
(Lettice et al., 2012). 
Many key developmental genes – which require a high degree of regulation 
to ensure correct spatio-temporal expression – inhabit gene-poor genomic territories; 
often adjacent to gene deserts. This thesis describes the work I have undertaken to 
delineate the roles of chromatin structure and conformation in the activation of Shh 
and the 5′ Hoxd genes by tissue-specific enhancers, particularly during distal limb 
development (Chapters 2 and 4). Both have neighbouring 500-800 kb gene deserts 
containing multiple enhancers (the limb-specific ZRS is of course located at the 
opposite end of the Shh gene desert within Lmbr1)  that ensure spatial and temporal 
expression is robustly regulated (Spitz et al., 2003; Lettice et al., 2003; Jeong et al, 
2006; Montavon et al., 2011). In addition, Chapter 3 described research into the 
opposing functions of two different groups of ETS factors that bind to the ZRS in the 
limb, thereby beginning to elucidate the biochemical processes that determine the 
activity of this limb-specific enhancer. 
 
5.1. Polycomb has a role in the regulation of limb-specific Hoxd 
expression 
In Chapter 2 I have presented the results from a thorough investigation into 
local chromatin conformation and histone modification over the HoxD cluster and 
how chromatin structure impacts upon gene expression. Work on ES cells had shown 
that polycomb has a direct role in chromatin compaction over the Hox clusters, and 
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that loss of H3K27me3 correlates with chromatin unfolding over HoxB and HoxD 
and progressive 3′ to 5′ expression of the genes (Eskeland et al., 2010). Chromatin 
compaction levels were then shown to be dependent on the polycomb PRC1 complex 
which recognises and binds chromatin with the H3K27me3 histone modification. I 
have established that similar polycomb driven processes occur during limb-specific 
Hoxd expression. In both E10.5 distal posterior cell lines and limb tissue there was a 
loss/reduction of H3K27me3 over the 5′ genes compared to anterior cell lines and 
limb tissue, chromatin decompaction was restricted to the distal posterior cells/tissue, 
and an upregulation of the 5′ genes in the distal posterior cell lines and dissected limb 
tissue. 
During this research I have made use of immortalised cell lines set up by A. 
Hill and extensive expression analysis has shown their veracity as a model system for 
limb development (Chapter 2, section 2.2). Over the Hoxd genes, the general pattern 
of expression is reflected by the cell lines, and FISH analysis established that the 
chromatin is more decompact over the HoxD locus in both posterior cell lines 
compared to anterior cell lines – therefore recapitulating the different compaction 
levels identified in their tissue of origin (Chapter 2, section 2.4) (Williamson et al, in 
press). 
 
5.2. Two groups of ETS factors influence limb-specific Shh expression 
through the ZRS 
As functioning enhancers are nucleoprotein complexes, biochemical 
processes occurring during enhancer activity need to be delineated for a full 
understanding of enhancer function. In Chapter 3 I described research into the role of 
several members of the ETS family of transcription factors in regulating the spatial 
activity of the Shh limb enhancer the ZRS. By ChIP-chip I established that GABP, 
ETS1, ETV4 and ETV5 bind to the ZRS, and in vitro EMSA analysis revealed that 
whereas ETS1 binds to the canonical AGGAA
G
/AT motif (Hollenhorst et al., 2011), 
ETV4 binds the novel AGAAA
G
/A motif (Fig. 3.2A). ETV4 and ETV5 have 
functional redundancy during limb development and repress anterior Shh expression 
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(Mao et al., 2009; Zhang et al., 2009). Reporter assays show that deletion of both 
ETV ZRS sites results in ectopic expression, indicating that the repressive activity of 
these factors is on the ZRS and not Shh directly (Lettice et al., 2012).  
The five AGGAA
G
/AT ZRS sites have varying potency for driving reporter 
gene expression, with sites 1 and 3 having the greatest input (Chapter 3, section 
3.6.1). The AUS mutation that creates an additional ETS site immediately adjacent to 
the ETV site B (Fig. 3.3D) can, however, compensate for both these sites alone; and 
with the other sites present the posterior expression domain increases towards the 
centre of the distal limb bud and an anterior expression domain is produced. This 
work implicates GABP and ETS1 as at least two of the ETS factors required to 
activate the ZRS in the distal posterior limb bud, and proposes a possible mechanism 
for ectopic anterior expression of Shh through point mutations in the ZRS creating 
additional binding sites for these factors; mutations that are the cause of the ZRS-
associated syndrome PPD2 in two families (Gurnett et al., 2007; E. Da Graaff, 
personal communication).       
 
5.3. Both 5′ HoxD and Shh regulatory regions are maintained in a 
compact higher-order chromatin conformation in expressing and non-
expressing tissues 
Analysis of the ~500 kb region 5′ of the HoxD cluster by FISH has revealed that the 
entire region is folded in a close chromatin conformation throughout the forelimb 
bud of E11.0 embryos (Chapter 2). Likewise, the ~800 kb Shh-ZRS region is being 
held in what looks to be a similar conformation in both limb and neural Shh-
expressing and non-expressing tissue and, surprisingly, ES cells (Chapter 4). 
Nevertheless, I have been able to quantify increased enhancer-gene co-localisations 
within expressing tissues compared with non-expressing. I have shown the GCR and 
5′ Hoxd genes spatially co-localise within the distal posterior E11.0 limb bud – 
thereby revealing at the single cell level the requirement for direct interaction 
between this enhancer and its target genes for upregulation of expression to occur 
(Chapter 2) (Williamson et al., in press). Another potential regulatory element 
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identified farther into the adjacent 5′ gene desert (island III (Montavon et al., 2011)) 
does not show a significant increase in co-localisation with either the GCR or 
Hoxd13 in the distal posterior forelimb, which suggests that this element is not 
required for 5′ Hoxd activation at this developmental stage. Therefore, the multiple 
potential regulatory elements identified by Montavon et al. (2011) in E12.5 limb 
buds may not all be required simultaneously for second phase Hoxd limb expression; 
but rather a more spatio-temporal mechanism is at work. One possibility is that 
GCR/Prox initiates expression earliest and specifically in distal posterior regions, and 
then subsequently the other elements drive expression in progressively more anterior 
domains throughout the later temporal stages (>E11.0 - E12.5) of second phase Hoxd 
limb expression. 
To gain a more complete understanding of the regulatory mechanisms 
controlling limb-specific Hoxd expression I intend to continue my investigations into 
the processes involved. Initially, I will use 5C, probably the chromatin conformation 
capture method most able to accurately quantify physical interactions of genes and 
regulatory elements and characterise local chromatin architecture (up to 1-2 Mb) 
(Dostie and Bickmore, 2012). Then, by combining 5C and FISH, I will interrogate 
the region further at progressively later developmental stages to build a more 
complete picture of chromatin structure over the 5′ HoxD regulatory region and how 
it is manipulated through this crucial phase of limb development when tight 
regulation of the 5′ genes is necessary for the correct patterning of the digits 
(Gonzales et al., 2007; Montavon et al., 2008; Montavon et al., 2011). My proposed 
model for the configuration of the regulatory region (Fig. 2.15) invokes the 
chromatin as a series of mini-loops, a configuration likely to require maintenance by 
biochemical mechanisms. Therefore, I will look for the binding of factors capable of 
forming chromatin loops, such as CTCF and cohesin (Hadjur et al., 2009; Mishiro et 
al., 2009; Nativio et al., 2009; Hou et al., 2010), by ChIP-chip. A functional role for 
chromatin looping in gene expression was recently shown at the -globin locus 
(Deng et al., 2012). Forced interactions between the -globin promoter and the LCR 
in non-expressing erythroid cells where the locus is normally in a relaxed state 
resulted in activation of transcription.  
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Several histone modifications and modifying enzymes are associated with 
enhancers, such as H3K4me1/2, H3K27ac and the histone acetyltransferase p300 
(Heintzman et al., 2007; Barski et al., 2007; Maston et al., 2006; Rada Iglesias et al., 
2010; Creyghton et al., 2010). ChIP-chip H3K4me1 data from E10.5 anterior and 
posterior limb tissue revealed that this modification was present across the distal 
limb bud at known and potential cis-regulatory elements of posterior-specific genes 
(Chapters 2 and 4). Therefore, H3K4me1 is not a good indicator for active enhancers 
in the limb. Acetylation of H3K27, however, has been shown to be a better mark for 
identifying active limb enhancers (Cotney et al., 2012). I intend to characterise the 
H3K27ac modification over these regions and the HoxD-associated island elements 
(using tiling arrays with wider coverage over the genomic regions containing limb 
genes) in E10.5 anterior and posterior tissue by ChIP-chip in order to determine 
whether this mark differentiates between active and inactive/poised enhancers. In the 
context of the 5′ HoxD regulatory region, these ChIP-chip assays may reveal 
differences in H3K27ac modification between GCR/PROX and the island elements 
at the E10.5-11.0 developmental stage. Consequently, I may then repeat this analysis 
on E11.5 and E12.5 anterior and posterior tissue in conjunction with FISH, 5C and 
ChIP-chip for CTCF/cohesin. 
The Shh-ZRS FISH data from limb and neural tissue and ES cells may be 
indicative of higher-order chromatin structure over developmental gene regulatory 
regions; a conformation maintained from before the embryonic stages when the gene 
is active at least until the period of expression has concluded. It is rather striking that 
the close chromatin conformation identified in Shh-expressing cells (floorplate and 
distal posterior limb bud) is also the state of the locus in E11.5 non-expressing tissue 
so far analysed and even in undifferentiated ES cells where Shh is never expressed 
(Chapter 4). These data partially contradict previous analysis of this locus, which 
indicated that Shh and the ZRS genomic regions were not in close proximity in limb 
tissue where the gene is never expressed (Amano et al., 2009) – a conformation I 
have yet to identify in limb, neural and adjacent tissues. Although more widespread 
analysis of E11.5 tissues is required (and of earlier stages), this unchanging higher-
order structure may be a general conformation of genomic regions containing 
developmental genes regulated by tissue-specific enhancers. Maintenance of a close 
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chromatin structure – possibly (as for Shh) from ES cells through differentiation and 
subsequent embryo development – ensures that regulatory elements and target 
gene(s) are in close proximity, reducing the nuclear search-space for the enhancers to 
optimise activation efficiency. Timing of activation and tissue-specificity would then 
rely upon the correct set of factors and co-factors being present at the enhancers and 
promoters. To investigate further this model of long-range regulation I will carry out 
the experiments described in section 4.6 of Chapter 4. 
 
5.4. Summary  
In this thesis I have presented novel data on the mechanisms of long-range cis 
regulation as imparted by distal enhancers upon target genes during mouse forelimb 
bud development. I have shown that two different aspects of chromatin higher-order 
structural manipulation occurs during 5′ Hoxd activation: chromatin decondensation 
across the cluster itself that correlates with a reduction of H3K27me3 and indeed the 
PRC1 component Ring1B (which also occurs during ES cell differentiation 
(Eskeland et al., 2010) and main body anterior-posterior development (Morey et al., 
2007; Soshnikova and Duboule., 2009)); and co-localisation of the limb-specific 
GCR and the 5′ end of the HoxD cluster (Williamson et al., in press (Appendix B)). I 
identified several ETS factors bound to the ZRS in vitro and in vivo and was part of a 
lab effort to elucidate the role of these factors in regulating Shh limb expression 
through the ZRS. Finally, I have established that compact chromatin configurations 
occur over both the 5′ Hoxd and Shh regulatory regions; a conformation that may be 



























6.1 General molecular biology reagents 
Solutions prepared by MRC Human Genetics Unit (HGU) Core Scientific Services: 
Tris-HCl                                                                                            
Tris[hydroxymethyl]aminomethane (Tris base) was dissolved in sterile water and pH 
adjusted using HCl. 
EDTA 
Ethyldiaminetetra-acetic acid di-sodium salt was dissolved in sterile water, solid 
NaOH added to increase pH to 8. 
TAE buffer, 50X stock 
Tris base 242g, glacial acetic acid 57.1 ml, 0.5M EDTA to a final volume of 1 litre 
with distilled water. 
PBS 
Phosphate buffered saline: NaCl 8g, KCl 0.2g, Na2HPO4 1.44g, KH2PO4 0.24g – in a 
final volume of 1 litre of distilled water and adjusted to pH 7.4. 
20X Saline Sodium Citrate (SSC) 
NaCl 175.3g; Sodium citrate 88.2g – in a final volume of 1 litre of distilled water and 
adjusted to pH 7.0. 
L-broth 
Tryptone 10 g 
Yeast extract 5 g 
NaCl 10 g 
Glucose 1 g 
Made up to 1 litre with water and autoclaved. 
Agar 
15 g agar was added to 1 litre L-broth to prepare solid media. 
Solutions prepared in the lab: 
TE buffer 
10 mM Tris.HCl (pH 8.0), 1mM EDTA 
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1X TAE buffer 
























6.2 Tissue culture 
6.2.1 Immortomouse cell lines from anterior and posterior distal limb 
The posterior third, and the anterior two thirds, of distal forelimb buds were dissected 
from E10.5 and E11.5 day embryos from an Immortomouse (H-2k-tsA58) x CD1 
cross. The transgenic mice were created by microinjection of a DNA fragment 
containing the a thermolabile large tumour (T) antigen (TAg) gene from a simian 
virus 40 (SV40) strain (tsA58, temperature sensitive (ts)) fused to the widely active 
H-2k
b
 promoter (Jat et al. 1991). After washing in PBS, limb buds were treated using 
trypsin (0.2 g/l)/Versene for 15-20 minutes, and then gently dispersed by repeated 
pipetting with a pastette. Cells were then plated into 6 well plates in DMEM 
(Invitrogen) with 10% Foetal Calf Serum (Sigma), Penicillin/Streptomycin and 20 
ng/ml -Interferon (Peprotech). The two pairs of E10.5 cell lines (A1/P1 and A2/P2) 
were derived from two litters, the E11.5 cell line (14fp) from a single litter 
Cells were grown at 33C – the permissive temperature for the temperature-
sensitive T antigen. Media was changed twice per week and cells were passaged as 
necessary. E10.5 cells were harvested no later than passage 12 due to a notable 
change in growing speed which may be indicative of a progressive loss of their 












6.3.1 Gel electrophoresis of DNA samples 
Separation of DNA fragments by size was done by agarose gel electrophoresis. 
Agarose (High Pure, BioGene) was dissolved in 1X TAE in a microwave to make 1-
2% (weight/volume) gels. Ethidium bromide (Electran, 10 mg/ml) was added to the 
gel before setting to a final concentration of 25 g/100 ml.  
Loading buffer (see 6.3.3) was added to the DNA samples before loading and 
gels were run at 60-100V, visualised under UV illumination and photographed on a 
Gel Doc XR (BioRad) imaging system. 
 
6.3.2 Gel electrophoresis of RNA samples 
As for DNA samples but with the following additional steps: added an equal volume 
of formamide to the sample volume containing 1g of RNA along with the loading 
buffer. Incubate samples for 10 minutes at 65°C, then 5minutes 4°C before running 
on a 1% gel. 
 
6.3.3. Agarose gel loading buffer 
Prepared as a 5X stock and stored at room temperature. 
                              Quantity    Final concentration 
Glycerol                  5 ml                  50% 
0.5M EDTA           100 l               5 mM 
Orange G                0.03 g               0.3% 






6.4 Analysing gene expression 
6.4.1 RNA extraction 
Total RNA was prepared using Trizol reagent (Invitrogen) according to 
manufacturer’s protocol (for limb buds, dissected anterior and posterior tissue was 
dissociated into single cell suspensions in Trizol using a syringe fitted with a 25G 
(0.5 mm) needle (BD Microlance)), followed by acid phenol:chloroform:isopropyl 
alcohol extraction and then digested with 2U DNaseI (Ambion) for 30 minutes at 
37°C. 
 
6.4.2 cDNA synthesis 
cDNA was made using a first strand synthesis kit (Roche) according to 
manufacturer’s instructions. A negative control reaction, lacking reverse 
transcriptase, was also performed for each RNA sample. 
 
6.4.3 RT (Reverse Transcription)-PCR  
First strand product was amplified by PCR using gene specific primers (Table 6.1) 
for 32 cycles (95°C for 20 s, 60°C for 30 s, 72°C for 30 s) and products visualised by 
electrophoresis. 
 
6.4.4 Quantitative real time (RT-q)PCR 
RT-qPCR was carried out on the BioRad CFX96 Real-Time System using Quantitect 
SYBR Green detection kit (QIAGEN) and using the thermal cycler programme: 15 
min Hotstart; 44 PCR cycles (95°C for 15 s, 55°C for 30 s, 72°C for 30 s). For each 
run, a standard curve for each primer set (Table 6.1) was obtained using anterior and 
posterior cell lines and limb tissue cDNAs. Fold expression in 3 biological replicates 
of posterior/anterior cells (cell lines and limb tissue) was calculated using the BioRad 
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CFX Manager software and normalized to GAPDH. Standard error of the mean 
(SEM) for fold change expression of P1, P2 and posterior limb tissue cells relative to 
A1, A2 and anterior limb tissue cells respectively and comparison of anterior and 




 Where Z is fold change, and A and B are two measured transcript levels with SEM 
ΔA and ΔB.  
Table 6.1. PCR primers for analysis of transcript levels 
Gene Oligo       Sequence                          Ref 
Hoxd1 
 
d1bUp            CCACAGCACTTTCGAGTGGA Morey et al., 2007 
Hoxd1 Hoxd1r ACTCTTTCTCTAGCTCTGTCAG  
Hoxd3 d3pA GAACTCCAAGCAGAAGAACAG Condie & Capecchi, 1993 
Hoxd3 Hoxd3r CAGATAGCGGTTGAAGTGGAAC  
Hoxd4 Hoxd4f GGAGAACGAGGGAGAACCA  
Hoxd4 Hoxd4r TCTGCTGCTGCTATGACTGC  
Hoxd8 Hoxd8f CACTTAAATCAGAGCTCGTCTCC  
Hoxd8 Hoxd8r GACCTCGATTCTCCTCTTCCTGG  
Hoxd10 Hoxd10f GTGCAGGAGAAGGAAAGCAAAG Modified from (Mizusawa et al., 
2004) Hoxd10 Hoxd10r TAACGCTCTTACTGATCTCTAGGC  
Hoxd11 Hoxd11f TCCAGGCAAACGAGAGAAAC  
Hoxd11 Hoxd11r TTGGCAAATAAGGTTTCTGGA  
Hoxd12 Hoxd12f CAACTTGAACATGGCAGTGCAAG  
Hoxd12 Hoxd12r CTGCTGCTTTGTGTAGGGTTTCC  
Hoxd13 Hoxd13f AGTCCTGGACGCTAGCCAACG  
Hoxd13 Hoxd13r GTAGACGCACATGTCCGGCTG  
Actin Actinf AGAGCTATGAGCTGCCTGACG  
Actin Actinr TGTGTTGGCATAGAGGTCTTTACG  
Lnp LnpaUp GTGGAAGGCTCAAGCTCAAC  
Lnp LnpbLo TGCTGGGCAATCTGAATATG  
GAPDH GABDHf ATCACCATCTTCCAGGAGCGAG  
GAPDH GABDHr GACCCTTTTGGCTCCACCCTTC Modified from (Boyer et al., 
2006) FgfR2b FGFR2f CTGTTCAATGTGACGGAGATGG  
FgfR2b FGFR2r ACAGACGCGTTGTTAYCCTCAC  
FgfR2c FGF2Cf CACTCTGCATGGTTGACAGTTC  
FgfR2c FGF2Cr CACTCTGCATGGTTGACAGTTC  
Fgf8 FGF8f AAAGTCACACAGCGACATGTGAGG  
Fgf8 FGF8r TCTGTGAATACGCAGTCCTTGCCT  
Fgf10 FGF10f AGCGGGACCAAGAATGAAGACTGT  
Fgf10 FGF10r CCTGCCATTGTGCTGCCAGTTAAA  
Etv4 Pea3f ACCATGGAGAGCAGTGCCTTTACT  
Etv4 Pea3r ATGCACATCCAGGGACATCTGAGT  
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6.4.5 Gene expression microarrays 
For expression arrays, 400 ng of total RNA from A2 and P2 cells (3 biological 
replicates for each) were amplified using the Illumina TotalPrep RNA Amplification 
Kit according to manufacturers’ instructions (Ambion). Amplified, biotinylated 
cRNA (1.5 g) were labelled and hybridized to Illumina MouseRef6 Gene 
Expression beadchip arrays and run on an Illumina Beadstation (Wellcome Trust 
Clinical Research Facility). 
Probe level expression data were exported from the Illumina beadstudio 
software and analysed in R using the limma (Smyth et al. 2005) and beadarray 
(Dunning et al. 2007) bioconductor packages (analysis by G. Grimes). Probes that 
were not detected on the microarrays (detection p-values <0.01) were removed from 
the analysis.  Probe signals were quantiled normalized to remove technical variation.  
Probes were assessed for differential expression using limma’s lmFit, eBayes and 
topTable function. P-values were corrected for multiple testing using the Benjamini 
& Hochberg method.  
To interpret functional differences in anterior-posterior expression, the 5944 
significantly differential expressed (DE) genes (adjusted p-value <0.05) were ranked 
according to p-value and searched for enriched gene ontology (GO) terms that appear 
at the top of the ranked list, using the Gene Ontology enrichment analysis and 
visualization tool (GOrilla) (Eden et al. 2009). Of the 13,427 total genes detected on 
the microarray, 10,581 genes could be mapped to GO terms in GOrilla. To avoid false 
positives we set a stringent P value of 10
-7
 as the cut off for GO terms to be 








6.5. Protein analysis 
6.5.1 Acid extraction of histones 
To isolate nuclei, 3-6 x 10
6
 A1, P1 and A2, P2 cells were washed in ice cold PBS and 
resuspended in 1 ml PBS containing 0.2% Triton X-100 and 0.2 mM PMSF. After 
centrifugation (12000 g, 20 minutes, 4°C), histones were extracted as described in 
(Bonaldi et al. 2004) and boiled in 100 μl SDS loading dye. For equal sample loading 
1, 2.5 and 5 l quantities from each cell line sample were run on a 17.5% SDS-
PAGE gel. Histones were stored at -20°C.  
 
6.5.2. Polyacrylamide Gel Electrophoresis (PAGE) 
17.5% polyacrylamide gels were cast in NuPAGE cassettes. Histone samples and 
Benchmark pre-stained protein marker (Invitrogen) were loaded, and gels were run 
in Tris-glycine buffer (25 mM Tris, 250 mM glycine, 0.1% SDS). Gels were stained 
with Coomassie Blue or subjected to Western Blotting. 
17.5% polyacrylamide gel 
Resolving gel                                     Stacking gel 5% (stock) 
PAA 30%              3.5 ml                   PAA 30%            8.5 ml 
Tris 1.5 M pH8.8 1.5 ml                  Tris 2 M pH6.8    3.125 ml 
H2O                        1 ml                      H2O                      38.125 ml 
SDS 20%               30 l    
APS 10%               60 l 
Temed                    3 l 
                                                           Stacking gel 5% 
                                                           Stock                    4 ml 
                                                           APS 10%             40 l 
                                                           Temed                  4 l 
 
 
6.5.3. Western Blotting 
Proteins on polyacrylamide gels were transferred to Hybond-P membranes 
(Amersham Biosciences) in buffer containing 25 mM Tris, 190 mM glycine and 15% 
methanol for 1.5 hours. Membranes were blocked in 3% BSA in TBS-T (0.1% 
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Tween-20) overnight at 4°C, then probed for 1 hour with antibodies that detect: -
H3K27me3 (1:1000, Millipore, 07-449) and -H3 (1:50000, Abcam, ab1791). Blots 
were washed 3 x 10 minutes with TBS-T and incubated with a secondary antibody-
horseradish peroxidise (HRP) conjugate (1:10000) in TBS-T for 30 minutes, and 
then a further 3 x 10 minute washes. Blots were incubated with Amersham enhanced 
chemiluminescence (ECL) reagent kit for 2 minutes and exposed to autoradiography 



















6.6. Preparation of nuclear extracts for EMSAs 
The cell extraction protocol was adapted from Schreiber, et al (1989). The 
components of Buffers A and B are below. Both buffers were kept on ice throughout 
the procedure. A minimum of four T150 flasks of a cell line growing confluently 
were washed twice in warm (37°C) PBS. Following the aspiration of the second 
wash, ice-cold PBS was added to each flask twice and the cells were scraped into a 
50ml centrifuge tube. The samples were spun down for 10 minutes at 600g and the 
PBS was removed. This centrifugation step and all subsequent steps were done at 
4°C. 6ml of ice-cold PBS was added to each centrifuge tube and the pellet was re-
suspended by pipetting up and down. 
The cell suspension in each 50ml centrifuge tube was divided into aliquots of 1ml 
and transferred to 1.5ml microcentrifuge tubes and spun down for 1.5 minutes at 600 
x g then resuspended in an equivalent volume of ice-cold Buffer A (vortex for 10 
seconds). Following incubation for 15 minutes on ice, 10% IGEPAL (or NP-40), for 
a final concentration of 0.2%, was added to each suspension and vortexed for 10 
seconds (immediately after the addition). The cell suspensions were incubated for a 
further 2 minutes on ice then spun down for 2 minutes at 13800g. The supernatant 
was aspirated and a further 0.5ml of Buffer A added to each pellet and vortexed. The 
suspensions were spun down 2 minutes at 13800g and the supernatant removed. 
The volumes of the nuclear pellets were estimated by eye and 3 volumes of Buffer B 
was added to each pellet and vortexed. The samples were incubated on ice for 30-60 
minutes with intermittent, vigorous, vortexing. All the samples were pooled and spun 
down for 10 minutes at 13800 g. The supernatant was collected and separated into 
aliquots and stored at -70°C. Protein concentration of each extraction was 1-2 mg/ml, 







Protein extraction buffers 
Buffer A                                                            Buffer B 
10 mM HEPES (pH 7.9)                                 20 mM HEPES (pH 7.9) 
10 mM KCl                                                       400 mM NaCl 
0.1 mM EDTA                                                  1 mM EDTA 
0.1 mM EGTA                                                  1 mM EGTA 
dH2O up to 50 ml                                             dH2O up to 50 ml 
 
l of 1M DTT and 1 protease cocktail tablet (Roche) dissolved in 1ml of dH2O 








































6.7 Electrophoretic mobility shift assays 
6.7.1 Oligonucleotides 
Table 6.2 lists the oligonucleotides used for EMSA analysis. The upper and lower 
strands were annealed by heating to ~95°C with an equimolar mixture of both single 
strands and slow cooling to room temperature. Upper strands were biotin-labelled 
before annealing (section 6.7.2), with commercially labelled wild type, Australian 
and Family AC upper strands also used (5′ end biotin label on the commercially 
labelled strands, 3′ end biotin labelling undertaken in the lab). All labelled double 
strand oligos were kept in 10fmol/l stocks for the EMSA assays and the unlabelled 
double strand oligos for EMSA competition assays were kept in 50, 100 and 
500fmol/l stocks (x5, 10 and 50). 
Table 6.2. EMSA oligos 
Oligonucleotide Sequence 
Wild type up TATTACAGAAAATGAAGTCATATC 
Wild type lo GATATGACTTCATTTTCTGTAATA 
AC up TATTACAGGAAATGAAGTCATATC 
AC lo GATATGACTTCATTTCCTGTAATA 
Aus up TATTACAGAAAAGGAAGTCATATC 
Aus lo GATATGACTTCCTTTTCTGTAATA 
Site1 up CTGAGGTCACTTCCTCTCTTAATT 
Site1 lo AATTAAGAGAGGAAGTGACCACAG 
Site3 up GAGCGATTCAGGAAGTGCTGCTTA 
Site3 lo TAAGCAGCACTTCCTGAATCGCTC 
All oligos recognize conserved regions of the ZRS. Wild type oligos bind to the 3′ region 





6.7.2 Biotin 3′ end labelling of oligonucleotides 
Oligonucleotides were biotinylated by 3′ tailing with terminal deoxynucleotidyl 
transferase (TdT) and 1-3 biotinylated ribonucleotides (Biotin-11-UTP) using the 
Pierce labelling kit (Pierce Biotechnology, Inc., protocol available at 
www.piercenet.com, product number: 89818). The procedure is optimised for 
labelling 5pmol of 3′-OH ends per reaction. Tailed oligos were extracted using 
chloroform:isoamyl alcohol and labelling efficiency was estimated using the Dot 
Blot by hand spotting procedure described in the protocol. The labelled oligo strand 
was then annealed to its complimentary strand as described in the previous section. 
 
6.7.3 Electrophoretic mobility shift assays 
Band shift assays were carried out as described in the Pierce LightShift
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Chemiluminescent EMSA Kit protocol (Pierce Biotechnology, Inc., available at 
www.piercenet.com, product number 20148). 
6.7.3.1 Preparation and pre-run polyacrylimide gel                                                               
Polyacrylimide gels (6%) containing 30% (w/v) acrylimide, 0.5X TBE, 25% (w/v) 
ammonium persulphate, TEMED and ultrapure water were prepared. The gels were 
pre-run with loading buffer in 0.5X TBE for ~60 minutes.  
6.7.3.2 Binding reactions 
The modified procedure for the binding reaction was as follows: 
1. Prepared 15 l binding reactions, including the labelled target oligo and the 
nuclear extract from a limb mesenchyme cell line. To prevent non-specific 
DNA-protein binding I incubated the reaction mixture containing the protein 
extract and the nonspecific Poly dI·dC competitor DNA for 5 minutes before 
adding the labelled target oligo and the unlabelled oligo if it was a 




2. Added l of 5X loading buffer to each reaction and mixed by pipetting. 
Electrophoresis of the binding reactions, electrophoretic transfer of binding reactions 
to a positively charged nylon membrane (Roche) and cross-linking of oligos to the 
membrane were all carried out as described in the protocol. 
Likewise, detection of the biotin-labelled oligo/protein complexes by 
chemiluminescence was done following the Pierce EMSA kit protocol. The 
membrane was exposed to Amersham ECL Hyperfilm (Buckinghamshire, UK), with 
exposure times ranging from 10 seconds to 8 minutes. 
Binding reaction components 
Binding buffer 1X 
Poly dI•dC 66.7 ng/l 
Protein extract ~4-8 g 
Unlabelled oligo 1000 fmol (for competition assays) 
Biotin end-labelled target oligo 20 fmol 















6.8. Chromatin Immunoprecipitation (ChIP) 
6.8.1 Native ChIP 
6.8.1.1 Native ChIP on cell lines 
Nuclei were prepared and resuspended in NB-R as previously described (Gilbert et 
al., 2003). Nuclei corresponding to 2 x 10
7
 – 1 x 10
8
 cells were digested with 40-46 
Boehringer units of MNase (Worthington) for 10 minutes at room temperature in the 
presence of 20g RNase A to obtain a chromatin ladder enriched in tri-, tetra-, and 
pentanucleosomes. The reaction was stopped by adding an equal volume of Stop 
Buffer and incubated on ice overnight. Between 50-150 g released chromatin were 
mixed with 10 g prebound (to Protein A or G magnetic beads, Invitrogen) 
H3K27me3 antibody (Abcam, ab6002) or mouse IgG (Santa Cruz, sc-2025) in the 
presence of 100 g BSA and incubated for 3 hours at 4°C. Beads were then washed 
3x with Wash Buffer and once in TE. Bound complexes were eluted with 0.1 M 
NaHCO3, 1% SDS at room temperature. Immunoprecipitated and input DNA were 
purified with Proteinase K (Genaxxon) and QIAGEN PCR purification kit. 
6.8.1.2 Native ChIP on limb tissue 
For limb tissue, distal anterior and posterior forelimb buds were dissected from 60 – 
70 E10.5 embryos and, due to the lower number of cells (~1 x 10
6
), native chromatin 
immunoprecipitation was performed with the following modifications: cells were 
digested with 8 - 9 Boehringer units of MNase (Worthington) for 10 minutes at room 
temperature in the presence of 20g RNase A to obtain a chromatin ladder enriched 
in tri-, tetra-, and pentanucleosomes. Between 10 - 30 g released chromatin were 
mixed with 3 - 5 g prebound (to Protein A or G magnetic beads, Invitrogen) 
H3K27me3 antibody (Millipore, 07-449) or H3K4me1 antibody (Abcam, ab8895) in 
the presence of 25 g BSA and incubated for 3 hours at 4°C. Immunoprecipitated 
and input DNA were purified with Proteinase K (Genaxxon) and QIAGEN MinElute 




6.8.1.3 Native ChIP buffers 
Solutions prepared in the lab and stored at 4°C. 
NBA    NBB    NBR 
85 mM NaCl    85 mM NaCl   85 mM NaCl                           
5.5% Sucrose   5.5% Sucrose   5.5% Sucrose                            
10 mM TrisHCl  pH 7.5  10 mM TrisHCl  pH 7.5 10mM TrisHCl pH7.5                 
0.2 mM EDTA  0.2 mM EDTA  3 mM MgCl2                             
0.2 mM PMSF  0.2 mM PMSF  1.5 mM CaCl2                              
1 mM DTT   1 mM DTT   0.2 mM PMSF                            
1X Protease Inhibitors 0.1% NP40   1 mM DTT  
                                                1X Protease Inhibitors 
Stop Buffer                             ChiP W1   ChiP W2 
215 mM NaCl              150 mM NaCl   200 mM NaCl                                                                                                                     
10 mM TrisHCl pH 8             10 mM TrisHCl  pH 8 10 mM TrisHCl  pH 8                                                                                                                                        
20 mM EDTA   2 mM EDTA   2 mM EDTA                                                                                                                         
5.5 % Sucrose   1% NP40   1 % Triton X 100                                                                                                                         
2 % TritonX 100  1 % Nadeoxycholate             0.2 mM PMSF                                                                                                       
0.2 mM PMSF                        0.2 mM PMSF                         1 mM DTT                                                                                                                 
1 mM DTT                             1 mM DTT                               2X Protease Inhibitors                                                                                                          
2X Protease Inhibitors            2X Protease Inhibitors 
Elution Buffer                        EX50                                         Sonication Buffer  
0.1 M NaHCO3                                 10mM HEPES pH7.6                2M NaCl                         
1 % SDS                                50mM NaCl                               5M Urea 
                                               1.5mM MgCl2 
                                               0.5mM EGTA 
                                               10% glycerol 
                                               1mM DTT 
                                               0.2mM PMSF 
 
Micrococcal Nuclease Buffer: 50% Glycerol, 10mM Tris pH7.6 and 50mM NaCl. 
 
6.8.2 Crosslinked ChIP on limb tissue 
6.8.2.1 Chromatin Immunoprecipitation for Ring1B and ETS factors 
Anterior and posterior E10.5 limb tissue cells (~5 x 10
6
 - ~1.5 x 10
7
 posterior cells, 
~1 - 3 x 10
7 
anterior cells)  dissected from the distal forelimb buds of 70 – 75 E10.5 
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embryos were fixed with 1% formaldehyde (25°C, 10 minutes) and stopped with 
0.125M Glycine. Crosslinked ChIP for Ring 1B was performed as described (Stock 
et al., 2007). Nuclei were sonicated using a Diagenode Bioruptor (Leige, full power 
30s on, 30s off, in an ice bath for 50 minutes) to produce fragments of <500bp. 
Between 30-50 g released chromatin were incubated with 1g of prebound (Protein 
A magnetic beads, Invitrogen) Ring1B antibody (MBL, D139-3) or mouse IgG 
(Santa Cruz, sc-2025) and washed and eluted as described  (Stock et al., 2007). 
Reverse crosslinked DNA was purified as for nChIP. 
For ChIP of ETS factors, cells from dissected E11.5 forelimbs were fixed and 
sonicated as above, except that the garments size after sonication was < 300bp. An 
arbitrary concentration of 350 g chromatin was incubated with 5 g prebound (to 
Protein A or G magnetic beads, Invitrogen) IgG (Santa Cruz, sc-2025) or ETS1 
(Hagman), ETV4 (Abcam, ab70425), ETV5 (Abcam, ab102010), GABP (Santa 
Cruz, sc-22810) or ELF1 (santa Cruz, sc-631) in the presence of 50 g of BSA and 
washed and eluted as described in (Stock et al., 2007). Reverse crosslinked DNA was 
purified with Proteinase K (Glenaxxon) and QIAGEN PCR purification kit.  
6.8.2.3. Crosslink ChIP buffers 
Solutions prepared in the lab and stored at 4°C. 
1% formaldehyde was prepared in PBS. 
Glycine stop buffer: 0.125M glycine in PBS. 
Swelling buffer                    Sonication buffer                         Wash sonication buffer 
25 mM HEPES pH7.9         50 mM HEPES pH7.9                  50 mM HEPES pH7.9 
1.5 mM MgCl2                               140 mM NaCl                               140 mM NaCl 
10 mM KCl                          1 mM EDTA                                 1 mM EDTA 
0.1% NP40                           1% Triton X100                            1% Triton X100 
0.2 mM PMSF                      0.25% Na-deoxycholate               0.1% Na-deoxycholate 
1 mM DTT                            0.1% SDS                                     0.1% SDS 
Protease inhibitor cocktail    0.2 mM PMSF                   
                                              1 mM DTT 








Elution buffer                                   Block solution                                Urea buffer 
0.1 M NaHCO3                                 1 x PBS                                          2 M NaCl 
1% SDS                                            0.5% BSA (
w
/v)                              5 M Urea 
 
 
Wash buffer A                                 Wash buffer B 
50 mM HEPES pH7.9                      20 mM Tris pH8.0 
500 mM NaCl                                   1 mM EDTA 
1 mM EDTA                                     250 mM LiCl 
1% Triton X100                                0.5% NP-40 
0.1% Na-deoxycholate                      0.5% Na-deoxycholate 
0.1% SDS                                                                 
 
                          
6.8.3 ChIP analysis 
6.8.3.1. ChIP-qPCR 
For relative quantification by real-time PCR, dilutions of MNase-digested (native) 
chromatin from E10.5 anterior and posterior limb cell lines and dissected limb tissue 
(input) were used to create standard curves for the immunoprecipitated H3K27me3 
and H3K4me1 chromatin (3 biological replicates). For each replicate, PCRs were 
performed in triplicate using Quantitect SYBR Green detection kit with a Peltier 
PTC-200 thermal cycler using an inbuilt Cromo4 continuous fluorescence detector 
connected to Opticom 3.1 software interface (using primers described in Table 6.3). 
Thermal cycler programme: 15 min Hotstart; 44 PCR cycles (95°C for 15 s, 55°C for 
30 s, 72°C for 30 s).  
For ETS enrichment at the ZRS, qPCR was carried out using equal 
concentrations of input, IgG and Chip DNA. Enrichment values for ETS1, ETV5 and 
ELF1 from E11.5 whole limb sonicated chromatin (crosslinked) are presented as fold 
differences relative to IgG and normalized to input with the formula 2
[(CtIgG-CtInput) - 
(CtAb-CtInput)]
 where Ct values are threshold cycles. PCRs were performed in duplicate 






Table 6.3. Real-time PCR primers for ChIP analysis 
Promoter/exon Oligo name      Sequence                          Ref 
Hoxd1 Hoxd1promf GAGTAACTTGACCTTCTCAGAG  
 Hoxd1promr ATTGCGGGAGAAAGGCAGGGAAG  
Hoxd10 Hoxd10prof TAGTAGATGTCGCTGTTGTCCG  
 Hoxd10pror ACATGACAACCAAGCCAATGAGA  
Olig2 Olig2f GCCTGACGCTACAGTGACAA (Boyer et al., 2006) 
 Olig2r GGCTAATTCCGCTCAATGAA (Boyer et al., 2006) 
Actin Actinf CCTCGATGCTGACCCTCATCC  
 Actinr GACACTGCCCCATTCAATGTCTC  
ZRS ZRS3f AGAAGAGAGTAGGAAGTCCAGCCT  
 
 
 ZRS3r GAGCCTTCCTCTTGCCTGTGATTT  
 
 
Nanog Nanogex2for GAAGACCTGCCTCTTCAAGGC  
 Nanogex2rev AGAACACAGTCCGCATCTTCT  
 
6.8.3.2. ChIP-chip 
Ten nanograms (optimal) of input or ChIP DNA were amplified using the WGA2 
whole genome amplification kit (Sigma). Amplified material was labelled with Cy3 
or Cy5 by random priming according to the NimbleGen ChIP-chip protocol (Roche). 
In total, 2 or 3 biological replicates with dye swaps were hybridized for 20 h and 
washed according to manufacturer´s protocol. A custom 3x720K mouse tiling array 
(NimbleGen, Roche) containing 179,493 unique probes from different genomic 
regions, with each probe represented by 4 replicates was used (Appendix 1 lists the 
genomic regions covered and the coordinates based on the Mouse NCBI37 (mm9) 
build). Arrays were scanned on a NimbleGen MS 200 Microarray scanner (Roche) 
using 100% laser power and 2 µm resolution. Raw signal intensities were quantified 
from TIFF images using MS 200 Data Collection software. 
Data processing was done by G. Grimes. Microarray data were analyzed in 
R/Bioconductor using the Epigenome (PROT43) protocol with the following 
parameters: the mean signal intensity of the 4 replicate probes on each array was 
taken. Loess normalization was used within arrays to correct for the dye bias, and 
scale normalization was used within replicates, to control inter-array variability. Log 
enrichment was calculated by subtracting the mean log2 input intensities from the 
mean log2 enriched intensities. Significant enrichment was tested using the 
significance analysis of microarrays (SAM) technique (Tusher et al., 2001), and the 
190 
 
local false discovery rate based on the SAM statistic was calculated using the Locfdr 
R package. A false discovery rate of 0.05 was used as the significance cut-off. 
To determine the significance of the difference in H3K27me3 and Ring1B 
enrichment over HoxD in anterior vs posterior limb tissue cells the median log 
enrichment value of probes covering the locus or specific locus sub-regions (5′, 3′; 
promoters, genes, intergenic regions) were calculated. The statistical significance of 
any anterior-posterior differences was assessed using the non-parametric Mann-
Whitney U-test. Mean log enrichment values for H3K27me3 were used to compare 
individual genes and promoter regions within HoxD and adjacent genes and 
statistical significance was assessed using the 2-sample Students T-test. 
The R/Bioconductor Ringo package (Toedling et al., 2007) and a previously 
published algorithm (Schwartz et al., 2006) were used to determine thresholds to 
quantify significantly enriched ETS factor peaks. Taking into account that reporter 
levels must exceed a certain threshold (y0), G. Grimes chose a mixture modelling 
approach as positive and negative control sets were not available. So, the distribution 
of reporter levels, y, were based on a mixture of two underlying distributions: the 
null distribution of probes in non-enriched regions and the alternative distribution in 
enriched regions. The resultant histogram based upon the mixture of these 
distributions allows the assumptions that the null distribution is symmetrically 
distributed around its mode, m0, close to y = 0, and the alternative distribution spread 
more widely and skewed to the right (greater than) of m0. Based on these 
assumptions, the null distribution is estimated as follows: m0 can be identified by the 
midpoint of the shorth of reporter levels that fall into the -1 - 1 interval on a log2 
scale. The null distribution is then estimated from the empirical distribution of m0-|y-
m0|, that is, by reflecting y < m0 on to y > m0. From this estimated null distribution the 
enrichment thresholds y0 were determined, using the 99.9% quantile (Toedling and 
Huber, 2008). To account for variation in antibody efficiency and noise levels due to 
differences in sample DNA quality, enrichment thresholds were calculated separately 
for each antibody. Peaks were scored as containing at least three probes with 
enrichment above these thresholds within a block of continuous enrichment up to 
500bp in size. 
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Conserved sites were based on the UCSC 30-way Multiz Alignment & Conservation 
track which identifies conserved sequences shared by 19 placental mammals. 
Aligned sequences from the remaining 11 non-placental mammal vertebrates (down 





















6.9. Fluorescent in situ hybridization 
6.9.1 Fosmid probe preparation 
6.9.1.1 Fosmid stocks 
Fosmids were streaked (Whitehead (Sanger), Table 6.4) on to agar plates containing 
chloramphenicol (12.5 ng/l) and incubated overnight at 37°C. I picked individual 
colonies and incubated overnight in 3 ml L-broth at 37°C with shaking. I then added 
170 l of glycerol to 830 l L-broth aliquots and stored at -70°C.  









     Coordinates 




      
Hoxd GCR WI1-2157A11 G135P63331H7 74242615     74282044 39429 
 Lnp WI1-482L15 G135P61870C5 74329582     74372986 43404 
 Hoxd13 WI1-469P2 G135P67444A12 74474157     74513003 38846 
 Hoxd3 WI1-121N10 G135P67844B8 74566983     74605438 38455 
 Island III WI1-1404J11 G135P64810D7 74040543     74081331 40788 
Pax6 Rcn WI1-1767E4 G135P601417F11 105221381  105259938 38557 
 
 Rpl10 WI1-1550J22 G135P601672D2 105387894  105425103 37209 
Shh Dpp6 WI1-1085J14 G135P600264D6  
 
27932527     27975636 43109 
 Shh WI1-574O18 G135P64333A4 28754458     28795879 41421 
  SFPE1 WI1-552F5 G135P65882F10 28798551     28841224 42673 
 SBE4 WI1-2751A6 G135P600205H10 29107140     29147593 40453 
 ZRS WI1-1047E14 G135P600929F6 29611727     29653695 41968 
 
Names are Ensembl (r 45) (http://jun2007.archive.ensembl.org/Mus_musculus/index.html). 
Mouse genome assembly number: NCBI m37.  
 
6.9.1.2 Fosmid miniprep 
I cultured a pipette tip amount of fosmid overnight at 37°C in L-broth containing 
chloramphenocol (12.5 g/ml). After removal of the supernatant, I added 200 l 
GTE buffer containing lyzozyme and mixed vigorously, then incubated for 5 minutes 
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at room temperature before adding 400 l lysis buffer, mixed by inversion and 
incubated again on ice for 5 minutes. I then added 300 l acetate buffer, vortexed, 
and incubated for a further 5 minutes on ice. Following centrifugation at 12000g for 
5 minutes at 4°C, I performed phenol:chloroform extraction. The fosmid prep was 
then washed in 70% alcohol and dried before resuspending in 25 l TE. Rnase A 
(1g) was added and incubated for 5 minutes at 37°C. Fosmid prep was stored at -
20°C. 
GTE buffer                                                                Lysis buffer 
50 mM glucose                                                          0.2 M NaOH 
25 mM Tris pH8                                                        1% SDS 
10 mM EDTA 
 
Acetate buffer (100 ml) 
5 M potassium acetate 60 ml 
Acetic acid                   11.5 ml 
Distilled water             28.5 ml  
 
6.9.1.3. Probe labelling (Nick translation) 
A reaction mixture containing the following– 
                                                        2 l Nick translation salts (stock) 
                                                        2.5 l 0.5 mM dATP 
                                                        2.5 l 0.5 mM dCTP 
                                                        2.5 l 0.5 mM dGTP 
                                                        2.5 l bio-16-dUTP (Roche) 
                                                 OR 1.5 l digoxygenin-11-dUTP + 1 l 0.5 mM dTTP 
                                                        6 l miniprep DNA (0.5-1 g) 
                                                        1 l DNase I (1:500) (Invitrogen) 
                                                        1 l DNA polymerase I (Invitrogen) 
–was incubated for 1.5 hours at 16°C. The reaction was stopped by adding 3 l 
EDTA and 2 l 20% SDS, then 65 l TE was added before purifying through a 
Quick spin column (Pharmacia). Labelled probes were stored at -20°C. 
Nick translation salts stock 
0.5 M Tris pH7.5 
0.1 M MgSO4 
1 mM DT 




6.9.2. 2D FISH 
Cells were swollen in 0.5% trisodium citrate/0.25% KCl followed by fixation in 
methanol acetic acid (MAA – 3:1 vol/vol). Slides were incubated in 100g/ml 
RNase A in 2 x SCC for 1 hour, washed in 2 x SCC and dehydrated through an 
alcohol series. Slides were denatured in 70% formamide/2 x SCC for 75 s at 70°C. 
Between 80-120 ng of biotin- and digoxigenin-labeled fosmid probes were used per 
slide, with 8-12 g of mouse Cot1 DNA (Invitrogen) and 10 g salmon sperm DNA. 
Probes were denatured at 70°C for 5 minutes, reannealed with Cot1 DNA for 15 
minutes at 37°C and hybridized to the denatured slides overnight at 37°C.  
Slides were washed 4 x 3 minutes in 2X SSC at 45°C, 4 x 3 minutes in 0.1X 
SSC at 60°C and transferred to 4X SCC, 0.1% Tween 20. Following incubation for 5 
minutes with blocking buffer (4X SCC, 5% Marvel) biotinylated probes were 
detected using fluorochrome-conjugated avidin (FITC or Texas Red) (Vector 
Laboratories) then biotinylated antiavidin (Vector Laboratories) followed by 
fluorochrome-conjugated avidin. Digoxigenin-labeled probes were detected using 
FITC-conjugated antidigoxigenin (Vector Laboratories) followed by FITC-
conjugated anti-sheep (Vector Laboratories). Slides were counterstained in 0.5 g/ml 
DAPI. 
 
6.9.3 Mouse embryo sectioning and DNA FISH 
Embryos from CD1 mice were collected at E10.5-11, fixed in 4% formaldehyde 
overnight at 4°C, dehydrated through a graded ethanol series, cleared in xylene and 
embedded in paraffin blocks. Sections were cut at 6 m and laid on Superfrost+ 
slides. The slides were baked at 60°C for 20 minutes, washed four times in xylene 
for 10 minutes each, rehydrated through an ethanol series before being microwaved 
for 20 minutes in 0.1 mol/l citrate pH 6 buffer, washed in water and rinsed in 2x SCC 
before use. FISH was performed as described above, except: for the denaturation step 
3minutes at 75°C in 70% formamide/2xSCC pH7.5 followed by 3 minutes in ice-
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cold 70% ethanol; and DAPI (0.05 g/ml) was added to the final wash (5 minutes 
room temperatute).  
 
6.9.4 Image analysis 
P. Perry wrote the scripts for 2D image capture and analysis and M. Pearson set up 
Volocity packages for 3D image capture and analysis. Both provided guidance for all 
the microscopy work described in this thesis. 
For 2D FISH, slides were imaged using a Hamamatsu Orca AG CCD camera 
(Hamamatsu Photonics (UK) Ltd, Welwyn Garden City, UK) and a Zeiss Axioplan 
II fluorescence microscope with Plan-neofluar objectives, a 100W Hg source (Carl 
Zeiss, Welwyn Garden City, UK) and Chroma #83000 triple band pass filter set 
(Chroma Technology Corp., Rockingham, VT) with the excitation filters installed in 
a motorised filter wheel (Prior Scientific Instruments, Cambridge, UK). Image 
capture and analysis were performed using in-house scripts (P. Perry) written for 
IPLab Spectrum (Scanalytics Corp, Fairfax, VA). Briefly, Interprobe distance, d, was 
calculated by segmenting the hybridization signals and determining the xy 
coordinates of the centroid of each. d was then calculated from d = [(x1 – x2)
2 






The squared interprobe distances (d
2
) were normalised to nuclear radius 
squared (r
2
). The statistical significance of differences in median-squared interprobe 
distances were assessed using the non-parametric Mann-Whitney U test to examine 
the null hypothesis that two sets of amine-modified oligos show the same 
distribution. Each data set consisted of at least 100 nuclei (200 loci) for each cell 
line, and for each probe combination. 
 
For 3D analysis of tissue sections, slides were imaged with a Hamamatsu 
Orca AG CCD camera (Hamamatsu Photonics (UK) Ltd, Welwyn Garden City, UK), 
Zeiss Axioplan II fluorescence microscope with Plan-neofluar or Plan apochromat 
objectives, a Lumen 200W metal halide light source (Prior Scientific Instruments, 
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Cambridge, UK) and Chroma #89014ET single excitation and emission filters 
(Chroma Technology Corp., Rockingham, VT) with the excitation and emission 
filters installed in Prior motorised filter wheels. A piezoelectrically driven objective 
mount (PIFOC model P-721, Physik Instrumente GmbH & Co, Karlsruhe) was used 
to control movement in the z dimension. Hardware control, image capture and 
analysis were performed using Volocity (Perkinelmer Inc, Waltham, MA). Images 
were deconvolved using a calculated PSF with the constrained iterative algorithm of 
Volocity (Perkinelmer Inc, Waltham, MA). Image analysis was carried out using the 
Quantitation module of Volocity (Perkinelmer Inc, Waltham, MA). For 3D FISH 
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Genomic regions covered by the NimbleGen tiling array. Coordinates taken from the 
Mouse NCBI37 (mm9) build (UCSC Genome Browser July 2007). 
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INTRODUCTION
Regulated Hox gene expression is important in anterior-posterior
(A-P) patterning of the primary embryonic axis, with Hox genes
being first activated at gastrulation (Wyngaarden et al., 2011;
Deschamps and van Nes, 2005). The HoxD cluster has also been
co-opted more recently in evolution into regulating the growth and
patterning of the limb and digits.
Polycomb repressive complexes (PRC1 and PRC2) are required
to maintain Hox genes in a silent compact chromatin state in
embryonic stem (ES) cells (Boyer et al., 2006; Lee et al., 2006;
Endoh et al., 2008; Stock et al., 2007; Eskeland et al., 2010).
Whereas roles of polycomb at Hox loci are well established in early
embryonic development and in differentiation along the primary
embryonic axis (Voncken et al., 2003; Faust et al., 1998;
Chambeyron et al., 2005; Soshnikova and Duboule, 2009), whether
polycomb-mediated chromatin changes are involved in Hox
regulation in the secondary body axis is unclear.
Two phases of Hoxd expression are important in limb
development and patterning (Tarchini and Duboule, 2006; Zakany
and Duboule, 2007). The first phase results in expression of 3
Hoxd genes (Hoxd1-9) earlier than the 5 genes. This restricts 5
HoxD expression to the posterior side of the distal limb bud and is
required for limb outgrowth, proximal limb development, limb A-
P polarity and the posterior expression of sonic hedgehog (Shh).
This 3-5 temporal and spatial collinearity is reminiscent of
regulation in the main embryonic axis, which is accompanied by
progressive loss of histone H3 lysine 27 tri-methylation
(H3K27me3) catalysed by PRC2 (Soshnikova and Duboule, 2009).
However, it might also require as yet undefined regulatory
elements 3 of HoxD (Spitz et al., 2005).
A later phase [embryonic day (E) 10.5] of Hoxd expression in
the distal limb is required for digit morphogenesis (Spitz et al.,
2003). This is characterised by ‘quantitative collinearity’ in which
expression of the most 5 gene, Hoxd13, is initially strongest in the
posterior distal mesenchyme, with progressively less strong
expression of Hoxd12 to Hoxd10. The Hoxd13 expression domain
then spreads anteriorly, so that by E12.5 it is the only Hoxd gene
for which expression is robust enough to be detectable on the most
anterior side (Montavon et al., 2008). This is driven by enhancer
elements including a ~40 kb global control region (GCR) located
180 kb 5 (centromeric) of Hoxd13 beyond Evx2 and Lnp, and the
Prox enhancer located between Evx2 and Lnp (Fig. 4A) (Spitz et
al., 2003; Tschopp and Duboule, 2011). It is not clear whether late
phase HoxD regulation involves polycomb-mediated repression.
Here, we use immortalised mesenchymal cells derived from
either the anterior (A) or the posterior (P) distal limb of E10.5
embryos, which show high levels of Hoxd13 expression in the
posterior-derived cells, to show that the ancestral role of polycomb
in regulating the HoxD cluster appears to be maintained during
distal limb development. There is a loss of H3K27me3 and a
decompaction of higher order chromatin structure over HoxD in
the distal posterior, compared with the anterior, limb cells. This is
confirmed by analysis in dissected limb buds. Furthermore, we
show a spatial colocalisation of the GCR and 5 HoxD that is
restricted to the distal posterior limb, consistent with the notion of
physical association between this enhancer and its target genes.
This is the first demonstration of differential chromatin compaction
and enhancer-gene colocalisation across the A-P axis of the
developing limb.
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SUMMARY
A late phase of HoxD activation is crucial for the patterning and growth of distal structures across the anterior-posterior (A-P) limb
axis of mammals. Polycomb complexes and chromatin compaction have been shown to regulate Hox loci along the main body axis
in embryonic development, but the extent to which they have a role in limb-specific HoxD expression, an evolutionary adaptation
defined by the activity of distal enhancer elements that drive expression of 5 Hoxd genes, has yet to be fully elucidated. We reveal
two levels of chromatin topology that differentiate distal limb A-P HoxD activity. Using both immortalised cell lines derived from
posterior and anterior regions of distal E10.5 mouse limb buds, and analysis in E10.5 dissected limb buds themselves, we show that
there is a loss of polycomb-catalysed H3K27me3 histone modification and a chromatin decompaction over HoxD in the distal
posterior limb compared with anterior. Moreover, we show that the global control region (GCR) long-range enhancer spatially
colocalises with the 5 HoxD genomic region specifically in the distal posterior limb. This is consistent with the formation of a
chromatin loop between 5 HoxD and the GCR regulatory module at the time and place of distal limb bud development when the
GCR participates in initiating Hoxd gene quantitative collinearity and Hoxd13 expression. This is the first example of A-P differences
in chromatin compaction and chromatin looping in the development of the mammalian secondary body axis (limb).
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Anterior-posterior differences in HoxD chromatin topology
in limb development
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The posterior third and the anterior two thirds of distal forelimb buds were
dissected from E10.5 mouse embryos from an Immortomouse (H-2kb-
tsA58)  CD1 cross (Jat et al., 1991). After washing in PBS, limb buds
were treated using trypsin (0.2 g/l)/Versene for 15-20 minutes, and
dispersed gently. Cells were plated into 6-well plates in DMEM, 10%
foetal calf serum, 20 ng/ml g-Interferon (Peprotech) and grown at 33°C,
the permissive temperature for the temperature-sensitive T antigen. A1/P1
and A2/P2 cell lines pairs were derived from separate litters.
RNA expression
RNA was prepared using Trizol reagent (Invitrogen) according to the
manufacturer’s protocol [for limb buds, dissected anterior and posterior
tissue was dissociated into single cells in Trizol using a syringe with a 25G
(0.5 mm) needle (BD Microlance)], followed by phenol:chloroform
extraction and digestion with 2U DNaseI (Ambion) for 30 minutes at 37°C.
cDNA was made using a First Strand Synthesis Kit (Roche) and amplified
by PCR or real-time qRT-PCR using specific primers (supplementary
material Table S1).
For expression arrays, 400 ng of RNA from A2/P2 cells were amplified
using the Illumina TotalPrep RNA Amplification Kit (Ambion). Amplified,
biotinylated cRNAs (1.5 g) were labelled and hybridised to Illumina
MouseRef6 Gene Expression beadchip arrays [Gene Expression Omnibus
(GEO) accession platform number GPL6887, expression data GSE38370].
Data were analysed in R using limma (Smyth et al., 2005) and beadarray
(Dunning et al., 2007) bioconductor packages. Probes with detection P-
values less than 0.01 were removed from further analysis. Signals were
quantile normalised to remove technical variation, and differential
expression was assessed using limma’s lmFit, eBayes and topTable
function. P-values were corrected for multiple testing (Benjamini and
Hochberg, 1995).
The 5944 genes with significantly differential A:P expression (adjusted
P<0.05) were ranked by P-value and searched for enriched gene ontology
(GO) terms using the Gene Ontology enrichment analysis and visualisation
tool (GOrilla) (Eden et al., 2009). To avoid false positives P<10–7 was set
as the cut off for terms to be considered, based on the Bonferroni
correction.
Acid extraction of histones and western blot analysis
Nuclei were isolated from 3-6106 cells and histones acid-extracted and
analysed as described (Eskeland et al., 2010).
Chromatin immunoprecipitation
Native chromatin immunoprecipitation (nChIP) from cell lines was
performed as previously described (Eskeland et al., 2010), except that 40-
46 Boehringer units of MNase (Worthington) was used to digest 1-6108
cells.
For tissue, distal anterior and posterior forelimb buds were dissected
from 50-55 E10.5 embryos. Owing to the lower cell numbers (~1106),
nChIP was performed with the following modifications: cells were digested
with 8-9 Boehringer units of MNase (Worthington). Released chromatin
(10-30 g) was incubated with 3-5 g prebound (to Protein A or G
magnetic beads, Invitrogen) H3K27me3 antibody (Millipore) in the
presence of 25 g BSA for 3 hours at 4°C.
For Ring1B ChIP, 0.5-3107 anterior and posterior limb tissue cells
dissected from the distal forelimb buds of 70-75 E10.5 embryos were fixed
with 1% formaldehyde (25°C, 10 minutes) and stopped with 0.125 M
glycine. Sonication was as described (Eskeland et al., 2010). Released
chromatin (30-50 g) was incubated with 1 g of prebound (Protein A
magnetic beads, Invitrogen) Ring1B antibody (MBL, D139-3) or mouse
IgG (Santa Cruz, sc-2025).
ChIP analysis
Relative quantification of ChIP by qPCR was as previously described
(Eskeland et al., 2010) using primers described in supplementary material
Table S2.
Input or ChIP DNA (10 ng) was amplified using the WGA2 Whole
Genome Amplification Kit (Sigma) and labelled with Cy3 or Cy5 by
random priming according to the NimbleGen ChIP-chip protocol (Roche).
Two or three biological replicates, with dye swaps, were hybridised for 20
hours to a custom 3720 K mouse tiling array (NimbleGen, Roche)
containing 179,493 unique probes from different genomic regions, with
each probe represented by four replicates (GEO accession platform number
GPL14936, array data GSE38526). Arrays were washed according to the
manufacturer’s protocol and scanned on a NimbleGen MS 200 Microarray
scanner (Roche) using 100% laser power and 2 m resolution. Raw signal
intensities were quantified from TIFF images using MS 200 Data
Collection software.
Microarray data were analysed and ChIP enrichments determined as
described by Pradeepa et al. (Pradeepa et al., 2012). To determine the
significance of the difference in H3K27me3 enrichment over HoxD in
anterior versus posterior limb tissue cells, the median log enrichment value
of probes covering the locus or specific locus sub-regions (5, 3;
promoters, genes, intergenic regions) were calculated. The statistical
significance of any A:P differences were assessed using the non-parametric
Mann-Whitney U-test. Mean log enrichment values were used to compare
individual genes and promoter regions within HoxD, and adjacent genes
and statistical significance was assessed using the two-sample Student’s t-
test.
Fluorescence in situ hybridisation (FISH)
2D FISH was as described previously (Chambeyron and Bickmore, 2004;
Eskeland et al., 2010). Fosmid clones (supplementary material Table S3)
were prepared and labelled as previously described (Morey et al., 2007).
Between 80 and 120 ng of biotin- and digoxigenin-labelled probe were
used per slide, with 8-12 g of mouse Cot-1 DNA (Invitrogen) and 10 g
salmon sperm DNA.
For 3D FISH, E10.5-11 embryos from CD1 mice were collected, fixed,
embedded, sectioned and processed as previously described (Morey et al.,
2007), except that sections were cut at 6 m.
Image analysis
For 2D FISH, slides were analysed as described (Morey et al., 2007) except
that the Chroma #83000 triple band pass filter set (Chroma Technology
Corporation, Rockingham, VT, USA) and a motorised filter wheel (Prior
Scientific Instruments, Cambridge, UK) were used.
For 3D analysis of tissue sections, slides were imaged with a
Hamamatsu Orca AG CCD camera (Hamamatsu Photonics, Welwyn
Garden City, UK), Zeiss Axioplan II fluorescence microscope with Plan-
neofluar or Plan apochromat objectives, a Lumen 200W metal halide light
source (Prior Scientific Instruments) and Chroma #89014ET single
excitation and emission filters (Chroma Technology Corporation) with the
excitation and emission filters installed in Prior motorised filter wheels. A
piezoelectrically driven objective mount (PIFOC model P-721, Physik
Instrumente, Karlsruhe, Germany) was used to control movement in the z
dimension. Hardware control, image capture and analysis were performed
using Volocity (PerkinElmer, Waltham, MA, USA). Images were
deconvolved using a calculated point spread function with the constrained
iterative algorithm of Volocity. Image analysis was carried out using the
Quantitation module.
RESULTS
Cell lines derived from the mesenchyme of E10.5
limb buds
Activity of limb enhancers in the HoxD GCR first becomes
apparent in posterior mesenchyme cells of the distal forelimb bud
at E10.5, followed later by anterior extension of this expression
zone across the distal limb (Spitz et al., 2003). Therefore, we
restricted our analysis to E10.5 limb buds to capture the initiation
of this second wave of HoxD regulation.
Analysing chromatin structure in the small number of cells
dissected from mouse embryos is challenging (Soshnikova and
Duboule, 2009). However, conditionally immortalised cell lines











can be derived from the transgenic ‘immortomouse’, which
expresses temperature-sensitive SV40 T antigen (Jat et al., 1991).
Such cell lines appear to retain many biological properties of the
cells from which they were derived, including gene expression
patterns and response to signalling pathways (Kohn et al., 2010).
We derived two sets of cell lines from dissected E10.5 forelimb
buds to represent the most posterior third of the distal limb (cell
lines P1 and P2) or the anterior two-thirds (A1 and A2) (Fig. 1A).
The embryonic limb bud consists of two main cell types:
mesenchyme and the surface ectoderm, which at the most distal
margin forms the apical ectodermal ridge (AER). The morphology
of the cell lines indicated that they were likely to be mesenchymal
in origin and RT-PCR analysis confirmed this (Fig. 1B). Fgf10 is
expressed in limb bud mesenchyme and signals to the Fgfr2b
receptor expressed in the AER to induce expression of Fgf8 there.
By contrast, Fgfr2c is expressed in both the mesoderm and
ectoderm of the developing limb bud (Lizarraga et al., 1999; Duboc
and Logan, 2011). The detection of mRNAs from Fgf10 and
Fgfr2c, but not Fgf8 or Fgfr2b in immortomouse-derived limb bud
cell lines thus indicates their derivation from the limb mesenchyme
(Fig. 1B). The origin of these cells from the distal, rather than
proximal, margin of the limb is supported by the expression of Etv4
(Mao et al., 2009). Analysis by expression microarrays provided
further evidence for this. Genes with proximally restricted
expression domains, such as Tbx15, Cart1 (Alx1 – Mouse Genome
Informatics), Emx2, Pax1 (chondrogenesis), Pax3 (myogenesis)
(Kuijper et al., 2005), Vcan, Ebf2 (neurogenesis) (Krawchuk and
Kania, 2008) and Shox (chondrogenesis, myogenesis,
neurogenesis) (Vickerman et al., 2011), could not be detected (data
not shown). We conclude that the four cell lines retain at least some
of the specific developmental functions expected of their limb
origin (Robert and Lallemand, 2006; Hill, 2007).
Expression microarrays provided further insight into the
differences between the anterior- and posterior-derived cell lines
(A2 and P2) (GEO accession number GSE38370). For example,
levels of Etv4 and Etv5 mRNAs (known to be expressed in the
distal limb mesenchyme and important for the posterior restriction
of Shh expression) (Mao et al., 2009) were higher in the anterior
cells than in posterior cells, whereas expression of other ETS
factors that define the spatial boundary of Shh were higher in the
posterior cells (Ets1) or similar (Gabpa) throughout the distal limb
bud (Lettice et al., 2012) (Fig. 1C). Genes involved in
mesenchymal-epithelial signalling and distal limb patterning were
upregulated in anterior (Bmp4, Spry4) and posterior (Twist1) cells
or expressed evenly across the A-P axis (Fgf10). Among the genes
with the highest ratio of expression in the posterior cells were those
involved in retinoid signalling, and in chondrogenesis, osteogenesis
or myogenesis (Fig. 1C).
Gene ontology analysis (GOrilla) indicated that the most
significantly different A/P expression levels were for genes
enriched for GO Biological Process terms (P<10–9) such as A-P
axis and pattern specification, anatomical structure morphogenesis
and embryonic skeletal system morphogenesis – categories that
reflect the cell lines’ origins from mesenchymal tissue of the A-P
axis of a developing appendage (supplementary material Fig. S1).
Cell lines reflect differential 5 Hoxd gene
expression in distal posterior limb bud
Spatial expression domains of Hoxd genes in E10.5 limb buds are
well characterised (Spitz et al., 2003; Spitz et al., 2005; Tarchini
and Duboule, 2006; Zakany and Duboule, 2007). We used RT-PCR
and qRT-PCR on both sets of cell lines and on tissue dissected from
E10.5 anterior and posterior forelimb buds to determine how
relevant the limb cell lines are for analysis of HoxD spatial
regulation.
Hoxd1 mRNA was not detected in any of the cell lines and only
very faintly in anterior limb tissue (Fig. 2A). Hoxd3 expression was
detected at generally low levels (Fig. 2A) that are similar between
the anterior and posterior limb tissue and the corresponding cell lines,
except for even lower levels in P2 cells (Fig. 2B). There was no
significant A/P difference in Hoxd3 expression in either cell line
pairs or limb tissue (Fig. 2C). Conversely, at the 5 end of HoxD,
Hoxd13 expression levels were 17-fold higher in posterior limb and
limb-derived cell lines than in anterior equivalents (Fig. 2C). A2/ P2
cell lines showed expression levels similar to those in anterior and
posterior tissue, but levels in A1/P1 were both proportionally lower
(Fig. 2B). We observed slightly higher Hoxd12 expression in the
posterior limb tissue than in the anterior, and higher Hoxd11 in P1
compared with A1 cells, but their expression levels of were both too
low for reliable quantification. Hoxd10 expression showed a high
A/P difference in both cell line pairs; the apparent large difference
(Fig. 2C) measured in the A1/P1 cell lines is due to the very low
expression levels in A1. Hoxd8 expression showed an A/P
differential (threefold higher in P2 than in A2) in the second cell 
line pair only due to its increased expression in P2 cells, expression 
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Fig. 1. Characterisation of cell lines from distal posterior and
anterior mouse forelimb. (A)Schematic of E10.5 forelimb bud
showing the dissection into anterior (A) and posterior (P) distal regions.
(B)RT-PCR to detect the expression of mesenchymal (Fgf10, Fgf2cR,
Etv4) and epithelial (Fgf8, Fgf2cR) markers in immortomouse cell lines
derived from the anterior (A) or posterior (P). The two cell line pairs
derive from embryos from different litters. Primer sequences are
indicated in supplementary material Table S1. –, negative control
lacking reverse transcriptase. (C)Log2 A/P expression from microarray













levels in A2, A1 and P1 being similar to limb tissue (Fig. 2B,C).
No A/P difference in Hoxd8 expression was detected in the E10.5
limb tissue. This suggests that both cell line pairs capture cells that
have activated 5 Hoxd genes specifically in the posterior
compartment at the start of the second wave of HoxD activation in
the distal limb and that this activation has a greater extension 3 in
the 2P cell line (to Hoxd8) than it does in 1P cells (Hoxd10). Gene
activation extends more 3 in both posterior-derived cell lines than
in the limb tissue. This could be due to the outgrowth of cells that
have more extensive gene activation than the average in the
posterior limb or, more likely, that the regulatory mechanisms
driving progressive 5-3 HoxD activation continue operating for
some time after tissue dissection and during cell immortalisation.
Beyond Hoxd13, Evx2 expression was not be detected in cell
lines (data not shown) suggesting that the cells might originate
from outside of the small Evx2 expression domain at the extreme
distal margin of the E10.5 forelimb bud (Tarchini and Duboule,
2006). Shh expression was also not detected, suggesting that it is
not required for maintenance of the second wave of HoxD
activation, at least in cell lines, as has been previously proposed
(Harfe et al., 2004).
Although both immortomouse-derived distal limb cell line pairs
show an A/P difference in 5 HoxD activity, the A2/P2 pair show
a more extensive domain of activation (Hoxd13 to Hoxd8) and so
were chosen for further study.
Loss of H3K27me3 over the HoxD cluster in
posterior cells
The PRC2 polycomb complex is fundamental to regulation of Hox
gene clusters during ES cell differentiation and early
embryogenesis and is responsible for blanketing HoxD with
H3K27me3 (Boyer et al., 2006; Lee et al., 2006). Polarised (3-5)
loss of H3K27me3 accompanies 3 Hoxd gene activation during
ES cell differentiation (Eskeland et al., 2010) and in the tail bud of
the primary axis during early embryogenesis (Soshnikova and
Duboule, 2009). PRC2 function in the limb is required for cell
survival and for proximodistal elongation of the limb (Wyngaarden
et al., 2011), but whether differential polycomb-mediated
chromatin changes are involved in regulating A-P Hoxd gene
expression during the late phase of distal limb patterning is unclear.
Immunoblotting shows similar H3K27me3 levels globally in A2
and P2 cells (Fig. 3A). Using native ChIP (nChIP) combined with
custom high-density tiling arrays covering multiple regions of the
mouse genome, including Hox loci (Eskeland et al., 2010), we
determined the H3K27me3 profile of the A2/P2 distal forelimb-
derived cell lines (Fig. 3B) (GEO accession number GSE38526).
H3K27me3 is pervasive over HoxD in anterior cells, with both
the 5 and 3 (Hoxd1-d4) genes densely covered (Fig. 3B). The dip
in H3K27me3 between Hoxd4 and Hoxd8, is similar to that seen in
ES cells (Eskeland et al., 2010). Whereas H3K27me3 still blankets
Hoxd1-d3 in posterior (P2) cells, it is largely absent over the 5
genes (Fig. 3B,C, upper two tracks). Beyond Hoxd13, H3K27me3
covers Evx2 in both cell lines. In contrast to ES cells, in which both
HoxB and HoxD loci are both blanketed (Eskeland et al., 2010),
H3K27me3 is largely absent from HoxB in A2 and P2 cell lines,
with only Hoxb13 enriched, emphasising the particular regulation
of HoxD across the A-P limb axis. As controls, the Pax6 polycomb
target was blanketed with H3K27me3 in both anterior and
posterior, whereas H3K27me3 was absent from the widely
expressed Brd3.
Of those arrayed probes significantly enriched in H3K27me3 in
anterior cells (log2 H3K27me3/input≥1) (Fig. 3E, upper pie chart)
only 8% are from HoxD. Yet 93% of probes with an at least twofold
(log2≥1) A/P difference in H3K27me3 enrichment are from this
locus and 88% are from 5 HoxD (Fig. 3E, lower pie chart). By
contrast, only 2% of probes with at least twofold A/P H3K27me3
difference are from HoxA. Therefore, extensive A/P differences in
H3K27me3 are specific to HoxD in these cell lines. Quantitative
PCR (qPCR) confirmed the lower H3K27me3 levels in P2 versus A2
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Fig. 2. Hoxd expression in distal anterior and posterior limb cell
lines and mouse tissue. (A)RT-PCR to detect the expression of 3
(Hoxd1, Hoxd3, Hoxd4, Hoxd8) and 5 (Hoxd10, Hoxd11, Hoxd12,
Hoxd13) Hoxd genes and the adjacent Lnp in both sets of cell lines (A1/
P1, A2/P2) and in E10.5 distal forelimb tissue (A and P). Primer
sequences are indicated in supplementary material Table S1.
(B,C)Quantitative (q)RT-PCR to compare expression levels of 3 (Hoxd3,
Hoxd8) and 5 (Hoxd10, Hoxd13) Hoxd genes in both sets of cell lines
and in anterior or posterior distal forelimb tissue. (B)Expression in each
cell line compared with the corresponding limb tissue. (C)Log2 P/A
expression for both sets of cell lines (white and grey bars) and in distal
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Fig. 3. H3K27me3 and Ring1B distribution in E10.5 limb cell lines and mouse forelimb tissue. (A)Western blot of H3K27me3 in A2 and P2
cells. Levels of H3 are shown for comparison. (B)Mean log2 H3K27me3/input at HoxD, HoxB, Pax6 and Brd3 loci in A2 and P2 cell lines (top two
rows, n2 biological replicates) and for anterior and posterior forelimb tissue (bottom two rows, n4 – 2 biological and 2 technical – replicates).
(C)As in B, but with an expanded view of the HoxD cluster. (D)Mean log2 Ring1B/input at the HoxD region for anterior and posterior forelimb
tissue. n2 biological replicates. (E)Pie charts showing the genomic distribution of different probes categories enriched for: (top) H3K27me3 in A2
cells (log2 H3K27me3/input≥1) versus (bottom) the proportion with an A2/P2 difference of log2≥1. (F)Mean (± s.e.m.) log2 H3K27me3/input at
HoxD and neighbouring genes and promoters in distal forelimb anterior and posterior tissue. Average log2 values were calculated from each
individual probe value that covered the genomic locations. The statistical significance of A:P differences in H3K27me3 enrichment over each gene











cells at Hoxd10 (Fig. 4A), with a less dramatic decrease at Hoxd1.
There was no significant A-P difference in H3K27me3 at Olig2
(positive control) or Actb (-actin, negative control).
The limb cell lines are apparently a relatively homogenous
mesenchymal cell population. By contrast, more heterogeneous cell
populations are inevitably present in dissected limb tissue, where
AER- and differentiating mesenchyme-derived cells expressing
different cohorts of Hoxd genes might mask differences in
H3K27me3 levels between the anterior and posterior mesenchyme.
Nevertheless, we analysed H3K27me3 in E10.5 anterior and
posterior dissected distal forelimbs (Fig. 3B,C, lower two tracks)
by nChIP. An H3K27me3 block covered the 3 end of HoxD (d1-
d4) in both limb regions. Both anterior and posterior limb samples
also show a second block of modification over the 5 end of HoxD,
from Hoxd9 through to Evx2, but this was at a significantly higher
level in anterior compared with the posterior region (Hoxd13-
Hoxd10; P<0.0001) (Fig. 3F; supplementary material Fig. S2A).
Whereas in the anterior distal limb H3K27me3 remains high from
Evx2 to beyond Hoxd12, in the posterior H3K27me3 declines from
the Evx2-Hoxd13 intergenic region up to Hoxd11 (Fig. 3C,F). This
A-P difference in H3K27me3 levels in limb tissue is specific to 5
HoxD (supplementary material Fig. S2B), being significantly
greater (P<0.0001) than that for all Hox loci combined. The A-P
difference for the 3 HoxD region is not significant (P0.57).
H3K27me3 was more pervasive over the HoxB locus in cells
dissected from the anterior or posterior limb tissues than in the cell
lines (Fig. 3B), probably reflecting the heterogeneity of the former
cell populations, and, unlike for HoxD, there were no differences
between H3K27me3 at HoxB in anterior versus posterior limb.
Lower H3K27me3 levels at the Hoxd10 promoter in the posterior
versus anterior limb tissue cell populations was confirmed by qPCR,
whereas levels at the Hoxd1 promoter were similar in both distal
limb samples (Fig. 4B). These data are consistent with a role for
polycomb-mediated repression in regulating A-P differences in Hoxd
expression during the patterning of the distal limb.
PRC1 levels are reduced over HoxD in distal
posterior cells
The PRC1 complex recognises and binds to H3K27me3-modified
chromatin to bring about chromatin compaction and gene
repression. The ChIP profile of the PRC1 component Ring1B
(Rnf2 – Mouse Genome Informatics) correlates with that of
H3K27me3 in E10.5 anterior and posterior dissected limb bud
tissues at HoxD (Fig. 3C,D), HoxB and Pax6 (supplementary
material Fig. S2C). A block of Ring1B extends from Evx2 to
Hoxd9 in distal anterior limb, whereas in posterior tissue Ring1B
coverage is more sparse over Hoxd13-11. The A/P difference in
Ring1B levels was significant throughout 5 HoxD (promoters,
genes and intergenic; P<0.0001) (supplementary material Fig.
S2D) and was greater than at all the Hox loci combined (P<0.0001)
(supplementary material Fig. S2E).
A-P differences in chromatin compaction at HoxD
in the distal limb bud
PRC1 brings about a chromatin compaction at target loci that is
detectable by measuring the spatial separation of fluorescence in
situ hybridisation (FISH) signals from closely apposed probe pairs
(Eskeland et al., 2010) (Fig. 5A). Using these approaches, a
decompaction of HoxD is seen as Hox genes are activated during
ES cell differentiation and in the tail-bud of the embryo (Morey et
al., 2007). We first used 2D FISH to assay chromatin compaction
(d2) across HoxD in limb bud cell lines. Any difference in inter-
probe distances due to variation in nuclear size between cell lines
was also assessed by normalising d2 to the nuclear radius (r2).
However, in practice the same conclusions were reached when
considering interprobe separation without normalisation to nuclear
size (supplementary material Table S4).
Chromatin across HoxD (Hoxd3-Hoxd13) was significantly less
compact in both distal posterior cell lines compared with the
anterior cell lines (P0.0002 and P0.03 for A1/P1 and A2/P2,
respectively) (Fig. 5B; supplementary material Table S4). This was
restricted to the region with differential H3K27me3, as there is no
significant A-P difference in compaction of the GCR-Lnp region 5
of HoxD where similarly low levels of H3K27me3 are seen
between A and P cell lines (Fig. 3B). Nor was there differential
compaction at a control region around Pax6 (Rcn-Rpl10) on the
same chromosome (MMU2) as HoxD, and which contains genes
with no known role in limb development and no differential
expression between A and P cell lines.
We sought confirmation of differential HoxD compaction by 3D
FISH in E10.5-11.0 embryo tissue sections cut through the anterior
and posterior regions of the forelimb (Fig. 6A). Here, not only were
we able to compare the distal anterior and posterior regions, but
also more proximal limb regions and indeed the flank region
adjacent to the forelimb bud tissue where Hoxd genes are not
expressed. As observed in the cell lines, HoxD chromatin was
significantly less compact (d2) at the distal posterior forelimb bud
compared with the distal anterior (P0.0008) but also compared
with other limb and non-limb regions analysed (proximal posterior,
P0.02; proximal anterior, P0.0002; flank, P0.0002) (Fig. 6B;
supplementary material Table S5). There was no significant
difference in HoxD chromatin compaction between any of the other
limb regions or even between these other limb regions and the
flank tissue. Likewise, no significant differences in chromatin
compaction could be identified between any of the tissue regions,
including the distal forelimb bud, at the GCR-Lnp and the Rcn-
Rpl10 control regions (Fig. 6B; supplementary material Table S5).
Analysis of the frequency of hybridisation signals separated
by defined distance (d) intervals also demonstrates the less
compact chromatin conformation of the HoxD locus compared
with the adjacent GCR-Lnp region. The proportion of
colocalised signals (<200 nm) was less for Hoxd3-Hoxd13 than
both GCR-Lnp (with a similar genomic distance) and the Rcn-
Rpl10 control region, which has a larger genomic distance
separating the two probes (supplementary material Fig. S3).
Conversely, the proportion of signal pairs >400 nm apart was
greater for Hoxd3-Hoxd13 than for the other two regions. The
subpopulation of HoxD probe pairs separated by >600 nm
RESEARCH ARTICLE Development 139 (17)
Fig. 4. Confirmation of A/P differences in H3K27me3 enrichment.
(A)qPCR analysis of ChIP for H3K27me3 at Hoxd1, Hoxd10, Olig2 and
Actb (Actin) promoters in A2 (white) and P2 (black) cells. Enrichment is
shown as mean percent input bound ± s.e.m. over three biological
replicates. (B)As in A, but from E10.5 distal anterior (white) and











(~25%) was significantly greater in the distal posterior forelimb
compared with the rest of the limb regions and the adjacent flank
(distal anterior, P0.0001; proximal posterior, P0.0001;
proximal anterior, P0.001; flank, P<0.0001) (supplementary
material Fig. S3 and Table S6). We conclude that chromatin
unfolding at HoxD accompanies the start of the second wave of
Hoxd gene activation during limb development.
Nuclear colocalisation of the GCR and 5 HoxD in
distal posterior cells
Developmental stage E10.5 marks the start of the later phase of
distal limb development, characterised by ‘quantitative collinearity’
in which strong expression of Hoxd13 is initiated in the distal
margin of the posterior mesenchyme. This is driven by enhancer
elements located 5 of HoxD, the best characterised of which is the
GCR ~180 kb centromeric of Hoxd13 (Fig. 3B, Fig. 5A)
(Montavon et al., 2008).
One possible mechanism for long-range cis-regulation invokes
the spatial colocalisation of the enhancer and target promoter
(Williamson et al., 2011). Indeed, modelling of gene expression
changes that occur as a consequence of 5 HoxD deletions led to
the suggestion that the first step in 5 Hoxd gene activation in the
distal posterior limb bud might be a long-range interaction
(looping) between regulatory sequences such as GCR and the
Hoxd13 region (Montavon et al., 2008). To test this model, we
analysed the hybridisation signals for the GCR and Hoxd13 regions
and determined the proportion that colocalised (d<200nm).
Multiple areas within the E11.0 limb bud were analysed (Fig. 7A),
including those where late phase gene activation initiates (distal
posterior); where it is poised for later activation (distal anterior);
where the early phase of 3-5 Hoxd gene activation, which does
not depend on the GCR, has occurred (proximal limb); and then in
the control flank mesoderm.
In contrast to the Hoxd3-d13 region, average GCR-Hoxd13
interprobe distances (d2) were significantly smaller in the posterior
distal limb bud compared with distal anterior (P0.04) and also
compared with the flank (P<0.0001), the proximal anterior
(P0.02) and proximal posterior (P0.002) (Fig. 7B;
supplementary material Table S7). This was not seen for distances
between GCR and a probe at the 3 end of Lnp (Fig. 6B) indicating
that there is not a simple compaction of the whole region 5 of
Hoxd13. Moreover, the proportion of alleles for which GCR and
Hoxd13 probe signals were spatially colocalised (d<200nm) was
far higher in posterior distal limb (>30%) than in all other areas
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Fig. 5. Chromatin decompaction at HoxD in distal posterior limb cells. (A)Schematic of the genomic region around HoxD. The grey boxes
above depict the probes used for FISH. Regulatory elements including the GCR and the PROX enhancer are also indicated. (B)2D FISH with probe
pairs at HoxD, the region centromeric to HoxD (GCR-Lnp) and a control region on MMU2, in A1 and P1 nuclei counterstained with DAPI (blue).
Scale bars: 5m. Probe positions are shown above the images. Box plots show the distribution of interprobe distances (d2) normalised to nuclear
radius (r2) for A1 and P1 cells. Shaded boxes show the median and interquartile range of data; crosses indicate outliers. n~400 for HoxD, n~300












tested (Fig. 7C; supplementary material Fig. S4A and Table S8).
These data are consistent with the formation of a chromatin loop
between Hoxd13 and the GCR regulatory module at the time and
place of distal limb bud development when the GCR participates
in initiating HoxD collinearity and Hoxd13 expression.
Recently, 4C analysis was used to identify sequences that could
be captured together with Hoxd13 by cross-linking in tissue from
across the distal limb at E12.5, a later stage of limb development
than that studied here (Montavon et al., 2011). This identified
multiple new potential regulatory regions in the extensive gene
desert centromeric of HoxD and located far beyond the GCR. It
was suggested that these elements might simultaneously interact
with each other and with 5 HoxD in the distal limb to form a
compact regulatory hub. One of these new elements, island III, is
~200 kb centromeric of the GCR. We measured the physical
separation between the island III region and the GCR – a genomic
distance equivalent to that separating GCR from Hoxd13 (~200 kb)
– and also between the island III region and Hoxd13 (Fig. 5A) in
E11.0 limb buds. We did not detect any significantly increased
frequency of colocalisation between island III and Hoxd13 or
between island III and GCR in posterior distal limb, compared with
other forelimb regions (Fig. 7C; supplementary material Fig.
S4B,C and Table S8). However, average interprobe distances (d2)
between 5 HoxD and island III are similar to those between 5
HoxD-GCR and GCR-island III despite the former being double
the genomic distance, and the compaction of the island III-Hoxd13
RESEARCH ARTICLE Development 139 (17)
Fig. 6. Decompaction of HoxD specific to the distal posterior region of E11 mouse forelimbs. (A)FISH on anterior and posterior tissue
sections. Schematic above indicates the position and plane of the sections. Below are examples of nuclei from each of the limb regions and the
adjacent flank, hybridised with HoxD probe pairs. Scale bars: 5m. (B)Box plots show the distribution of interprobe distances (d2) at the HoxD,
GCR and control loci for the proximal and distal anterior and posterior forelimb bud and the adjacent flank. n100 for HoxD, n>80 for GCR, n>80











region is higher in distal limb than in the proximal region (Fig. 7;
supplementary material Table S7). These data suggest that the
entire ~400 kb genomic region from the 5 end of HoxD into the
centromeric gene desert is configured in a relatively compact, yet
flexible, conformation.
DISCUSSION
Differential 5 Hoxd gene expression across the
limb A-P axis in mouse E10.5 embryos
We have shown that immortalised cell lines derived from the
anterior versus posterior E10.5 distal limb sustain global expression
patterns consistent with their mesenchymal origin from the limb
during A-P axis specification (Fig. 1). Moreover, they maintain
some of the differential Hoxd gene expression patterns of the
temporal developmental stage from which they are derived (Fig.
2). Limb-specific secondary activation of HoxD initiates in the
distal posterior forelimb bud at ~E10.5 in the mouse. We confirmed
that 5 Hoxd gene expression is significantly higher in distal
posterior E10.5 cells relative to distal anterior (Fig. 2),
commensurate with the spatial and temporal aspects of late phase
collinearity (Spitz et al., 2003). This A-P difference is lost by
E11.5-12.5 as the 5 genes are activated in more distal anterior
regions, but with Hoxd13 still being the most strongly expressed
(supplementary material Fig. S5) (Montavon et al., 2008).
A model for late phase HoxD activation in the distal limb proposes
a reciprocal activation pathway involving restriction of earlier 5
Hoxd expression to the posterior margin of the limb bud that then
ensures posterior-only Shh activation, which in turn effects the
initiation of secondary 5 Hoxd expression in the distal posterior limb
bud (Harfe et al., 2004; Robert and Lallemand, 2006). We did not
detect Shh expression in either (P1 or P2) posterior-derived cell lines,
which nonetheless maintain upregulated 5 Hoxd gene expression,
especially of Hoxd13 (Fig. 2). However, late phase Hoxd gene
expression still occurs in Shh–/– Gli3–/– mice, and is only reduced in
Shh–/– mice (Litingtung et al., 2002). Shh expression prevents Gli3
repression of 5 Hoxd genes, both by repressing Gli3 expression
posteriorly and by antagonising Gli3 processing to Gli3R (repressor
form). Gli3R has been suggested to be the repressor of 5 Hoxd gene
expression in anterior limb (Tarchini and Duboule, 2006). It is likely
that posterior Shh expression in the embryonic limb, up to the point
of cell immortalisation, was sufficient to activate late phase HoxD
expression. The subsequent strong maintenance of Hoxd13
expression in the posterior limb-derived cell lines suggests that Shh
is not required for maintaining HoxD activity. Lack of Shh
expression in cell lines could be due to the loss of interaction
between the mesenchyme and the overlying AER (Laufer et al.,
1994; Ogura et al., 1996).
Posteriorly restricted Hoxd expression is
accompanied by chromatin decompaction and
reduced polycomb binding
We identified differential H3K27me3 over 5 Hoxd genes between
anterior- and posterior-derived limb cell lines. In anterior cells,
there is extensive H3K27me3 over Hoxd13 towards Hoxd10 that is
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Fig. 7. GCR–5 HoxD
colocalisation at the E11 distal
posterior mouse forelimb bud.
(A)Nuclei from distal limb and flank
tissue sections after FISH with GCR
and 5 HoxD probe pairs. Scale bars:
5m. (B)FISH with probe pairs:
GCR–5 HoxD, GCR–island III and 5
HoxD–island III at distal and proximal
forelimb bud and flank regions.
n≥100 for each. Distribution of
interprobe distances as in Fig. 6B and
statistical analysis shown in
supplementary material Table S7.
(C)Percentage colocalised probe
pairs (d<200 nm) for each of the
genomic regions assayed in the distal
anterior, distal posterior, proximal
anterior, proximal posterior forelimb
bud and the flank. n100. Error bars
indicate s.e.m. obtained from two
different tissue sections. The
statistical significance of the
differences in colocalisation between
the limb regions and the flank were
examined by Fisher’s exact test












absent from posterior cells (Fig. 3). That this contributes to the
repression of 5 Hoxd genes in the anterior distal limb is consistent
with the ectopic anterior expression of Hoxd11 and Hoxd13 in
E10.5 limb buds after ablation of the PRC2 component Ezh2
(Wyngaarden et al., 2011). As Hoxd genes have been
transcriptionally active during the earlier phase of limb
development, we cannot determine whether there is active
H3K27me3 removal from 5 HoxD in cells of the posterior distal
E10.5 limb, or re-establishment of H3K27me3 in anterior distal
cells. The presence of H3K27me3 over 3 HoxD in both anterior
and posterior cell lines and in limb tissue probably represents a re-
imposition of this histone mark after the initial phase of Hoxd gene
expression in early, proximal limb bud development (Fig. 3).
Late phase 5 Hoxd gene expression in the posterior distal limb
bud is also accompanied by reduced Ring1B binding (Fig. 3;
supplementary material Fig. S2). Consistent with a requirement for
PRC1 to maintain Hox clusters in a silent, compact chromatin state
in ES cells (Eskeland et al., 2010), we found differential chromatin
compaction at HoxD both between the anterior- and posterior-
derived limb cell lines and in limb tissue (Figs 5, 6), with a greater
degree of decompaction in cells from the posterior distal region
than in cells measured in any other region of the limb bud at this
stage of development (Fig. 6). Our data suggest that dynamic
polycomb-mediated control of HoxD expression and higher-order
chromatin structure, previously described as occurring along the
main A-P body axis (Morey et al., 2007; Soshnikova and Duboule,
2009) is recapitulated during limb-specific Hoxd gene expression.
Enhancer-promoter looping restricted to the
posterior distal region of the limb bud
We observed a closer average proximity, and higher absolute
colocalisation frequency, of the GCR to Hoxd13 specifically at the
distal posterior limb bud (Fig. 7; supplementary material Fig. S4A),
consistent with the formation of a chromatin loop between enhancers
of the GCR and the 5 HoxD at the time and place of distal limb bud
development when the GCR is involved in initiating HoxD
quantitative collinearity and Hoxd13 expression (Spitz et al., 2003;
Montavon et al., 2008). Our analysis at single cell resolution is
consistent with average interaction frequencies captured between the
5 HoxD region and GCR by 4C analysis in the limb bud (Montavon
et al., 2011), although there was no analysis of anterior versus
posterior regions of the limb in that study. By contrast, we did not
find significantly increased colocalisation of 5 HoxD and a more
distal regulatory region (island III) (Fig. 7C; supplementary material
Fig. S4C) previously identified by 4C analysis. However, that study
was conducted at a later developmental stage (E12.5) and any
colocalisation might therefore occur later than E11. Our analysis
does indicate that the ~400 kb region extending out from the 5
HoxD locus into the adjacent gene desert is in a generally compact
chromatin conformation in all the limb regions tested (Fig. 7A,B;
supplementary material Table S7). Thus, the entire regulatory
domain may be configured to minimise the nuclear search space for
enhancer-gene interactions to then occur at the correct time and
place. Further analyses over the entire temporal stage of late phase
HoxD activity (E10.5-12.5) and across the A-P distal axis should
clarify the spatial and temporal specificity of the multiple regulatory
elements. We could not assess the colocalisation of the Prox
regulatory element (Fig. 5A) as it is too close to Hoxd13 for us to
resolve by FISH.
This article demonstrates that complex higher-order chromatin
dynamics is implicated in the regulation of Hoxd gene expression
during distal limb development, with two different processes
occurring: chromatin decompaction and looping. It also establishes
immortomouse-derived cell lines as a tractable model system to
investigate chromatin states in relation to spatiotemporally
regulated gene expression in development. This is the first
demonstration of differential chromatin compaction and enhancer-
gene colocalisation across the A-P axis of the developing limb, as
a previous study analysing the spatial colocalisation of Shh and its
limb enhancer reported similar colocalisation in both posterior
(Shh-expressing) and anterior (no Shh expression) limb regions
(Amano et al., 2009).
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Sonic hedgehog (Shh) expression during limb devel-
opment is crucial for specifying the identity and
number of digits. The spatial pattern of Shh expres-
sion is restricted to a region called the zone of polar-
izing activity (ZPA), and this expression is controlled
from a long distance by the cis-regulator ZRS. Here,
members of two groups of ETS transcription factors
are shown to act directly at the ZRS mediating a
differential effect on Shh, defining its spatial expres-
sion pattern. Occupancy at multiple GABPa/ETS1
sites regulates the position of the ZPA boundary,
whereas ETV4/ETV5 binding restricts expression
outside the ZPA. The ETS gene family is therefore
attributed with specifying the boundaries of the
classical ZPA. Two point mutations within the ZRS
change the profile of ETS binding and activate Shh
expression at an ectopic site in the limb bud. These
molecular changes define a pathogenetic mecha-
nism that leads to preaxial polydactyly (PPD).
INTRODUCTION
The zone of polarizing activity (ZPA) was experimentally defined
as the region located at the posterior margin of the developing
limb bud that determines digit number and identity (Hill, 2007;
Tickle, 2006). The polarizing activities attributed to the ZPA are
mediated by sonic hedgehog (SHH) which is postulated to act
as a diffusible morphogen. A number of models have been
proposed to explain Shh activity (Towers and Tickle, 2009) and
most recently, SHH was shown to act as both a morphogen
and a mitogen to coordinate digit formation by integrating
growth with digit specification during limb development (Towers
et al., 2008; Zhu et al., 2008). The restricted spatial expression
within the ZPA is an essential element of all the proposedmodels
of Shh function (Ahn and Joyner, 2004; Harfe et al., 2004; Yang
et al., 1997).
A critical step in understanding the complexity of Shh expres-
sion was the identification of the cis-regulatory element called
the ZRS for ZPA regulatory sequence (Lettice et al., 2002,Developm2003) (also called MFCS1 [Sagai et al., 2005]). The ZRS
comprises 800 bp of a multispecies conserved sequence
and encodes most, if not all, of the information that regulates
the spatiotemporal pattern of Shh expression in the developing
limb bud. The ZRS is the paradigm for long-range gene regula-
tion, operating over 1 Mb to regulate Shh (Lettice et al., 2003;
Sagai et al., 2005). Single point mutations in the human ZRS
are found in patients presenting with a range of limb skeletal
malformations. These include preaxial polydactyly type 2
(PPD2), triphalangeal thumb polysyndactyly (TPTPS), syndactyly
type IV (SD4), and Werner’s mesomelic syndrome (WMS),
collectively referred to as ZRS-associated syndromes (Lettice
et al., 2003, 2008; Farooq et al., 2010; Furniss et al., 2008; Gur-
nett et al., 2007; Semerci et al., 2009;Wieczorek et al., 2010). The
point mutations function to generate ectopic expression at the
anterior margin of the limb bud (Furniss et al., 2008; Lettice
et al., 2008), which is the underlying cause of PPD.
Here, members of the large group of ETS transcription factors
(Sharrocks, 2001) are shown to play distinct roles in the spatial
pattern of Shh. Occupancy at multiple ETS sites, which bind
the factors GABPa and ETS1, regulates the position of the Shh
expression boundary in the limb, thus defining the ZPA. Multiple
binding of ETV4 and ETV5 at the ZRS, in contrast, represses
ectopic Shh expression outside the ZPA. In addition, we show
that two PPD mutations disrupt the balance in number of ETS
binding sites derepressing expression in the anterior limb bud.
RESULTS
Multiple ETS Sites Identified in the ZRS
The notion of ‘‘homotypic clustering’’ (Gotea et al., 2010; Lifanov
et al., 2003; Wagner, 1999) suggests that cis-regulators contain
multiple sites for crucial regulatory factors. Analysis of the
ZRS identified a 7 bp motif (AGGAAG/AT) that is repeated five
times (Figure 1A), with each repetition located in a highly
conserved position (Figure S1A available online). This purine-
rich sequence is contained within the consensus for the 8 bp
ETS1 binding motif (C/G/AAGGAA
G/AT) found in putative distal
regulators of genes in T cells (Hollenhorst et al., 2009). None of
the numerous point mutations in the ZRS that cause limb defor-
mities fall within these conserved motifs; however, mutations
identified in two families with PPD2, Family A & C (AC) (Gurnett





Figure 1. Point Mutations Alter Shh Expression and Protein Binding Profiles
(A) Schematic showing the ZRS (yellow box), which resides within intron 5 of LMBR1, 1 Mb for the Shh gene. The positions of the ETS sites 1–5 and ETV sites A
and B identified within the ZRS aremarked by blue and green boxes, respectively. The sequences around themutations identified in families with PPD (Family AC
and AUS) are shown.
(B and C) Limbs from transgenic animals carrying wild-type (B) andmutant (C) ZRS reporter constructs (forelimb buds are shown on top and hindlimb buds below)
demonstrate that the AUS mutation results in expansion of the posterior expression (compare to B) and ectopic staining in the anterior mesenchyme (arrows).
(D–H) EMSA analysis of nuclear extracts from anterior (A) and posterior (P) halves of E11.5 limb buds.
(D) Nuclear extract was incubated with ds-oligos containing theWT, AC, or AUS sequence. TheWT sequence produced a specific band (1); the AC point mutation
resulted in a higher migrating band (2); and the AUS mutation produced a combination of WT and AC binding; bands 1 and 2. A nonspecific (NS) band was
observed for all ds-oligos.
(E–G) EMSA using the ACds-oligo (E),WT ds-oligo (F), and AUS ds-oligo (G), and using an unlabeled NS sequence, ETS consensus sequence (EtsCon),WT, or AC
oligonucleotide as their competitors.
(H) Comparison by EMSA of the binding for thewild-type ZRS sites 1–5, showing a greater extent of binding to the ACmutant site and sites 1 and 3. The unlabelled
AC oligonucleotide (lanes labeled +) specifically competes for band 2.
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ETS motifs (Figure 1A).
Transgenic analysis using a construct containing the ZRS
drives expression of the LacZ reporter gene in the expected
posterior position in the limb (Furniss et al., 2008; Lettice et al.,
2003, 2008) (Figure 1B). Addition of the AUS point mutation to
the ZRS was sufficient to drive the ectopic expression at the
anterior margin of E11.5 limb buds (Figure 1C, arrows). (The
number of transgenic embryos is reported in Table S1.)
The mutation also caused an overall increase in the width of
posterior expression such that the boundary extended deeper
into the middle of the limb (Figure 1C).
Differential Binding at the Mutant and Wild-Type
Sites of the ZRS
The protein-binding profile associated with the 7 bp motif was
analyzed by electrophoretic mobility shift assays (EMSAs) using
biotin-labeled double-strand oligonucleotide (ds-oligos) probes
and nuclear extracts from E11.5 embryonic limbs. Initially, the
AUS and AC mutant sites were analyzed using a series
of 24 bp ds-oligos (Figure 1A) spanning either the wild-type
sequence (WtB) or the mutant sequences. The WtB sequence
probe produced a single specific band (band1 in Figure 1D),
which was replaced by a higher migrating band in the presence
of the ACmutation (band 2 in Figure 1D). In comparison, the AUS
mutant probe exhibited a combination of both the WtB and AC
mutant band-shift patterns. Specificity of binding was confirmed
using unlabelled competitors for either theWtB or the ACmutant
sequence (Figures 1E–1G). An unrelated sequence (Fisher et al.,
1992) that contained the 8 bp ETS1 CAGGAAGT motif (desig-
nated EtsCon) competed for the upper band detected by both
the AC (Figure 1E) and AUS (Figure S1B) probes; whereas, the
WtB probe competed but with an appreciably lower affinity
(Figure 1F). In contrast, competition with the unlabelled WtB
sequence did not affect the AC banding pattern (Figure 1E) but
did disrupt binding of the lower band detected with the AUS
sequence (Figure 1G). These data are consistent with the two
point mutations binding similar proteins (Figure 1A) at closely
apposed positions. The two mutations affect wild-type protein
binding differently; whereas the AC mutation causes replace-
ment of wild-type binding, the AUS mutation allows binding of
either protein.
The five endogenous AGGAAG/AT sites within the 800bp ZRS
(Figure S1A) were also analyzed. ds-Oligo probes for sites 1, 2
and 3 each generated a band that migrated to the same position
as that for the AC probe (Figure 1H) and showed specificity for
binding by competition with the unlabelled AC probe. Site 4
probe did not detectably bind a protein while site 5 bound an
unidentified, higher migrating band which was not competed
with the AC sequence.
Identification of the Factors that Bind the ZRS In Vivo
A number of ETS family members are expressed in the early-
stage limb and are distributed along the distal mesenchyme.
Ets1 and Ets2 (Ristevski et al., 2002) (Figures 2A and 2B) are
expressed in the posterior mesenchyme overlapping the Shh
domain in the limb bud at E10.5 and by E11.5 extend distally,
incorporating the anterior margin (Figure 2A). Etv4 and Etv5
(also called Pea3 and Erm, respectively) (Figure 2C and 2D)Developm(Mao et al., 2009; Zhang et al., 2009) are expressed in the
mesenchyme along the entire distal edge.Gabpa (EMAGE:2836)
(Ristevski et al., 2004) is reportedly more highly expressed in
the distal mesenchyme in the posterior margin of the limb and
Elf1 (EMAGE:1462) is expressed throughout the entire limb
mesenchyme (Richardson et al., 2010).
To investigate the binding of candidate ETS proteins to the
ZRS sequences, we used ETS antibodies specific for ETS1,
ETS2, GABPa, ELF1, ETV4, and ETV5. Western blot analysis of
limb extracts (Figure 2E) showed that these proteins are
produced in both anterior and posterior halves of the limb bud
and are enriched in the nuclear extracts. EMSA analysis showed
that the anti-ETV4 (aETV4 in Figure 2F) antibody depleted the
binding of the wild-type protein responsible for the WtB banding
pattern, whereas the anti-ETS1 antibody (aETS1 in Figure 2F)
depleted the protein binding to the upper band of the AC
sequence. The other antibodies did not detectably affect the
banding pattern (data not shown).
The sequence that ETV4 binds encompasses the noncanoni-
cal site AGAAAAT (referred to as ETV4 site B) (Figures 1A and
S2A) (Xin et al., 1992). A second ETV4 binding site found to
contain the AGAAA sequence (referred to as site A) (Figures 1A
and S1) is the site of the previously published PPD2 mutation
Belg2 (Lettice et al., 2003). The Belg2 mutation, which converts
the sequence to AGGAA, was previously shown to drive ectopic
expression in transgenic assays (Lettice et al., 2008). EMSA
demonstrated that ETV4 binds the Belg2 wild-type ds-oligo
(WtA), as confirmed by depletion with the ETV4 antibody
(aETV4 in Figure 2G). Analysis of the mutant Belg2 sequence,
however, showed binding to an additional unidentified factor
(band 2 in Figure 2G).
To establish that ETS factors bind directly to the ZRS in the
limb, we performed chromatin immunoprecipitation (ChIP) in
nuclear extracts from whole autopods of E11.5 embryonic limbs
with the series of antibodies above. GABPa and ELF1 were of
particular interest, given that recent analysis of ETS1 binding
in vivo showed co-occupation by these factors at a substantial
subset of sites (Hollenhorst et al., 2007, 2009). In our initial
screen of the ChIP, neither the ETS2 nor the ELF1 antibody
showed any appreciable binding to the ZRS using qPCR (data
not shown). Further analysis using high-density tilingmicroarrays
showed the binding of both ETS1 and GABPa to the ZRS region
(Figure 2H). The binding profiles suggested that GABPa
occupied the whole region of the ZRS, whereas ETS1 binding
overlapped but was skewed toward the 30 end of the ZRS.
Accordingly, the two sites at the 30 end (sites 4 and 5) contain
the sequence AGGAAAT (Figure S1A), while the remaining sites
contain AGGAAGT. The Shh gene (Figure 2H), including the
promoter, and other control regions showed no binding to any
of these ETS factors. ELF1 was used as a negative control and
showed no binding (Figure 2H) at the ZRS, while appreciable
binding was detected at a clustering of AGGAAA sites located
near the 50 end of an uncharacterized SH3-containing gene
(30Hba, Figure 2H).
ETV4 and ETV5 act to repress Shh expression in the posterior
margin of the limb bud to ensure that no ectopic production
occurs (Mao et al., 2009; Zhang et al., 2009). In limb extracts,
both the anti-ETV4 and the anti-ETV5 antibodies detect binding
to the ZRS region (Figure 2H). ETV4 binding appeared as twoental Cell 22, 459–467, February 14, 2012 ª2012 Elsevier Inc. 461
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Figure 2. ETS Factors Are Expressed in the Limb and Bind to the ZRS
(A–D) Whole-mount in situ hybridization analysis for Ets1 (A), Ets2 (B), Etv4 (C), and Etv5 (D) are shown in E11.5 embryos and limb buds.
(E) Western blot analysis using antibodies raised against ETS factors, designated aETV4, aETV5, aETS2, aELF1, aETS1, and aGABPa, and against histone H3
(aH3) and actin (aactin), with nuclear extracts from the anterior (A) and posterior (P) halves of the limb buds (E11.5). Also shown is a comparison between limb
nuclear extracts (NE) and cytoplasmic extracts (CE). aH3 and aactin were used as loading controls.
(F) EMSA shows WtB and AC ds-oligo binding in nuclear extracts depleted for ETV4 or ETS1 using specific antibodies (aEtv4 and aEts1). (IgG was used as
a nonspecific control.) Extracts from anterior (A) or posterior (P) halves or whole limbs (L) from E11.5 limb buds were used. Band 1 observed with the WtB probe
was specifically depleted by the addition of aETV4 antibody, while Band shift 2 observed with the AC probe was specifically depleted by the addition of aETS1
antibody.
(G) EMSAs were conducted with ds-oligos containing the sequence for the wild-type ETV4 site A (WtA) or the Belg2 mutation (Bg). WtA ds-oligo shows a specific
band (1) while that for Bg sequence gives an additional higher migrating band (2). The anti-ETV4 antibody depletes Band 1 observed with WtA and Bg probes
(nonspecific IgG used as control).
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two predicted ETV4 sites. Surprisingly, ETV5 occupies a broad
region of >5 kb with a peak of binding over the whole of the
ZRS (Figure 2H). ETV5 binding is highly specific for the ZRS
region, as shown by the tiling microarray over the whole 1 Mb
of the Shh locus (Figure S2B). ETV5 binds the ZRS directly; the
broad region may reflect the high density of AGAAAG/A sites
available at nearby sites (Figure 2H).
Ets1 is expressed not only in the posterior mesenchyme but
also along the anterior margin overlapping the ectopic domain
driven by the AUS mutation (Figure 1C). To determine whether
ETS1 binds to the ZRS at both the anterior and the posterior
halves, we dissected limb buds at E11.5 for ChIP. qPCR showed
significant binding of ETS1 at the ZRS (Figure S2C) in both the
anterior and posterior halves, suggesting that the ZRS is open
for factor interactions on the quiescent as well as the active
side of the limb.
Ectopic Shh Expression Occurs by Two Mechanisms
We investigated two possible explanations for the ectopic
expression driven by the AUS point mutation. First, by displacing
the ETV4/ETV5 repressor at site B (Figure 1A), the binding of
GABPa/ETS1 to the mutant site may lead to ectopic activation.
To investigate this possibility, we generated two different
mutations that disrupt site B. Neither a terminal deletion of
44 bp (tDel, Figure 3A), which removes the entire site, nor
replacement of three base pairs within the ETV4 binding site
(AGAAAAT/AGAGCGT) (-ETVB, Figure 3B) caused ectopic
expression in transgenic embryos. In fact, expression levels
decreased but importantly, the spatial boundary appears unaf-
fected. Thus we tested a second possibility, specifically that
the AUS mutation, by creating an additional AGGAAGT site,
may directly drive ectopic activity. An extra AGGAAGT site was
added to the ZRS. A putative neutral position, a variable stretch
of Ts that differ in mammalian species (human has six Ts, mouse
has eight, and rat has 22), was selected as the site for the inser-
tion (Figure 3E). Themodified ZRS generated ectopic expression
activity (Figure 3G), whereas the control (insertion of seven Ts
[Figure 3E]) showed no detectable ectopic expression (Fig-
ure 3F). These data show that an additional GABPa/ETS1 site
is sufficient, on its own, to generate ectopic expression.
These analyses, as a consequence, raised questions about
the direct role ETV4/ETV5 plays in restricting ectopic expression
of Shh. To investigate the regulatory role of the ETV4/ETV5
proteins further, the three-base-pair replacement in site B, dis-
cussed above, was made in site A. Similar to the case with
loss of only site B, no ectopic expression was observed with
loss of site A (Figure 3C). The double mutation of both sites A
and B, however, resulted in ectopic expression along the distal,
anterior margin of the limb (Figure 3D). The simultaneous
removal created a loss of ETV function and confirms that this
ETV subfamily acts directly at the ZRS to restrict the expression
pattern of Shh to the posterior margin.(H) ChIP using antibodies to five different ETS factors (ETV4, ETV5, Elf1, ETS1, an
using three different genomic regions, the y axis is Log2 for each ChIP/input DNA a
containing the ZRS is highlighted by the gray shading. As controls, the whole of
a-globin locus (30Hba) are shown. Scale bars are shown at the top and the positio
sites at the bottom of each panel.
DevelopmThe Endogenous GABPa/ETS1 Sites Define the
Boundary of Shh Expression
To investigate the consequences of having multiple, clustered
ETS sites, the five endogenous sites in the ZRS were systemat-
ically inactivated (AGGAAG/AT/ CTTAA
G/AT) and evaluated by
the transgenic assay (Figures 3H–3Q). For each transgenic, the
relative domain widths of the limb buds were measured as
indicated in Figure 3H and plotted. The mean domain widths of
fore- and hindlimbs combined for each experimental group
were then compared. The mean size of the expression domain
was found to be highly significantly related to the combination
of ETS sites that were disrupted (analysis of variance [ANOVA]
p < 0.0001). The results of subsequent pairwise comparisons
(Tukey’s HSD test) are shown in Table S2.
Disruption of both sites 1 and 3 (the two sites that showed
highest affinity for ETS1 binding in vitro) (Figure 3L) resulted in
a significant reduction (p values in Table S2) in reporter-gene
expression as compared to the wild-type construct (Figure 3I),
whereas singly (Figure 3J), neither site detectably changed
limb-bud expression (Figures 3I–3K). Disruption of additional
sites resulted in no further reduction in the expression domain
(Figure 3H). The activity levels of sites 1 and 3 were further
analyzed. The sole presence of either one of these sites (Figures
3O and 3P) established boundaries of expression approaching
that of the wild-type construct, whereas the presence of both
1 and 3 together (Figure 3Q) generated a wide expression
domain that was indistinguishable. Sites 2, 4, and 5 (Figure 3L)
showed some activity, as in the presence of either site 1 or 3,
producing an expression domain similar to that of the wild-
type (Figure 3H).
The addition of the extra AUS mutant site caused a further
upregulation in transgenic embryos, with expression extending
deeper into the center of the limb (Figure 3H). The construct
carrying the AUSmutation but lacking site 1 showed little change
(Figure 3R), whereas, again, removing sites 1 and 3 caused
a retraction of the expression boundary (Figure 3S) but only to
the extent of that generated by the wild-type construct (Fig-
ure 3H). Further removal, deleting sites 1, 2 and 3 together (Fig-
ure 3T), or all five sites, caused little further change in expression,
suggesting that this single high-affinity site is sufficient for gener-
ating the wild-type transgenic expression. With the inclusion of
the AUS mutation, ectopic anterior expression occurs in the
limbs (Figure 1C); however, in the absence of both sites 1 and
3 the number of limbs with ectopic expression decreases from
83% to 33%, and in the absence of all five sites (Table S1), no
ectopic expression was detected, suggesting that the wild-
type ETS sites assist in the ectopic expression. In addition, an
earlier stage of limb development was examined (E10.5) using
constructs containing the wild-type ZRS, and with site 1 and
sites 1 and 3 disrupted and with the AUS mutation added. The
relative size differences of the expression domains were
unchanged; thus, no temporal differences were apparent (data
not shown).d GABPa) analyzed by hybridizing to tiling microarrays. Summary is presented
nd the x axis represents a segment of DNA from themicroarray. The DNA region
the Shh coding region plus promoter (Shh) and the region downstream of the
ns of potential ETS1/GABPa (AGGAAG/A) and ETV4/ETV5 (AGAAA
G/A) binding
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Figure 3. Transgenic Analysis of Embryos Carrying Mutant ZRS Sequences
(A–D) Limbs from transgenic embryos carrying the following mutant ZRS sequences: the 44 bp terminal deletion (tDel) (A), the 3 bp change in the ETV4 Site B
(-ETVB) (B), and Site A (-ETVA) (C). Disruption of both sites in combination (D) results in ectopic expression in the anterior of the limb.
(E–G) Position of the run of Tswithin the ZRS and the changes added are shown in red. Expression due to these changes is shown by comparison of the addition of
seven Ts (F) and the extra ETS1/GABPa site (AGGAAGT) (G). Ectopic expression is detected in (G).
(H) Graphical representation of the expression pattern resulting frommutations within the endogenous ETS sites. Expression pattern is the ratio of the width of the
expression domain divided by the width of the limb, expressed as a percentage (see p values in Table S2).
(I–Q) Examples of transgenic embryos for the ETS mutations analyzed are shown. The ETS sites remaining are depicted in the lower-left-hand corner of each
figure.
(R–T) Transgenic embryos that represent the addition of the AUS mutation in combination with ETS site mutations are shown. A close-up of a forelimb for each is
shown in the insets.
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Asymmetric expression is essential for SHH morphogen activity
in the developing limb. The ETS gene family plays a central role in
the Shh spatial pattern, both positioning the expression of Shh at
the posterior margin of the limb and repressing ectopic expres-
sion at the anterior margin. The limitation of the cell-free
approach to identify the full spectrum of ETS family members
was highlighted by the in vivo ChIP analysis, which identified
additional binding factors. The co-occupancy identified for
ETS1 and GABPa at the ZRS corresponds to the genome-wide
occupancy analysis of Hollenhorst et al. (2009), which shows464 Developmental Cell 22, 459–467, February 14, 2012 ª2012 Elsevthat the vast majority of GABPa sites colocalize with those that
bind ETS1 sites. In addition, the ChIP approach showed that
both ETV4 and ETV5 act directly at the ZRS. Even with the
resolution afforded by ChIP in combination with tiling microar-
rays, it is difficult to determine whether GABPa and ETS1 or
ETV4 and ETV5 are competing for the same sites; however,
the differences in profiles do suggest that there are site
preferences.
Redundancy within this large group of ETS factors compli-
cates both the biochemical and genetic analysis of gene func-
tion of individual family members. However, sequential inactiva-
tion of the ETS sites provided an approach to investigate theier Inc.
A
B
Figure 4. A Model Representing the Fine Balance
of ETS Factor Binding and Their Effects on Shh
Expression
(A) Representation of the expression patterns of the acti-
vating ETS factors (ETS1 and GABPa) and the repressing
ETS factors (ETV4 and ETV5).
(B) A summary diagram of how four of the transgenic
constructs are proposed to interact with the available ETS
factors in the limb, with the expression pattern observed
for each construct shown in the middle. The change in the
balance between activating and repressing activity rep-
resented on the right shows the relative balance in the
anterior and posterior margins of the limb. The size of the
lettering represents the relative amounts of the activating
and repressing activities.
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the Shh expression boundary delineating the experimentally
defined ZPA. Our data suggest that Shh expression is most
substantially affected by either site 1 or 3, and it appears that
the two sites act cumulatively to achieve the wild-type position
of the spatial boundary. Clearly, other sites participate given
that, for example, the boundary produced by site 1 is
augmented by the presence of sites 2, 4, and 5. The five
binding sites do not participate equivalently, and affinity of
binding, as detected in the EMSA, is probably part of the expla-
nation. The combinatorial nature of these sites is further sup-
ported by the addition of the AUS mutant site in the ZRS, which
causes extension of the expression boundary further into the
middle of the limb bud. This mutant binding site is the most
active of the sites analyzed and, on its own, is capable of
driving expression to the approximate boundary of that gener-
ated by the wild-type construct. ETS1 and GABPa are ex-
pressed at highest levels in the posterior domain of the limb.
We suggest that the levels of ETS1/GABPa and the multiple
binding sites act in concert to establish a regulatory balance
at the ZRS to, first, adjust the position of the Shh boundary
and, second, in combination with the repressive activity ofDevelopmental Cell 22, 459ETV4/ETV5, to restrict expression to the ZRS
(see summary in Figure 4).
Two ETV4/ETV5 binding sites were identified
in the ZRS. In transgenics, a single ETV binding
site is sufficient to repress ectopic expression;
the loss of both sites results in the loss of
repressor activity and as a consequence activa-
tion of ectopic expression. Previously, expres-
sion of both ETV4 and ETV5 in the distal mesen-
chyme of the limb bud was shown to be
maintained by FGF signaling emanating from
the AER (Mao et al., 2009; Zhang et al., 2009).
FGF is known to be essential for limb outgrowth
and maintenance of Shh expression. We show
that ETV4/ETV5 binding links FGF signaling
directly to regulation at the ZRS, showing an
unexpected role for FGF, acting through these
factors, to repress expression at the anterior
margin of the limb.
The AUS mutation has an additional pathoge-
netic activity, which is to drive ectopic expres-sion in the developing limb bud. We show that the wild-type sites
contribute to the ectopic expression but are dependent on the
additional activity provided by the extra binding site. Previous
data suggest that the ZRS is primed for activity in both the ante-
rior and posterior margins of the limb bud (Amano et al., 2009). In
accord, we show that the ZRS is open and fully capable of
binding to activating factors such as ETS1 in the anterior domain
of the limb bud. As a result, a new, mutant site such as that
produced by the AUS mutation would be capable of binding
ETS factors at both the normal and the ectopic domains of
expression. ETV4/ETV5 is crucial for ensuring that at the primed
ZRS, ectopic anterior expression does not occur during limb
development (Figure 4). The addition of an extra single high-
affinity ETS binding site (as with the AUS mutation) apparently
overrides ETV4/ETV5 repression, causing the loss of Shh spatial
restriction. These molecular events lead to the ectopic expres-
sion of Shh that underlies the preaxial polydactyly caused by
the AC and AUS mutations.
The high conservation throughout the 770 bp of the ZRS
suggests that there is scope for binding a complex mixture of
factors. The ETS factor binding sites are most likely functioning
alongwith the binding of other factors at the ZRS. In combination,–467, February 14, 2012 ª2012 Elsevier Inc. 465
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would not only delineate the boundary but also dictate precise
temporal activity. In addition, multiple ETS sites along with other
factorsmay encode an activity that is sufficiently robust to enable
long-range recognition and activation of the Shh promoter.
EXPERIMENTAL PROCEDURES
Materials
The antibodies used were: IgG (Santa Cruz, sc-2025), ETS1 (Maier et al.,
2003), ETS2 (a kind gift from R. M. Roberts), ETV4 (Abcam, ab860902),
ETV5 (Abcam, ab102010), GABPa (Santa Cruz, sc-22810), and ELF1 (Santa
Cruz, sc-631).
Transgenic Assay and In Situ Hybridization
Transgenic embryos were made and stained in accordance with standard
techniques (Lettice et al., 2003), and assembly of mutant ZRS constructs is
described in the Supplemental Information.Whole-mount in situ hybridizations
were described previously (Hecksher-Sørensen et al., 1998). The Etv4, Etv5,
and Ets2 probes were transcribed from EST cDNA clones (Geneservice),
whereas the Ets1 probe was generated by RT-PCR and cloned into pZero
(Invitrogen). Primers used to amplify Ets1 were 50-GGAGCATCTAGAGAT
CCTGC-30 and 50-CAGCCATCTCCTGTCCAGC-30.
Measuring the Depth of ZRS Staining and Statistical Analysis
Measurement of the extent of expression in each transgenic in the ZRS shown
in Figure 3H was measured in Photoshop and calculated as a percentage of
the width of the limb bud (to correct for stage differences between the
embryos), as shown in Figure 3H.
Statistical comparisons were performed using the statistical package
R (http://www.r-project.org/) (R Development Core Team, 2008). For these
comparisons, the hind- and forelimb data for each injected construct
were combined and a one-way analysis of variance (ANOVA) was used to
compare the mean values between each of the 19 groups. The result was
highly statistically significant. Therefore, further pairwise post-hoc tests were
performed to compare the individual groups using Tukey’s HSD (honestly
significant difference) test. The table of significance values is found in
Table S2.
Electrophoretic Mobility Shift Assays
Nuclear extracts were prepared directly from embryonic limb tissue (E11.5).
EMSA analysis is described in detail in the Supplemental Information.
Chromatin Immunoprecipitation and Tiling Microarrays
Cells from dissected E11.5 limbs were fixed with 1% formaldehyde (25C,
10 min) and stopped with 0.125 M glycine. Crosslinked ChIP was performed
as described (Stock et al., 2007). In brief, the nuclei were sonicated using a
Diagenode Bioruptor (Leige, full power 30 s on, 30 s off, in an ice bath for
50 min) to produce fragments of <300 bp. Chromatin (350 mg) was incubated
with 5 mg prebound (to Protein A or G magnetic beads, Invitrogen) IgG
(Santa Cruz, sc-2025) or antibodies raised to ETS1 (Maier et al., 2003), ETV4
(Abcam, ab860902), ETV5 (Abcam, ab102010), GABPa (Santa Cruz, sc-
22810), or ELF1 (Santa Cruz, sc-631) in the presence of 50 mg of BSA, washed,
and eluted. Reverse crosslinked DNA was purified with Proteinase K
(Glenaxxon) and QIAGEN PCR purification kit. ChIP DNA and input DNA
were amplified (WGA2 kit, Sigma), labeled, and hybridized according to the
manufacturer’s protocol to a 33 720,000 probe custommicroarray containing
specific tiled regions encompassing 8.2 megabases of the mouse genome
(Nimblegen). The array platform number is GPL14936 and the GEO accession
number for the ChIP data is GSE33997.
Microarray data were analyzed in R/Bioconductor (http://genomebiology.
com/2004/5/10/R80) with the Epigenome (PROT43) protocol (http://www.
epigenome-noe.net/WWW/researchtools/protocol.php?protid = 43) with the
following parameters. The mean signal intensity of the four replicate probes
on each array was taken. Loess normalization was used within arrays to
correct for the dye bias, and scale normalization was used within the repli-
cates group to control interarray variability. The log enrichment for each466 Developmental Cell 22, 459–467, February 14, 2012 ª2012 Elsevgroup was calculated by subtracting the mean of log2 input intensities
from the mean of log2 enriched intensities. Probes were tested for significant
enrichment using the significance analysis of microarrays (SAM) technique
(Tusher et al., 2001), and the local false discovery rate based on the SAM
statistic was calculated using the Locfdr R package (Efron, 2007). A false
discovery rate of 0.05 was used as the significance cutoff. The median value
of each probe was then calculated from a five-probe rolling window to
overcome outliers with values that are very different from their neighboring
probes.
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In mammals, long-range gene regulation became apparent through simple Mendelian disease genetics in
human and developmental genetics in the mouse. Can the insights into gene control, provided by the study
of these enhancers, help us understand the functional significance of sequence variation associated with
common/complex human disease and quantitative traits?Enhancers are cis-regulatory DNA se-
quences capable of inducing transcrip-
tion from a distant promoter and can be
located either upstream or downstream
of the activated gene. A plethora of such
candidate cis-regulatory regions are
being identified through their chromatin
signatures, including DNase hypersensi-
tivity, histone variants (H2A.Z), histone
modifications (histone H3 lysine 4 mono-
or dimethylation, histone H3 lysine 27
acetylation), bound cofactors (p300,
mediator), and even RNA polymerase II
itself. Functional studies are still in their
infancy, but tissue-specific enhancer
activity for a number of noncoding se-
quences has been demonstrated using
transgenic assays. Sequence conserva-
tion across species is also a guide to the
genomic location of some, but not all,
enhancers (Blow et al., 2010).
The Role of Distal Enhancers
in Evolution and Development
How did such cis-regulatory sequences
evolve? Whereas simple elements that
bind few factors may have arisen de
novo by small base changes, it seems
unlikely that complex enhancers could
have arisen this way. Possible routes are
the exaptation of retroposons to form
clusters of protein-binding motifs at new
genomic locations (Santangelo et al.,
2007; Sasaki et al., 2008) or the acquisi-
tion of novel regulatory functions by
promoters of archaic geneswhose coding
sequences have been subsequently lost.
Existing enhancers may also evolve to
acquire new functions in development.
What are the evolutionary conse-
quences of mutation and/or deletion of
existing enhancers? Whereas alteration
of coding regions may have quite blunteffects on protein function, alterations at
enhancers have the potential to subtly
adjust levels of gene expression—a situa-
tion required for the evolution of quantita-
tive traits and response to environmental
stresses. Moreover, phenotypic effects
of mutating enhancers can be confined
to discrete tissues or developmental
stages and so could allow a preexisting
gene to be harnessed to a new develop-
mental scenario (Rebeiz et al., 2009). For
instance, neural-specific activation of
Lunapark and Evx2, situated between
the HoxD cluster and the global control
region (GCR), is regulated by enhancer
elements within the GCR. Co-option of
the GCR to then facilitate HoxD13-10 ex-
pression during limb development may
have been due to the accrual of mutations
to produce an element able to function in
the developing limb (Gonzalez et al.,
2007). A limb-specific enhancer of Prx1—
which promotes bone elongation in the
forelimb—is responsible for higher tran-
scription levels and more extensive
expression domains at key limb bud loca-
tions and embryonic stages in the fruit bat
(Cretekos et al., 2008). Replacing the
endogenous mouse enhancer with the
bat equivalent produced mouse embryos
with longer forelimbs but no morpholog-
ical effects in other organs where Prx1 is
expressed. Similarly, in transgenic mouse
assays, human-specific point mutations
within a highly conserved noncoding
element (HACNS1) confer a limb expres-
sion pattern, including the presumptive
anterior wrist and proximal thumb, that
appears human-specific compared to
that conferred by orthologous sequences
from nonhuman primates (Noonan and
McCallion, 2010). Human-specific dele-
tions, of mostly noncoding sequencesDevelopmental Cthat are highly conserved between chim-
panzees and other mammals, include
regions near the androgen receptor
locus and the neural-specific GADD45G
(McLean et al., 2011). These contain
tissue-specific enhancers whose loss
correlates with human-specific traits:
loss of secondary sexual characteristics
associated with androgen signaling and
the expansion of specific brain regions.
The Genomic Context of Enhancers
A sizeable proportion of enhancers are
situated tens to hundreds (even thou-
sands) of kilobases from their target
genes, often in large gene-poor regions.
Indeed, many genes with tight spatial
and/or temporal expression domains
tend to be located adjacent to such
gene deserts. The absence of other
neighboring genes could help ensure
regulatory specificity between enhancer
and promoter. An example of problems
that can arise from the promiscuous
action of enhancers placed within gene-
rich domains is illustrated by the ectopic
activation of neighboring genes when
the b-globin locus control region (LCR)
is integrated into a gene-rich domain
of housekeeping genes (Noordermeer
et al., 2008).
However, there must be specificity
between some enhancers and promoters.
The sonic hedgehog gene (Shh), which
codes for a morphogen directing cell
fate in several tissues during organogen-
esis, is adjacent to a gene desert contain-
ing at least three enhancers that are active
only within Shh-expressing tissues of the
embryonic brain. However, Shh expres-
sion during limb development is regulated
by another enhancer, the zone of polar-
izing activity regulatory sequence (ZRS),ell 21, July 19, 2011 ª2011 Elsevier Inc. 17
Figure 1. The Sonic Hedgehog Regulatory Region and Possible Mechanisms of Enhancer Activity
(A) Linear representation of genes (green boxes) at the Shh locus showing the location of long-range neural-specific and limb-specific enhancers (black boxes).
(B) Models of enhancer-promoter communication. Factors bound to the enhancer and promoter recruit chromatin-modifying factors that: reorganize the
intervening chromatin, with the factors themselves being the signal for gene activation (left), enable direct enhancer-promoter interaction by the formation of
chromatin ‘‘mini-loops’’ (middle), or allow for spatial colocalization of the enhancer and promoter, with looping out of the intervening chromosomal region (right).
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Forumsituated about 1megabase away, beyond
the neural enhancers and within an intron
of another gene (Lettice et al., 2003)
(Figure 1A). The ZRS bypasses both
the gene in which it is located and
a neighboring gene in order to activate
only Shh.
How Do Long-Range Enhancers
Activate Target Genes?
Enhancers are clusters of transcription
factor (TF) binding sites. There have been
three, not entirely mutually exclusive,
mechanisms proposed for enhancer-
gene communication (Figure 1B). In the
first, sequence-specific factors bound to
the enhancer and/or promoter recruit
further factors—perhaps even including
RNA polymerase—to reorganize chro-
matin throughout the intervening region
as the signal for gene activation (Bulger
and Groudine, 2010). Due to the large
genomic distances involved, and even18 Developmental Cell 21, July 19, 2011 ª20intervening promoters, this is unlikely to
be a feasible mechanism for very long-
range control, such as that at Shh. The
secondmechanismalso involves reorgan-
izing the intervening chromatin, but to
allow for direct enhancer-promoter inter-
action, possibly through a series of
‘‘mini’’ chromatin loops.
The third mechanism invokes the
spatial colocalization in the nucleus of
the enhancer and promoter, which can
then directly interact with each other if
the necessary factors are bound, looping
out the intervening region. An attractive
feature of this model is that it ensures
that an enhancer can activate the expres-
sion of only one gene at a time. However,
enhancer-promoter mediated looping
may be insufficient for gene activation.
Nuclear colocalization of the ZRS and
Shh is observed in both expressing and
nonexpressing halves of the developing
limb bud, but on the posterior side, the11 Elsevier Inc.active Shh locus is additionally extruded
from its chromosome territory (Amano
et al., 2009). A similar looping out from
chromosome territories is induced by an
ectopic b-globin LCR (Noordermeer
et al., 2008).
Does there need to be direct physical
interaction between enhancer and
promoter for activation of gene expres-
sion? Clustered TF binding sites at
enhancers might simply act to reduce
the effective nuclear search space of
these proteins for a promoter by diffu-
sion/nonspecific binding. Enhancer-
promoter specificity would then rely
upon shared high-affinity binding sites
for the same set of factors. Moreover,
enhancers themselves often bind RNA
polymerase II (De Santa et al., 2010) and
produce short noncoding (nc) RNAs (Kim
et al., 2010). Whether all such ncRNAs




Mutations associated with b-thalas-
saemia, an inherited disorder caused by
altered expression of globin genes, were
what first led to the identification of the
b-globin LCR. Deletions that affect an
enhancer’s function, or translocations
that separate enhancers from their
cognate promoters, are also the cause
of several simple Mendelian human
genetic diseases (Noonan & McCallion,
2010). Point mutations in the Shh ZRS in
preaxial polydactyly result in a gain of
function of enhancer activity and ectopic
activation of Shh expression in the ante-
rior limb bud (Lettice et al., 2003).
However, almost half of single nucleo-
tide polymorphisms (SNPs) that show
statistical associations with common/
complex human disease and quantitative
traits in genome-wide association studies
(GWAS) are within noncoding regions
and gene deserts and thus potentially
involve enhancers (Noonan and McCal-
lion, 2010). For example, a SNP within an
intronic enhancer ofRET confers a greater
risk of Hirschsprung disease than the
major allele. SNPs in a gene desert
330 kb upstream of the c-myc protoonco-
gene are associated with greater risk
of several cancers (Wasserman et al.,
2010). Why might so much of the genetic
variation apparently associated with
complex human disease be in enhancers?
Whereas point mutations in protein cod-
ing regions can completely ablate gene
function and so produce strong and pene-
trant phenotypes, point mutations in an
enhancer may alter binding affinity for
a specific TF and so result in only subtle
changes in the level, time, or place of
gene expression. The resulting phenotype
could therefore be more modest and
subject to interaction with other genes
and with the environment.
Future Prospects
Our current lack of mechanistic under-
standing about how enhancers regulatetemporal and spatial patterns of expres-
sion from the correct target gene is
impeding exploitation of the investments
made in GWAS and the functional
analysis of human disease. What needs
to be done to better understand how
enhancerswork? The dearth of knowledge
on enhancer biochemistry needs to be
addressed in order to gain a more com-
plete understanding of how enhancers
integrate and process signaling informa-
tion that promotes transcription. Enhancer
elements function as nucleoprotein
complexes, with multiple associated se-
quence-specific and nonspecific binding
proteins. What are these proteins and
how do they act together? There could be
a high level of cooperative and coordinate
action between the bound TFs to give
unitary outputs to the transcriptional ma-
chinery, or they may instead form multiple
functional units that each independently
regulate gene expression. In the former
case, mutation of individual factor binding
sitesmayablateenhancer function,where-
as in the latter case they would be less
detrimental to enhancer function.
The precise chronological sequence of
chromatin events at enhancers is also to
be elucidated. Do direct physical
enhancer-promoter interactions only
occur once factors are bound to both
elements, or does the interaction itself
contribute to the loading of TFs or tran-
scriptional machinery to the promoter?
Current assays for long-range physical
interactions—fluorescence in situ hybrid-
ization (FISH) and chromosome confor-
mation capture (3C) and its derivatives—
only give snapshots or cell population-
averaged information, respectively. There
is a need for dynamic assays of chromo-
some organization to capture long-range
interactions as they occur in real time.
There is also a need for these techniques
to be coupled to methods for quantifying
levels of gene expression in single cells
at defined times and places in differentia-
tion and development.Developmental CREFERENCES
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